Western University

Scholarship@Western
Canadian Journal of Surgery

Digitized Special Collections

11-1-1979

Volume 22, issue 6
Canadian Medical Association

Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons

Recommended Citation
Canadian Medical Association, "Volume 22, issue 6" (1979). Canadian Journal of Surgery. 127.
https://ir.lib.uwo.ca/cjs/127

This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western.
It has been accepted for inclusion in Canadian Journal of Surgery by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Significance of Thymus-Dependent Lymphocytes
in the Biology of Human Breast Cancer
Carcinoma of the breast was the first
malignant tumour for which a TNM
classification was proposed by the In
ternational Union Against Cancer
(UICC) 25 years ago.1 The recognition
that the volume and distribution of
tumour burden is clinically important
has had a major impact on the man
agement of this disease. More re
cently, it has been appreciated that
the value of assessing anatomical
extent can be enhanced by including
postsurgical histopathological data.1
These data afford an opportunity to
improve therapy and prognosis. But
even with such advances in knowledge,
patients with stage I or stage II breast
tumours (UICC) form a highly hetero
geneous group in regard to the dura
tion of disease-free survival.
Evidently, additional factors must
play important roles in determining
the clinical expression of breast cancer.
Among these must be considered the '
interaction between the immune system
and the malignant tumour. Indeed, it
has been suggested that the degree of
tumour infiltration by lymphocytes
correlates directly with the duration of
survival.2 Particular attention has
focused on the potential role of the
adjacent lymph nodes in the control of
local disease and in the formation of
metastases. Support for such a concept
has come from experimental studies of
mixtures of tumour cells and lympho
cytes from regional nodes.3 Since the
effector mechanism in cell-mediated
immunity centres on the thymus-de
pendent lymphocyte (T cell), it is im
portant that there is general agreement
on the occurrence of a relative deple
tion of T cells in the regional lymph
nodes of patients with breast cancer,
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irrespective of nodal involvement by
tumour.4 Only occasional dissenting
data have been presented.5 Despite the
clarity of these associations, the biol
ogic role of nodal lymphocytes in breast
cancer remains unresolved.6’7
Lymphadenectomy restricts the study
of cell populations in regional nodes
to a single occasion in each patient
who has a mastectomy. However,
lymphocytes undergo continuous ex
change between solid lymphatic tis
sues, including nodes, and the cir
culating blood.8 Serial sampling of
peripheral blood will therefore provide
the opportunity to evaluate cellmediated immunity during the sub
sequent course of the disease. Often,
investigators have failed to take ac
count of several independent variables
when devising studies of peripheral
blood lymphocytes in patients with
breast cancer. For example, with ad
vancing age there is progressive T
lymphocytopenia6'11 and diminished re
sponsiveness to phytohemagglutinin.12"16
Again, immediately following opera
tion there may be transient T lympho
cytopenia17 and a reduction in respon
siveness to phytohemagglutinin for 1
to 2 weeks.17"20 Changes resulting from
radiation therapy are even more pro
nounced and can persist for years,13’21"24
while alterations in lymphocyte number
and function, due to cytotoxic chemo
therapy, are well recognized.
Finally, much of the published data
are based on retrospective analyses.
Such data, although often quoted,25 are
at best difficult to evaluate. Likewise,
reports on small numbers of patients26"29
and accounts lacking sufficient clinical
detail30"34 contribute little useful infor
mation.

The aim of studies on peripheral
blood lymphocytes in breast cancer
should be the determination of simple
prognostic indices. Although it may be
possible to achieve this for a single
therapeutic modality, such as oophor
ectomy,22’35 for the reasons already
outlined it is more likely that a
fruitful outcome will result from in
vestigations that begin in the un
treated patient. Papatestas and associ
ates36,37 have already demonstrated in
verse correlations between the pre
treatment absolute total lymphocyte
count in peripheral blood and meta
stasis and survival. The more sophis
ticated studies of the Cardiff group
have not revealed such strong prog
nostic associations,38"43 and their find
ings are supported by others.44 How
ever, all these studies failed to consider
adequately such variables as the long
term effects of radiotherapy.
Some of the reported abnormalities
in the numbers of T lymphocytes, re
sponsiveness to phytohemagglutinin
and even delayed hypersensitivity skin
reactions to recall and primary anti
gens,38’40"45 which have been described
in patients with breast cancer, may
reflect the inhibitory effect of a soluble
plasma factor.46"48 In such circum
stances, enumeration of T cells by a
cytochemical technique46 may be ad
vantageous.
Although the whole concept of the
immunologic surveillance of tumours
is currently being subjected to critical
reappraisal,50 it remains appropriate to
carry out well-designed, controlled
clinical studies of immunocompetence
in patients with breast cancer, with a
view to defining the role of the im
mune system in this disease,45 thus
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affording opportunities not only for
an understanding of endogenous dis
ease control (and its breakdown), but
also for the national development of
protocol for therapeutic immunomodulation.
R onald D. Barr,

md, frcp (glas),

M RC PATH

P eter B. M c C ulloch,

md, frcp [c]

Faculty of health sciences,
McMaster University,
Hamilton, Ont.
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Occult Signs of Sepsis
Management of the septic process has
evolved rapidly in recent years. Fulmi
nant septic shock, as a systemic sign of
sepsis, is not common at present be
cause of early recognition of the “sep
tic state” and effective management
with volume replacement, antibiotics,
drainage and inotropic agents. An in
creasing number of patients with major
sepsis are referred to surgical intensive
care units with syndromes that appear
entirely unrelated to their primary in
fectious problem.
The secondary manifestations of sep
sis have now become the hallmarks of
ongoing “occult” sepsis and should
prompt the search for, and drainage
of, the septic focus. These occult signs
or syndromes are respiratory failure,1,2
renal failure,3"4 gastrointestinal hemor
rhage,5 thrombocytopenia with or with
out bleeding6 and jaundice7’8 together
with shock. The shock may be mainly
hypovolemic because of major shifts
in the distribution of body fluids, or
may be classic septic shock with all
of its hyperdynamic manifestations. It
has become apparent that the treat
ment of the secondary occult signs
of sepsis is futile unless the primary
process is identified and effectively
managed. This management specifically
includes adequate drainage.
These points were well demonstrated
in the July issue (page 382) by Turcot
and associates. Their patient was trans
ferred from another hospital, apparent
ly because of primary respiratory fail
ure; upon arrival at the medical inten
sive care unit he was found also
to be hypotensive secondary to both
sepsis and hypovolemia. Within hours,
2000 ml of foul-smelling purulent ma

terial had been drained from the pleural
cavity which, with appropriate fluid
management, resolved the shock com
ponent of the man’s illness. It was not,
however, until the pericardium and
then the mediastinum had been drained
that the presenting syndrome, respira
tory failure, and the third occult sign,
jaundice, resolved. Experience in our
institution confirms this sequence and
further emphasizes the importance of
the concept that the secondary mani
festations of sepsis will not improve
until the last abscess is drained. The
continued presence of these occult ma
nifestations of sepsis is usually a sign
of inadequately drained infection.9
These secondary effects of sepsis do
not always resolve immediately after
complete drainage. Respiratory failure
takes a variable time to correct itself
because of wasting secondary to cata
bolism of major sepsis. The inefficiency
of the wasted respiratory musculature
adds to the original gas exchange ab
normality. Renal failure may resolve
promptly but, if dialysis is required, the
patient may have a relatively protracted
recovery.3,9 Septic shock and hemor
rhagic gastritis respond most promptly
once the hypovolemic component is re
solved, usually within hours of draining
the septic focus. Thrombocytopenia and
jaundice resolve in an intermediate
time period. We have had many pa
tients who presented with a single oc
cult sign which resolved with adequate
drainage.
The traditional signs of sepsis may
be absent or inadequate to identify the
patient with sepsis. Modern medicine
and surgical management, as exem
plified in intensive care units, are suf

ficiently sophisticated that the occult
signs of sepsis may be valuable guides
to identify the patients in w hom hidden
sepsis must be searched for and that
last abscess drained.
Jonathan L. Meakins,

md, frcs[c]

Department of surgery,
Royal Victoria Hospital,
Montreal, PQ
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Osteosarcoma
The results of treatment for osteosar
coma remained quite constant during
the years before 1970. The treatment
itself was relatively standard consisting
chiefly of amputation. Variations, in
cluding the use of Coley’s toxin, irra
diation of the lesion, irradiation of the
lungs, whole body irradiation, delayed
amputation and administration of
chemotherapeutic agents did not appre
VOLUME 22, NO. 6, NOVEMBER 1979 /

ciably affect the results. Five-year sur
vival ranged from 0% to 20% . Some
workers believed that amputation was
too mutilating a procedure for such
small benefit. Reports of survival better
than 20% were suspect and when such
high survival rates were given, the re
porters felt the need to emphasize that
their patients did in fact have osteo
sarcoma and not a less malignant condi

tion with which it might have been con
fused.1 At any rate this statistic remains
as the high figure for survival in that
era.2 Occasionally a metastatic lesion
was successfully resected from the lung
in a rather bold and radical gesture.
In a more systematic effort in 1971,
Martini and associates3 reported a
27% , 5-year cure rate using amputation
with resection of pulmonary metastases.
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CORRESPONDENCE

Use of Drains in
Cholecystectomy

To the coeditors: In the July issue (page
297) Dr. Marvin Wexler commented on
our paper “Cholecystectomy with and
without drainage” (page 358). A retro
spective study does have inherent dis
advantages which we attempted to ob
viate by carefully matching the pa
tients, unlike other retrospective studies
to date.1'6
Before commenting further we would
like to correct Dr. Wexler. All the
patients who did not have drains placed
were drawn from the files of one
surgeon (N.G.), whilst 56 patients who
had drainage belonged to the second
surgeon (G.M.), not vice versa. We
tested the validity of this process by
comparing the results shown in two
tables: Table I compares the complica
tion rate for the patients with drainage
of one surgeon with that of the
other; Table II compares the complica
tion rate of patients with and without
drainage who were managed by N.G.
The difference in respiratory complica
tions in Table II is not significant at
the 5% level, but is close enough to
suggest a trend which is subsequently
confirmed in the complete study.
The point about obesity affecting
wound infection rates is well taken,
but in our series height and weight
were rarely recorded on the patient’s
chart. On the other hand any patient
who was identified as being “grossly
obese” was excluded from the study;
we believe this “complicates” routine
cholecystectomy! Todd and Reemtsma,7 however, found no statistical
difference in the rate of wound infec
tion between obese and nonobese pa
tients. The results of our ongoing
prospective study, in which the depth
of subcutaneous fat in the incision line
is measured, may clarify this conten
tious issue.
Differences in surgical technique are
a problem in any study and would
Contributions to the Correspondence sec
tion are welcomed. They should be type
written and double spaced.
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be even greater in the multicentric
study suggested by Dr. Wexler. In our
study both surgeons used similar sub
costal incisions, neither deliberately
protected the wound edge with towels
or adhesive drapes, both closed the
wound in layers and both reperitonealized the gallbladder bed. The impor
tance of this last maneuver is em
phasized by Carpenter, Kambouris and
Allaben.1 In our series a patient was
excluded from the study if the gall
bladder bed was left open.
Postoperative pyrexia is mentioned
twice by Dr. Wexler, first as a com
plication of the surgery. We did not
record it as such, merely as a state
ment of fact. Second, he questions the
importance of the difference in mean
temperature of the drained and un
drained groups on the first postoper
ative day. The difference is truly sig
nificant (P < 0.05), applying Student’s
/-test. The cause of the raised temper
ature is debatable.
We, like Wexler, were alarmed by
the mean length of time (5.9 days) that
the drains were left in place. We
pointed out that there was a definite
relationship between this time and the
complication rate. We note Dr. Wexler’s comments on the short-term use
of sump drains, and also that he quotes
Polk8 who found no significant differ
ence in the infection rate in his two
groups (Penrose versus sump drainage)
and who also found that drainage

failed to prevent the accumulation of
bile in 2.1%, four out of five of the
patients having Penrose drains. (Polk
did not reperitonealize the gallbladder
bed.)
Bile culture is thoroughly topical and
its relationship to postoperative wound
infection is still being clarified.9"18
The studies so far include all types of
biliary tract surgery which should be
taken into account in any prospective
study. Bacteria entering by way of the
drain site are a potential source of
serious infection. A closed drainage
system may prevent this problem. Of
interest are the observations that have
recently been made on the placement
of intravenous catheters for long-term
use.14 A long subcutaneous route is
favoured because it provides a barrier
to bacteria. This may be true for any
foreign body put in place by the
surgeon, in which case the position of
the drain is important.
Dr. Wexler is concerned with scien
tific reliability and we therefore think
it relevant to point out that the refer
ences he quotes do have problems in
this regard. The reader is encouraged
to look them up.7,8,15'17 Our con
clusions should have pointed out that
we do not decry the use of drains,
especially in cases which cannot be
described as “uncomplicated”. We
agree that the length of time that a

Table II—Comparison of Complication Rate
of N.G.’ s Patients Who Underwent Chole
cystectomy with or without Drainage
Table 1—Comparison of Complication Rate
of Cholecystectomy with Drainage in
Patients Managed by N.G. and G.M.
Percentage (and no.
of patients)
Complication
Morbidity
Respiratory compli
cations
Wound infections
Urinary tract
infections

N.G.
(n = 44)

G.M.
(n = 56)

20.45 (9) 30.35 (17)
18.2 (8) 16.1 (9)
9.1 (4)
5.3 (3)
0

7.1 (4)
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Percentage (and no.
of patients)

Complication
Morbidity
Respiratory compli
cations
Wound infections
Urinary tract
infections
B ile peritonitis

With
Without
drainage drainage
(n = 100) (n = 44)
22

20.4 (9)

7
8

18.2 (8)*
9.1 (4)

8
1

0
0

*P = 0.056 (not significant).
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drain is left in place is critical. In our
institution we do not favour the use
of sump drains, but we look forward
to a prospective study to provide a
scientifically valid answer to that
issue. Meanwhile, we recommend the
randomized prospective study by Maull
and associates,18 which supports our
retrospective findings. Whether, how
and whom to drain are all pertinent
issues; on the other hand, we still
question the rationale of leaving a
drain in at all in uncomplicated cases
of cholecystectomy.

15. C ruse PJE, F oord R: A five-year
prospective study of 23,649 surgical
wounds. Arch Surg 107: 206, 1973
16. G upta S, R auscher G, Stillman R,
et al: The rational use of drains after
cholecystectomy. Surg Gynecol Obstet
146: 191, 1978
17. Stone HH, H ooper CA, M illikan
WJ JR: Abdominal drainage following
appendectomy and cholecystectomy.
Ann Surg 187: 606, 1978

D iamond A. K assum , m a , m b , b c h ir ,
FRCS, FRCS[C]
N enad M. G agic , MD, FRCSfC]
G opinath T. M e n o n , m b , bs , frcs ,
FRCS[Cl

Host Defence Mechanisms

18. M aull KI, D augherty ME, Shearer

GR, et al: Cholecystectomy: to drain
or not to drain. A randomized study
of 200 patients. J Surg Res 24: 259,
1978

To the coeditors: Thank you for the
opportunity to reply to several points
in the editorial “Prognostication or
biology: acquired abnormalities of host
defence mechanism in surgical patients”
Department of surgery,
by J.L. Meakins (September issue, page
McMaster University,
403). In our study of patients with
Hamilton, Ont.
sepsis it was impossible to obtain data
before the onset of the infective
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to lymphocytes. The cells used in the
study were 97 ± 2% lymphocytes and
2 ± 0.5% large mononuclear cells with
less than 1% polymorphonuclear cells
and erythrocytes. We calculated the
values for the total number of lympho
mononuclear cells. Any error, the re
sult of inclusion of other cells, must
have been small. Meakins, in his studies,
has shown that serum factors are im
portant. We used washed cells and did
not study the effect of serum.
Meakins raises the important point
that different treatments could affect
the observed changes. It would have
been ethically wrong to treat all the
patients in the same manner since a
number required operation for drain
age of an abscess, different antibiotics
were used, the number of blood trans
fusions varied and a small number of
patients were given steroids. Animals
must be used to study each of these
individual variables. Our results showed
that ADCC activity was decreased ini
tially in the patients with sepsis, that
the values continued to decrease in
those who died but returned to normal
in survivors.
Lentnek, Schreiber and MacGregor1
found that adherence of polymorpho
nuclear cells was increased in patients
with sepsis while we found that it was
decreased. The explanation may be
that they studied patients with localized
sepsis while we studied those with
systemic sepsis. We found a substantial
decrease in intracellular killing. The
biologic importance of this is not
known. The statement by Meakins in
his editorial that 0.5 log difference is
necessary for it to be biologically sig
nificant seems more arbitrary than our
use of a statistical method which is
universally accepted.
In our studies of chemotaxis we
looked at the number of cells that had
migrated a fixed distance (not the
speed of migration), which is the
method originally described and most
often employed in laboratories. The
statement that it is a relatively non
discriminating end point is not justified.
Skin testing using recall antigens was
performed on only a small number of
our patients. The results confirmed the
observations made by Meakins and his
group.
J o h n A. M c C r e d ie , m c h , f r c s [c ]
Department of surgery,
Victoria Hospital Corporation,
University of Western Ontario,
London, Ont.

Reference

1. L entnek AL, Schreiber AD, M ac
G regor RR: The induction of aug
mented granulocyte adherence by in
flammation—mediation by a plasma
factor. J Clin Invest 57: 1098, 1976

THE CANADIAN JOURNAL OF SURGERY

509

SB

Save a Spleen

m d , f r c s [c ],

FACS

Antiarrhythmic Agent

Precaution must be taken when treating any supra
ventricular arrhythmia on an emergency basis as it may
be caused by an undiagnosed Sick Sinus Syndrome.
Teratology and reproduction studies in animals have not
revealed any evidence of impaired fertility or teratogenic
potential. However, as with any patients of child bearing
potential, anticipated benefits must be weighed against
possible hazards.
The safety and efficacy of ISOPTIN in children, has not yet
been established.

ACTIONS AND CLINICAL PHARMACOLOGY

ADVERSE REACTIONS

ISOPTIN (verapamil hydrochloride) is a synthetic
papaverine derivative. Its antiarrhythmic effects are be
lieved to be brought about largely by its action on the sinus
and atrio-ventricular nodes. ISOPTIN depresses AV nodal
conduction and prolongs functional refractory periods.
Through this action, it interrupts re-entrant pathways and
slows the ventricular rate. It is a potent depressant of
myocardial contractility and its pharmacological effects
are largely independent of autonomic influences. It is not
a ^-adrenergic blocking agent. The mechanism of its anti
arrhythmic effects is believed to be related to its specific
cellular action of selectively inhibiting transmembrane
fluxes of calcium in cardiac muscle, coronary and sys
temic arteries and in cells of the intra-cardiac conduction
system. ISOPTIN blocks the transmembrane influx of
calcium through the slow channel, without affecting to any
significant degree the transmembrane influx of sodium
through the fast channel. This results in a reduction of free
calcium ions available within these cells.
The onset of action of a single intravenously administered
injection is usually 1 - 2 minutes, with peak effect occurring
between 3 -5 minutes and virtual dissipation of the
hemodynamic effects between 10-20 minutes. However,
changes in the A-H interval, still detectable at 6 hours on
His bundle electro-cardiography, suggest a preferential
uptake and binding of ISOPTIN by AV nodal tissues.
Plasma elimination half-life varies from 3.5 to 7.4 hours.
There is extensive first pass metabolism with 63-70%
eliminated in the urine. Protein binding is 90%.

Incidence of all adverse reactions, including those seen
with oral use of ISOPTIN (verapamil hydrochloride) is
about 9%, with 1% of patients requiring discontinuation
of the drug because of side effects. The most common
adverse effects seen with verapamil are hypotension and
bradycardia. The following adverse reactions, divided by
systems, were observed:

(verapamil hydrochloride)
5 mg in 2 ml of solution

INDICATIONS
ISOPTIN (verapamil hydrochloride) may be used in
1. paroxysmal supraventricular tachycardia
2. atrial fibrillation of recent onset, with rapid ventricular
response
3. atrial flutter of recent onset, with rapid ventricular
response.
CONTRAINDICATIONS

Department of surgery,
Misssissauga Hospital,
Mississauga, Ont.
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In the opinion of the adjudicat
ing committee none of the entries
for the 1979 Davis & Geek Surgi
cal Essay Award for residents was
of sufficiently high calibre to
merit the award.
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I S O p t i n injectable

To the coeditors: It is now well recog
nized that two complications can occur
as a result o f splenectomy, especially
in children. These serious complications
are post-splenectomy fulminant sepsis1
and diffuse intravascular clotting.2
O f 50 consecutive splenectomies per
formed between 1974 and 1978 at the
Mississauga Hospital, Mississauga, On
tario, 21 were done for traumatic rup
ture. In this group the average age of
the patients was 29 years, but included
nine children under 16 years o f age.
Another group of 10 patients who had
splenectomy because of iatrogenic op
erative injury to the spleen, brings to
31 (62% ) the number of splenectomies
that might have been avoided had
Morgenstern’s technique3,4 of splenic
preservation by the use of a micro
fibrillar collagen hemostat (Avitene,
A vicon Inc., Forth Worth, TX) been
used. In the remaining 19 patients
(38% ) splenectom y was unavoidable.
In view o f the high morbidity and
mortality associated with post-splenec
tomy fulminant sepsis and diffuse intra
vascular clotting it would seem worth
while to join the crusade to save a
spleen.
E.G. R a w l in g ,

■ ■

1. Acute myocardial infarction.
2. Overt heart failure.
3. Cardiogenic shock or other low blood pressure states.
4. AV conduction disturbances.
5. Sick Sinus Syndrome (See Precautions).
6. Left bundle branch block.
7. Marked bradycardia.
8. Concomitant use of beta blockers and cardiac
depressant drugs.
The use of ISOPTIN with these drugs can produce a
reduction in myocardial contractility. This myocardial
depressant effect (independent of changes in heart rate)
can be significant in patients with impaired left ventri
cular performance. ISOPTIN and propranolol have
been reported to have a synergistic effect on SA and
AV nodal function.
9. Hypersensitivity to the drug.
WARNINGS
Because of the drug's negative inotropic effect, ISOPTIN
(verapamil hydrochloride) should not be used in patients
with poorly compensated congestive heart failure, unless
the failure is complicated by or caused by an arrhythmia. If
ISOPTIN is used in such patients, they must be digitalized
prior to treatment. Continuous monitoring is mandatory
when ISOPTIN is used in these patients.
Severe hypotension has occasionally occurred following
administration of the drug. On rare occasions, this has
been followed by loss of consciousness. If severe hypoten
sion develops, ISOPTIN should be promptly discontinued.
ISOPTIN may cause an AV block, which in extreme cases
may result in asystole. If this occurs, the measures recom
mended under SYMPTOMS AND TREATMENT OF OVER
DOSAGE should be promptly carried out.
Intravenous administration may precipitate ventricular
fibrillation. Should this complication arise following the
administration of ISOPTIN, measures recommended
under SYMPTOMS AND TREATMENT OF OVERDOSAGE
should be followed.

Cardiovascular (3.7%): Bradycardia, transient asystole,
hypotension, development or worsening of heart failure
and development of rhythm disturbances, including AV
block and ventricular dysrhythmias.
Central Nervous System (2.2%): Headache, dizziness.
Gastrointestinal (2.2%): Constipation, nausea.
Respiratory (2.2%): Bronchospasm, dyspnea.
Miscellaneous Side Effects (0.8%): Skin reactions,
muscular cramps.
SYMPTOMS AND TREATMENTS OF OVERDOSAGE
Transient hypotension and prolongation of AV conduc
tion time or even A V dissociation may be seen. Rarely,
severe hypotension, bradycardia or asystole have been
reported. In such cases the usual cardiopulmonary
emergency measures should be taken: cardiac massage
and mouth-to-mouth resuscitation, and the intravenous or
intracardiac injection of isoproterenol or adrenaline.
In the case of ventricular asystole, one or two blows with
the clenched fist against the sternum will restore regular
cardiac contractions in many cases. When the diagnosis of
ventricular asystole has been established, cardiac pacing
may be called for. Electrical defibrillation or an attempt at
medical treatment with procainamide should be used in
cases of ventricular fibrillation.
Hypotension following the intravenous injection of
ISOPTIN may be controlled by use of vasoconstrictor
substances. When the hypotension is significant and
results from cardiac decompensation, administration
of an appropriate intravenous digitalis preparation is
recommended.
DOSAGE AND ADMINISTRATION
INTRAVENOUS INJECTION -ADULTS
The dosage of ISOPTIN (verapamil hydrochloride) should
be individualized for each patient, based on response and
tolerance. Its intravenous use may be accompanied by a
hypotensive response which can be precipitous. Intraven
ous ISOPTIN should therefore only be administered in
hospital, where coronary care facilities are available and
continuous electrocardiographic and blood pressure
monitoring performed. Concomitant use of /3-blockers is
•contraindicated.
One ampoule of ISOPTIN Injectable (verapamil hydro
chloride) 5 mg may be given intravenously over60 seconds
(0.07- 0.1 mg/kg). Elderly patients (over 60 years of age)
and those with a history of cerebrovascular insufficiency
should receive this dose over a minimum of 3 minutes.
In many cases, doses smaller than those recommended
appear sufficient. Injection should only be continued
until obvious signs of its effects are noted.
Where the tachyarrhythmia persists or recurs, another
5 mg may be injected 5 to 10 minutes after the first, with
the same precautions.
If the arrhythmia recurs, the ISOPTIN regimen described
above can be repeated twice, at six hour intervals.
Standard maintenance oral antiarrhythmic medication
(except beta-adrenergic blockers) should replace
intravenous therapy as soon as possible.
AVAILABILITY
ISOPTIN (verapamil hydrochloride) is available in
packages of 5 ampoules, each containing 5 mg in 2 ml
isotonic aqueous solution, without preservative.
Product Monograph available
on request.
*Reg. T.M.of Knoll AG, Ludwigshafen
W. Germany

PRECAUTIONS

Sept. 1979

Following the injection of ISOPTIN (verapamil hydro
chloride), decrease in peripheral resistance may lead to
hypotension or worsening of heart failure. Hypotension
appears to be particularly frequent in patients with marked
underlying hemodynamic dysfunction. On rare occasions,
a severe hypotension may occur. To maintain an adequate
blood pressure, vasoconstrictor substances are indicated
as described in SYMPTOMS AND TREATMENT OF
OVERDOSAGE.
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UROLOGY PAPERS

Pharmacologic Treatment of Disorders of Bladder
and Urethra: a Review
S.A. A WAD,

MB, B CH, FRCS[c ],

The use of pharmacologic agents in
treating disorders of the bladder and
proximal urethra has expanded because
of new knowledge gained in the past
few years. A better understanding of
the properties of these organs as they
relate to drugs has contributed to this
expansion. The authors present their
experience with a number of drugs in
treating disorders of the detrusor
muscle and proximal urethra, and they
briefly review the literature.

J.W.

DO W N IE, P H D * AND

K i RULUTA, MB, B CH, F R C S [c]f

muscle, for example, has been tradi
tionally treated with anticholinergic
agents such as belladonna products and
propantheline bromide. Because of the
limited success of these agents and
recent findings that nerve mediated
contraction of the detrusor muscle is
only partly cholinergic, interest has
arisen in drugs that have a direct re
laxant effect on smooth muscle. Also,
until recently, the role of the sympa

thetically innervated smooth muscles
of the proximal urethra in urinary con
tinence and micturition has been ques
tioned. Since it has become evident that
these muscles contribute to urethral
closure,1-4 a more rational basis has
developed for the use of adrenergic
agents in treating disorders of the
proximal urethra.
Although both the detrusor muscle
and proximal urethra receive parasym-

T rade N am es and M anufacturers of D rugs, M entioned in the Text, W hich A re
Available in C anada

L'emploi d'agents pharmacologiques
dans le traitement des troubles de la
vessie et de I’uretre proximale s’est
etendu a cause des nouvelles connaissances acquises au cours des dernieres
annees. Une meilleure comprehension
des proprietes de ces organes et de
leurs rapports avec les medicaments a
contribue a cette expansion. Les auteurs
presentent leur experience avec un
certain nombre de medicaments dans
le traitement des troubles du muscle
vesical et de I'uretre proximale, et ils
revoient brievement la litterature.

bethanechol

Recent developments in our under
standing of the pharmacologic proper
ties of the detrusor muscle of the blad
der and of the proximal urethral muscu
lature have resulted in increasing clinic
al use of drugs to treat disorders of this
system. Hyperactivity of the detrusor

From the departments of urology and
pharmacology, Queen’s University,
Kingston, Ont.
*Scholar, Medical Research Council
of Canada

Reprint requests to: Dr. S.A. Awad,
Victory 4, Kingston General Hospital,
Kingston, Ont. K7L 2V7
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pathetic and sympathetic innervations,
the known physiologic functions are
carried out by the parasympathetic
nerves in the detrusor muscle and by
the sympathetic nerves in the proximal
urethra. Thus, for clinical purposes,
one attempts to manipulate the para
sympathetic system for disorders of
the detrusor muscle and the sympathetic
system for disorders of the proximal
urethra.
In view of the presence of the soma
tically innervated external sphincter in
the proximal urethra, skeletal muscle
relaxants have also been used to treat
obstruction due to external sphincter
spasticity (“somatic dyssynergia”).
This report is based mainly on our
experience with selected drugs used for
detrusor and proximal urethral disor
ders. However, we shall refer to some
other agents that have been reported
by other investigators to be effective.
Drugs Used in Detrusor
Muscle Disorders

Detrusor Hypoactivity {or
Hypotonicity)
Excitatory neurotransmission to {he
detrusor is probably mediated by chem
icals other than, and in addition to,
acetylcholine.5 Nevertheless muscarinic
receptors are present and excite the
muscle, consequently hypoactivity in
the detrusor is often treated with mus
carinic stimulants, most commonly bethanechol. Subcutaneous administration
of bethanechol (2.5 to 10 mg) effect
ively induces bladder contraction in
most individuals. A regimen for treat
ing “atonic bladder” is well established6
and bethanechol can also be used
to differentiate neurogenic and nonneurogenic bladder lesions—the de
nervation supersensitivity test.7,8 Since
the oral equivalent of 5 mg of betha
nechol given subcutaneously is prob
ably over 100 mg, high dosage oral
therapy is required for equivalent re
sults. The pharmacologic basis for using
muscarinic agents orally to condition
the bladder rather than to induce con
traction is unclear. Some improvement
in the hypotonic bladder appears to
occur in about 60% of cases (Awad
SA: Unpublished data, 1978) but a
blind trial showed no objective effects
of orally administered bethanechol on
cystometrograms obtained in healthy
individuals.9
Many other substances stimulate the
detrusor in vitro but most have no
clinical significance.10 However, prosta
glandins of the E series have been
shown to contract human detrusor
muscle11 and have been instilled into
the bladder in cases of chronic reten
tion.'2 The reason for the long-term
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clinical effect observed in the latter
study is unknown.
Detrusor Hyperactivity
(or Spasticity)
Hyperactivity and hyperirritability of
the urinary bladder are associated with
a number of conditions. Excitatory
neurotransmission to the bladder may
not be entirely cholinergic so these con
tractions might not be amenable to
muscarinic blockade. Indeed, atropine,
the prototypical antimuscarinic drug is
relatively ineffective,13 but other syn
thetic antimuscarinic agents having
some degree of ganglion-blocking abil
ity as well (e.g., methantheline or pro
pantheline) are more effective13-15 and
are now a part of standard therapy.
Nevertheless, these agents cannot al
ways maintain control over hyperac
tivity at doses that are free of anti
muscarinic side effects (e.g., dry mouth,
blurred vision, constipation).
Because of these limitations atten
tion has shifted recently to the so-called
direct-acting antispasmodic drugs such
as dicyclomine, flavoxate and oxybutynin. These agents have some anti
muscarinic activity but the basis of
their action is likely to be interference
at a postreceptor event in the contrac
tion process.16-18 All have been found
effective in reducing bladder hyperex
citability and have resulted in fewer
side-effects than those encountered with
antimuscarinic agents.19-24 The results
with dicyclomine are shown in Table I.
Two or 3 months of therapy is often
necessary before maximum improve
ment is achieved. In approximately two
thirds of the patients who became
asyrrtptomatic the drug could be discon
tinued without recurrence of symp
toms.
Other drugs that oppose smooth mus
cle contractions by acting on a post
receptor step are the antagonists of
transmembrane movement of calcium
such as verapamil and nifedipine.25
Nifedipine effectively suppressed de
trusor contractions in vitro and marked
ly increased the volume of residual urine
but did not alter the bladder capacity,
as measured by the cystometrogram, in
patients with urgency or urge incon
Table I—Response to Administration of
Dicyclomine in 54 Patients
Response

Females

Males

Excellent*
Good)
Poorf

14
10
6

12
8
4

*Patient became asymptomatic.
(Persistence of some diurnal frequency,
nocturia or urgency but no incontinence.
(Unchanged.
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tinence, or both, but without unin
hibited detrusor contractions.26 It has
been found useful in managing neuro
genic bladder disturbances character
ized by uninhibited contractions.27
Imipramine has many actions which
may contribute to its effect on the
urinary tract.28-32 It appears to exert
some influence on the urethra30 but its
clinical effectiveness on detrusor ac
tivity is controversial.32"33
Under circumstances of parasympa
thetic decentralization in man there
appears to be alteration in sympathetic
nervous excitation of a-adrenergic re
ceptors.34 Treatment of patients with
autonomous bladders (lower motor
neuron lesions) with a-receptor anta
gonists (e.g., phenoxybenzamine) may
be useful in this situation.35
Drugs Used in Proximal
Urethral Disorders

Sphincteric Incontinence
It has been well demonstrated that
sympathetically innervated smooth mus
cles play a role in urethral closure.3
Both a and /3 receptors are present;36
the former produce contraction and an
increase in closure and the latter relaxa
tion and reduction in closure.37 The dis
tribution of these muscles is not limited
to the bladder neck; they extend to the
mid-urethra in the female and to the
region of the verumontanum in the
male.2,4 This fact has provided a ra
tional basis for the use of a stimulants
in the treatment of sphincteric incon
tinence in patients who have undergone
prostatectomy.38 Phenylpropanolamine
is an a stimulant that is effective when
given orally. Although surgical treat
ment of stress incontinence in the
female is often successful, a conserva
tive approach is sometimes desirable.
We have treated 26 women with phenyl
propanolamine; the indications and re
sults are shown in Table II. The poorest
results were in those who had been
operated upon unsuccessfully, often
more than once. In these cases the ure
thral smooth muscle was believed to
have been damaged and replaced by
fibrous tissue. A recent double-blind
study showed a more modest effect of
phenylpropanolamine, but patients who
had previously undergone urogenital
surgery (9 of 25) were not assessed
separately.39 In men, surgical treatment
of sphincteric incontinence is often
complex and unsuccessful. In 8 of the
10 men we treated, incontinence had
developed after prostatectomy. Follow
ing phenylpropanolamine therapy, four
became continent, four improved and
in two there was no change. The re
sponse will obviously depend on the
degree of weakness or damage of the

THE CANADIAN JOURNAL OF SURGERY

Table II— Response of 26 Women to Administration of Phenylpropanolamine
Results
Indications

Number

Continence

Improvement

Failure

8
9
9

6
1
3

1
2
2

1
6
4

Poor surgical risk (or refused
surgery)
Failed surgery
Ambiguous diagnosis

smooth muscle component of the supramembranous urethra and its ability to
respond to the drug.
In the presence of hypertension or
a history of thyroid dysfunction phenyl
propanolamine should not be used. Side
effects have been infrequent. Of our
36 patients, 1 had headache and
dizziness and another restlessness and
nonspecific symptoms. In our experi
ence patients must continue taking the
drug in order to maintain their re
sponse.
Phenylpropanolamine is a major
component of some common cold
remedies (e.g., Ornade®, Contac-C®).
Ornade® has been used in the treat
ment of stress incontinence40 with good
results. However, it is preferable to use
phenylpropanolamine without the antihistaminic agents that are also present
in these cold remedies. Ephedrine can
also be effective41 but since it acts
mainly by the release of norepinephrine
in all tissue, side effects are common,
particularly in the cardiovascular and
central nervous systems. Midodrine, an
a stimulant, has also been used success
fully42 but is not available on this conti
nent. Propranolol, a /3-blocking agent,
increases urethral closure indirectly and
has been shown to be effective.43 How
ever, it does not appear from the liter
ature to have been used extensively.
Urethral Obstruction due to
“Sympathetic Dyssynergia”
Dysfunction of sympathetically in
nervated smooth muscle can cause ure
thral obstruction. This is usually seen
in the presence of neurologic disorders
(upper motor neuron or lower motor
neuron). Because of the anatomical
location of this muscle, the obstruction
Table III— Response to Phenoxybenzamine
of 31 Patients with Neurologic Lesions

Response
Good*
Fair)
Poorj

Upper motor
Lower motor
neuron lesions neuron lesions
8
4
7

4
1
7

‘ Reduction of residual urine to < 100 ml.
(Reduction of residual urine to < 200 ml.
(Persistence of a large residual volume of
urine or ureteric obstruction.
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can be at the bladder neck44 or in the
distal part of the proximal urethra.4,45
The obstruction appears to be mediated
through a receptors, and a blockers are
often effective.
Phentolamine (5 mg in an intra
venous drip) combined with uroflowmetry46 or voiding cystourethrography45
can be a useful test to select patients
for therapy. In some instances, how
ever, the result of this test is incon
clusive or the test is difficult to per
form.47
Phenoxybenzamine, an a-adrenergic
blocker that is effective when given
orally, is the most commonly used drug
for the treatment of this condition and
its side effect of hypotension is not
troublesome in nonambulatory patients.
Our experience with this drug* in pa
tients with upper and lower motor
neuron lesions is shown in Table III.
The drug can also be used to treat auto
nomic dysreflexia without urethral ob
struction.48 Our experience suggests that
usually patients must continue taking
the drug to maintain their response.
However, periodic attempts to discon
tinue the drug will detect those cases in
which the obstruction is transient.
Urethral Obstruction due to
“Somatic Dyssynergia"
Simultaneous recording of electro
myographic activity of the external
urinary sphincter during cystometrography permits the objective diagnosis
of “somatic dyssynergia”.49 Several
agents have been recommended for
their nonspecific action in the treatment
of this condition. Of these diazepam is
probably the most widely used. A more
specific drug, however, is dantrolene
sodium. It exerts its effect by a direct
action on skeletal muscle without alter
ing the muscle action potentials.50 Thus,
electromyographic activity cannot be
used to monitor the response of the
drug. The drug is not selective in its
action and a generalized muscle weak
ness may be a side effect. A low start
ing dose should be used and gradually
increased until the desired response is
*Phenoxybenzamine (Dibenzyline) was
obtained from Smith, Kline & French
Canada Ltd., Mississauga, Ont., for in
vestigation purposes with the permission
of the Health Protection Branch, Health
and Welfare Canada.

obtained without generalized weakness.
Hepatotoxicity has been reported in
older patients. Experience with the drug
has mainly been in the treatment of limb
spasticity, and reports on its effective
ness in treating the spastic external
sphincter are scarce.51,52 In our limited
experience with 19 patients, 9 with mul
tiple sclerosis and 10 following spinal
cord injury, the drug has been found
more effective in the relief of ob
structive symptoms in female patients
with multiple sclerosis (three of five),
than in the others.
Conclusions
Recent advances in basic knowledge
of the pharmacologic characteristics of
the lower urinary tract have permitted
the use of drugs in bladder and urethral
disorders to be extended. This progress
should be considered preliminary since
there are still limitations and unresolved
problems. The choice of drugs used
should be based on knowledge of their
pharmacologic actions as well as on an
accurate diagnosis of the disorder. A
continuing interest in the application of
new pharmacologic developments to
this system will prove beneficial.
The authors acknowledge the assistance
of J. Fenemore, RN.
These studies were supported by Phy
sician’s Services Inc., Toronto, Ont., Norwich-Eaton Pharmaceuticals, Norwich,
NY and Parke, Davis & Co. Ltd., Scar
borough, Ont.
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Results of Retransplantation in Individuals
Who Received Two Successive Cavader Kidneys
A. R ook,

md ,

S. P richard, m d , D.D. Morehouse, md, frcs [c], R.D. Guttm ann ,
J.L . M eakins, md , frcs[c] and T.A. H utchinson , mb , frcp [c]

At the Royal Victoria Hospital in
Montreal, 22 patients received two
successive cadaver renal transplants.
The results were analysed to determine
which factors have the best predictive
value for success or failure in renal
retransplantation. The fate of a second
cadaver renal allograft was found to be
about the same as the first if the initial
transplant has been lost because of
rejection and not technical failure.
The duration of survival of the initial
transplant serves as the best guide to
potential outcome of retransplantation
after rejection of the initial graft.

transplant had about the same dura
tion of survival as the first. Further
more, by subdividing the population
into “high immunologic responders”
(those who quickly rejected the kidney)
and “low immunologic responders”
(those who rejected the kidney more
slowly), they showed that the latter
group fares much better than the
former when retransplantation is per
formed.4
This report analyses results of renal
retransplantation at the Royal Victoria
Hospital in Montreal, in patients who
received two successive cadaver kid
neys, to assess which factors have
the best predictive value for success or
failure in retransplantation.

A I'Hopital Royal Victoria de Montreal,
22 patients ont regu deux greffes
renales successives d'origine cadaverique. Les resultats ont ete analyses
afin de determiner les facteurs ayant la
meilleure valeur previsionnelle du
succes ou de I'echec d’une deuxieme
greffe renale. Le sort d’une seconde
allogreffe renale d’origine cadaverique
s ’est avere a peu pres le meme que
pour la premiere lorsque la perte du
greffon initial etait due au rejet et non
a un echec technique. La duree de survie
de la greffe initiale constitue le meilleur
guide du resultat possible d’une
deuxieme greffe apres le rejet du
premier greffon.

Patients and Method

Twenty-two patients received two
successive cadaver renal transplants
over a 12-year period from 1965 to
1977 because of either graft rejection
or technical failure. The total number
of cadaver transplants performed dur
ing this period was 265. All 22 patients
studied were followed up for at least
18 months after retransplantation. The
data on each patient are listed in
Tables I and II'. The age of the patients
at the time they received the first
transplant ranged from 13 to 52 years.
Factors that were analysed for corre
lation with graft survival included age,
original renal disease, duration of dia
lysis-dependent uremia, pretransplant
bilateral nephrectomy, HB antigen car
rier state, titer of pretransplant lymphocytotoxic antibodies and HLA
matching. The graft recipient routinely
received post-transplant immunosup
pressive agents including azathioprine,
1.5 to 2.0 mg/kg body weight daily, and
prednisone, which was given in an in
itial dose of 100 m g/d and then re
duced by 10 mg every 4th or 5th day
until a dose of 50 m g/d was reached.
Prednisone was reduced gradually to
a dose of 15 mg/d, 1 year after trans
plantation. Also, infusions of 750 mg
methylprednisolone and 400 mg cyclo
phosphamide are now administered
routinely on days 0, 2, 7, 14 and 21
after transplantation. In some cases.

Many factors thought to be related to
the success of human kidney trans
plantation
have been thoroughly
examined.1 It has been emphasized that
the elements governing the outcome of
first kidney grafts play a similar role
in the case of second kidney grafts.2,3
Moreover, information gathered during
the course of first transplants can be
employed to make a good assessment
of potential outcome in patients who
have rejected a graft and later become
candidates for retransplantation.
Opelz and Terasaki,4 in a large series
of cases drawn from a number of
centres, found that a second cadaver
From the transplantation service, Royal
Victoria Hospital and McGill University,
Montreal, PQ
Reprint requests to: Dr. A. Rook,
Transplantation service, Royal Victoria
Hospital, 687 Pine Ave. W, Montreal, PQ
H3A IA1
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particularly since 1971, donors were
pretreated with cytotoxic drugs to re
duce graft immunogenicity.5
Statistical evaluation of data was by
the x2 and Fisher’s exact tests.
Results

In these 22 patients, we compared
survival of their first and second trans
plants at various times after trans
plantation. At 12 months after re
transplantation, 13 (59.1%) of the pa
tients had a functioning graft com
pared with only 8 (36.4%) at 12
months after the first transplantation
(Table III). Similarly, at 24 months
following retransplantation, 10 (45.5%)
had a viable kidney compared with
only 6 (27.3%) at 24 months after the
first procedure. Although not statisti
cally significant, the data suggest that
the second cadaver transplant tends to
have a better rate of survival than the
first.
To determine whether or not there
were real reasons for these differences,
we examined the causes of graft failure
after each transplant. The major dif
ference was the relatively greater num
ber of technical failures in patients re
ceiving first transplants. Seven of the
22 patients who underwent retrans
plantation had lost their first allograft
because of technical failure, but only
1 patient lost a second transplant for
this reason.
Six of the total of the eight technical
failures occurred relatively early in
our experience. Five of these six pa
tients had renal infarction with obstruc
tion of a major artery; in four of them
the infarction occurred within 2 weeks
of transplantation, and in the fifth at
18 days after the procedure. In the
sixth patient an episode of renal in
farction caused the graft to rupture.
The remaining two technical failures
were in one patient (no. 6) who had
an uncontrollable hemorrhage following
renal biopsy performed during a severe
episode of rejection 2 days after trans
plantation; 24 days after retransplanta
tion an episode of bleeding from the site
of the renal artery anastomosis neces
sitated removal of the second allograft.

THE CANADIAN JOURNAL OF SURGERY

519

Table I— Patient Data before First Transplant Procedure Including Duration of Survival of First Allograft

Age at time
of transplan
Patient
tation,
no.
Sex
yr
i

43

M

2

26

F

3
4
5
6

34
28
43
27

M
M
F
M

7

43

F

8

49

F

9
10

39
40

M
M

11

46

M

12
13
14
15
16

52
13
44
30
44

M
M
F
M
M

17

37

M

18
19

24
36

F
M

20

32

M

21

35

M

22

45

M

Original renal
disease

Time on
dialysis
before
Presence
trans
Bilateral
of HB
plantation, nephrectomy antigen
mo
performed
state

Rapidly progressive
glomerulonephritis
Chronic
glomerulonephritis
Nephrosclerosis
Obstruction
Polycystic kidney
Rapidly progressive
glomerulonephritis
Chronic
glomerulonephritis
Chronic
glomerulonephritis
Polycystic kidney
Chronic
glomerulonephritis
Chronic
glomerulonephritis
Gouty nephropathy
Congenital reflux
Diabetic nephropathy
Chronic pyelonephritis
Chronic
glomerulonephritis
Chronic
glomerulonephritis
Chronic pyelonephritis
Rapidly progressive
glomerulonephritis
Chronic
glomerulonephritis
Membranoproliferative
glomerulonephritis
Polycystic kidney

Sensitization
No. of
Duration
before
transfusions
No. of
of
trans
before
No. of
HLA
survival
trans
plantation,
HLA
mis
of 1st
plantation matches matches allograft
%

_

5

No

No

10

Yes

No

—

>30

___

_

5
6
4
8

Yes
Yes
Yes
No

No
Yes
No
No

—

—

___

—

___

10
0

5
>30
5
>30

2

No

No

0

11

No

No

10
2

Yes
No

No
No

4

Yes

No

3
3
3
24
14

No
Yes
Yes
No
No

No
No
No
No
No

1
1
10

No
No
No

No
No
No

—

10

No

No

—

3
12

No
Yes

No
No

0
10

12 d*
54 mo

0
0

2
2

22 mo
44 mo
6 d*
2d*

0

0

3

7 d*

20

2

1

2

48 d

0
0

10
0

0
0

3
3

15 mo
10 d*

—

>30

—

10
20
o 5
—

10

0
2
3
>30
1
5
0
0

—

0
—

84 mo

—

0
0
1

1
1
2

0

2

—

—

___

—

___

1
—

0
2

2
___

0
3

3
1

11 mo
3 mo
14 d
66 mo
25 d*
120 mo
72 mo
20 d
7d
18 d*
5 mo

‘ Technical failure.

Table II— Patient Data before Second Transplant Procedure Including Duration of Survival of Second Allograft

Patient
no.

Age at time of
retransplantation,
yr

i
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

43
31
36
32
43
27
44
49
41
40
39
53
13
44
33
45
42
26
36
33
36
45

Time on dialysis Bilateral
between two nephrectomy
transplants, mo performed
5
21
2
1
6
6
6
8
0
4
6
18
3
1
3
11
6
21
14
18
8
1

No
Yes
Yes
Yes
Yes
No
No
No
Yes
No
Yes
No
Yes
Yes
Yes
No
Yes
Yes
No
No
No
Yes

Presence of
HB
antigen Sensitization before
state
retransplantation, %
No
No
Yes
Yes
No
No
No
No
Yes
No
No
Yes
No
No
No
No
No
No
No
No
No
No

30
90
0
10
10
0
70
10
10
10
5
10
90
30
0
30
0
10
30
30
10
20

No. of transfusions
Duration
No. of
No. of
between two
of survival
HLA
HLA
transplant
of 2nd
mis
procedures
matches matches allograft
10
>30
>30
>30
1
10
5
4
0
2
>30
7
5
2
>30
5
>30
>30
5
17
7
3

1
0
1
2
0
1
1
0
1
2
1
0
0
0
0
0
0
1
0
1
1
2

1
2
2
1
2
2
1
3
2
0
1
2
1
2
2
3
4
3
4
2
2
2

22 mo
87 mo*
76 mof
85 mo*
67 mot
24 dt
5 mo
8d
4 mo
37 mot
53 mof
58 mo*
8 mo
2 mo
53 mo*
30 mo*
22 mo*
21 mo*
2 mo
18 mo*
28 d
2 mo

*Had functioning allograft at conclusion of study.
fDied with functioning allograft.
^Technical failure.
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six of them the kidneys were still
functioning at 24 months. This differ
ence in the survival of second grafts in
patients whose first allograft survived
less than, or more than, 12 months, is
statistically significant (P < 0.05,
Fischer’s exact test). Analysis of the
outcome of retransplantation in the
seven patients who lost their first
grafts early due to technical failure
revealed results that were intermediate
between patients who had early and
late rejection of the first graft. Four
of the seven had functioning second
grafts for more than 12 months while
two had graft rejection in less than 12
months. The seventh patient was the
one who had renal arterial bleeding fol
lowing the first transplant procedure
and required removal of his second
transplant for the same reason 24 days
after operation.
Looking for those factors that had a
significant correlation with second
transplant results, we could find only
two in this small series. The rate of
rejection of a first graft is one that we
have mentioned previously. The other
factor that correlated in a statistically
significant manner was the history of
transfusion preceding each transplant.
As a group, those patients who had
received more than five transfusions
had a better 1-year graft survival rate
than those who had received five or few
er transfusions. The apparently positive
influence of transfusions on graft sur
vival has been extensively reviewed.6'7
Some workers8 have suggested that
the presence of preformed lymphocytotoxic antibodies should be an im
portant negative factor in selecting
patients for retransplantation. In our
study, comparison of 1-year survival of
second grafts in patients who had less
than 30% lymphocytotoxins to a ran
dom panel as opposed to those who
had more than 30%, showed a modest
improvement in the former group that
was not statistically significant. A criti
cal level of 30% lymphocytotoxins was
chosen to facilitate the division of the
small study population into two numer
ically comparable groups.
The duration of dialysis-dependent
uremia before the first transplant pro
cedure did not appear to be important.
If those who had technical failures after
the first transplant are excluded, the
time on dialysis did not differ for those
who rejected their first grafts within
1 year from those whose first graft
functioned for longer than 1 year. The
mean time on dialysis was 7.3 months
for the former group and 7.6 months
for the latter. Since we found a con
sistent relationship between the out
come of the first and second trans
plants, it appears that the duration of
dialysis-dependent uremia did not play

The greater number of technical fail
ures associated with first allografts may
be due to a bias in selection, making
patients whose first graft fails for
technical reasons more likely to be
chosen for retransplantation. We there
fore compared the results of first and
second transplant procedures only for
the 15 patients whose first grafts failed
for nontechnical reasons. The results
we obtained on duration of survival
were similar for first and second trans
plants. There were seven cases of graft
loss due to irreversible rejection within
12 months of transplantation and eight
of the patients had lost their grafts
because of irreversible rejection within
12 months of retransplantation.
Evaluating the results of the second
transplant procedure with respect to
the first provided some useful informa
tion. By dividing the patients into two
groups—those in whom the duration
of survival of the first allograft was less
than 12 months and those in whom
graft survival was more than 12
months— it was possible to see a con
sistent relationship in terms of per
formance in each of the two transplant
attempts (Table IV). Fourteen patients
lost their first allograft within 12
months (7 due to rejection and 7 due
to technical failure). Of the first seven
patients, five suffered irreversible
graft rejection within 12 months of
retransplantation. Of the eight patients
whose first allograft survived more
than 12 months after transplantation
seven had a functioning graft at 12
months after retransplantation and in

Table III—Comparison of Survival Rates of
First and Second Allografts
No. of patients (and % )
with functioning grafts
Time, mo
1
3
12
24

1st graft

2nd graft

12 (54.5)’
10 (45.5)
8 (36.4)
6 (27.3)

19
16
13
10

(86.4)f
(72.7)
(59.1)
(45.5)

’ Includes 7 technical failures.
(Includes 1 technical failure.

Table IV— Duration of Survival of First Graft
Related to That of Second
No. of second grafts
functioning,
First graft
survival, mo*

<12 mo

<12 (n = 7)

5

2

> 1 2 (n = 8)

1

7

> 1 2 mo

’ Excludes technical failures leading to loss
of 1st graft.
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a major role in determining the out
come of the second graft. Also, the
time patients spent on dialysis between
the two transplant procedures did not
seem to affect significantly the out
come of retransplantation.
The other variables that had no ap
parent effect on graft survival in this
small series were HLA matching, the
original renal disease, age, pretransplant
bilateral nephrectomy and the presence
of the HB antigen carrier state.
Discussion
The results in 22 patients who under
went retransplantation demonstrated a
remarkable degree of consistency in
performance of each of two successive
cadaver renal allografts. With some ex
ceptions, those who rejected a first
transplant rapidly, rejected the second
one similarly. Conversely, those who
retained their original allograft for 12
months or longer had a good result with
the second transplant. Hence the out
look for retransplantation may be pre
dicted in terms of the rate of rejection
of an initial renal allograft.
The 12-month graft survival rate fol
lowing each of the two transplants was
not markedly different when technical
failures were excluded. Previous studies
in both adults and children are in agree
ment with our observation that the out
come of a second cadaver transplant
will be similar to the first.4,9
Although the biologic concept that
insertion of an allograft will immunize
the recipient to the “foreign” antigenic
specificities and lead to accelerated
graft rejection during retransplant ex
posure to the same specificities may be
sound, our results of retransplantation
and those of others4 do not bear this
out. Recently, Opelz and Terasaki4
reviewed a large series of patients who
were re-exposed to mismatched HLA
specificities when retransplanted. They
failed to show an immunization effect.
In their study, a group of 22 patients
with two repeated mismatches had a
55% 1-year graft survival rate com
pared with 41% following retrans
plantation in 925 patients with no re
peated mismatches.
Implicit in the results of our study
is that transplant recipients who re
ceive more than one renal allograft
maintain a relatively constant state of
immunologic responsiveness following
successive transplants. There is a grow
ing body of evidence to support this
suggestion. Heideman and Claes,10 in a
survey of 149 retransplrnts in 117 pa
tients, showed that those who rejected
a primary graft early had a similarly
poor performance after further trans
plant attempts, and those with long
term primary graft survival behaved in
a similar fashion upon retransplanta-
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tion.10 Opelz and Terasaki,4 noting sim
ilar results, concluded that the rate of
rejection of a first renal transplant
should serve as the most important cri
terion for selecting individuals for re
transplantation, as their immunologic
responsiveness to a kidney graft will
remain unchanged from one grafting
experience to another.
The only other factor in our study,
in addition to the rate of first graft
rejection, that affected the outcome of
retransplantation was a history of more
than five blood transfusions; this cor
related well with improved graft sur
vival. At present, the experience at
many transplant centres suggests that
those who receive transfusions before
transplantation have a superior graft sur
vival rate compared with nontransfused
patients. The mechanism of improved
graft survival after transfusion and the
quantitative aspect of the problem are
not well defined.
An explanation of the better results
in transfused patients is that trans
fusion may cause patients to become
nonreactive and thus to do well with
transplantation or that it affects the
length of time sensitized patients must
wait for transplantation. Approximately
half the patients who are heavily trans
fused will produce lymphocytotoxic
antibodies.11 When these antibodies are
at a high concentration in pretransplan
tation blood tests, the patient will likely

be refused a transplant because of the
high risk of rejection. Thus, only the
nonreactive transfused patients, who
produce fewer antibodies and are
therefore less likely to reject a kidney
transplant, will be selected for trans
plantation. In contrast, when patients
are not heavily transfused the difference
between reactive and nonreactive pa
tients may not be evident before trans
plantation. The rapid graft rejection
after transplantation by the unidentified
reactive patients will tend to lower the
average graft survival rate in the non
transfused patients. The poorer results
in patients who have not been trans
fused will make it appear that trans
fusion has a beneficial effect on graft
survival. This type of effect is likely
to influence the selection of patients
being considered for retransplantation.
Conclusions

Two conclusions may be drawn from
this small series of patients who re
ceived two successive cadaver renal
allografts. First, in patients who un
dergo retransplantation, the second
cadaver graft can be expected to
behave in a manner similar to first. It
follows from this, that consideration of
a candidate for retransplantation should
be made with particular emphasis on
the duration of function of the primary
allograft.
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Autotransplantation for
Treating Renovascular Hypertension
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Autotransplantation is presented as a
surgical technique for the repair of
diseases of the renal artery causing
hypertension. Investigation of patients
with renovascular hypertension is
reviewed stressing the importance of
radiologic studies.
The author discusses the results
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obtained in 31 patients who underwent
renal autotransplantation. In his
experience the procedure has proven
to be particularly effective for
repairing renal artery stenosis and in
patients presenting with severe
renovascular hypertension. Associated
lesions of the renal artery requiring
extensive reconstruction may be repaired
with greater safety to both the patient
and the kidney using this technique.

L’autotransplantation est presentee
comme technique chirurgicale permettant
de corriger des maladies des arteres
renafes qui sont la cause d'hypertension.
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La revue de la recherche effectuee
chez les patients souffrant d’hyper
tension arterielle souligne (’importance
des etudes radiologiques.
L'auteur discute les resultats obtenus
chez 31 patients qui subirent une
autotransplantation renale. Selon son
experience, I'intervention s’est averee
particulierement efficace pour corriger
les stenoses de I'artere renale et
dans des cas d'hypertension arterielle
grave. Grace a cette technique les
lesions associees de I'artere renale
qui necessitent une reconstruction
etendue peuvent etre reparees avec
plus de securite pour le patient et dans
de meilleures conditions pour le rein.
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Surgery as treatment for renal hyper
tension has evolved through many
stages since Goldblatt first described
his phenomenon in 1934. Since then
many operations have been performed
in patients with a combination of hy
pertension and renal disease with no
improvement in the blood pressure. It
is evident that one must carefully select
those patients in whom the hypertension
is directly related to the renal disease
and then perform an operation that
corrects the hypertension or cures this
disease. Diseases of the main renal ar
tery or its primary branches represent
the commonest cause of reversible renal
hypertension (renovascular hyperten
sion).
Simple nephrectomy has been the
most successful procedure for treating
renovascular hypertension. However,
the kidney distal to the site of obstruc
tion is often potentially normal and in
hypertension of long duration may be
the patient’s better kidney in terms of
future renal function. Therefore, many
operative procedures to correct the
vascular lesion have been developed,
including arterial bypass grafts, synthe
tic bypass grafts, saphenous vein by
pass or patch grafts and autotransplan
tation.1,a This paper presents our ex
perience with autotransplantation for
the treatment of renovascular hyper
tension.
Technique

Autotransplantation was first de
scribed by Hardy in 1963.3 In this pro
cedure the kidney is mobilized, the
renal artery and renal vein are divided
and are subsequently reanastomosed to
the ipsilateral iliac artery and vein. We
leave the ureter intact to avoid the

commonest technical problem of ho
motransplantation.
After dividing the renal vessels and
while the iliac vessels are being pre
pared to receive the graft we perfuse
the kidney with a balanced salt solu
tion at 4°C to provide renal preserva
tion during the period of ischemia. The
kidney is then inverted (Fig. 1) allow
ing the redundant ureter to run a
smooth course superiorly from the kid
ney and then interiorly into the bladder.
The renal artery is anastomosed endto-end to the internal iliac artery and
the renal vein end-to-side to the ex
ternal iliac vein. A postoperative intra
venous pyelogram demonstrates the
new anatomical position of the kidney
and the unobstructed ureter (Fig. 2).
Preoperative Investigation

The selection of patients for surgical
repair of renovascular hypertension re
mains critical. A hypertensive profile
is obtained, which includes a rapid se
quence intravenous pyelogram, a reno
gram, selective renal angiograms, dif
ferential renal vein levels and the
results of differential renal function
studies.
The saralazin test4 has not been ac
curate in our hands so it is no longer
used. Differential studies of renal vein
renin predict most accurately which pa
tient will respond favourably to opera
tion.5
Most important in arterial localiza
tion before operation is renal angio
graphy with selective studies and
oblique views. Right and left oblique
views will frequently fail to demon
strate overlying vessels. However,
superior-inferior rotational views (Fig.
3) will often separate these vessels on
the film clearly outlining the anatomy.

Patients

We have performed autotransplanta
tion for renovascular hypertension on
31 patients whose ages ranged from 18
to 66 years. Seventeen patients had
fibromuscular dysplasia and 14 had
arteriosclerosis. Seven patients had total
occlusion of the renal artery and in
three the occlusion was acute. Five
patients presented with renal failure.
Results

Our criteria for assessing results of
surgery are outlined in Table I and
our results in Table II. In 28 of the
31 patients the result was good; 19
have a normal blood pressure without
medication. Two patients have poor
control of blood pressure and there has
been one failure. All seven patients
with total occlusion of the renal artery
have good results. The kidney involved
has been sustained by collateral arterial
vessels from the adrenal or ureter. All
of the five patients with renal failure

FIG. 2— Intravenous pyelogram follow
ing autotransplantation.

FIG. 1—Autotransplantation.

VOLUME 22, NO. 6, NOVEMBER 1979 /

tional view. Bottom: Right-left oblique
view.

THE CANADIAN JOURNAL OF SURGERY

523

have had good control of blood pres
sure postoperatively and all have had
greatly improved renal function. In
this situation the affected kidney has
been protected from the hypertension
by the stenosis of the renal artery.
Complications

Complications have been infrequent.
One patient whose blood pressure was

Table 1— Classification of Results of
Operation (Diastolic Blood Pressure)
Result

Diastolic blood pressure, mm Hg

Cure
< 90 (without medication)
Good
< 100 (with or without medication)
Poor
>100
Failure
> 100 (or thrombosis)

Table II— Results of
Autotransplantation in 31
Patients
Result

No. of patients

Cure
Good
Poor
Failure

19
9
2
1

normal died of a myocardial infarction
6 months after operation. One patient
who had had a stroke 6 years before
operation had a mild stroke; in this
patient the diastolic blood pressure was
100 mm Hg without medication. Our
one failure was in a patient with a small
contracted kidney which was removed
3 months after operation because it
was not functioning.
Discussion

A major advantage of autotransplan
tation in treating renal artery disease is
that the renal and recipient vessels
can be tailored to fit. Stenosis extending
into a bifurcation, which is often en
countered, may be excised by spatulating the branches but keeping the bi
furcation intact. The hypogastric vessels
may then be tailored to receive the
graft (Fig. 4). We have performed
trifurcation graft repairs in this man
ner. End-to-side anastomosis of renal
artery to the common or external iliac
artery has also been performed.
Autotransplantation has been par
ticularly effective in patients requiring
extensive reconstruction of the renal
artery. At the time of hypothermic per
fusion, after division of the renal ves
sels, the kidney may be brought up into
the wound where extracorporeal (bench)
surgery may be performed. In this way
technical procedures previously pro
hibited by limited exposure, hemostasis
or time, may be executed with greater
safety to both the kidney and the pa
tient. The combination of renal artery
stenosis and renal artery aneurysm has
been a frequent manifestation of fibro
muscular dysplasia in our series of
patients with renovascular hypertension
(Fig. 5). These patients often require
major reconstruction of the renal ves
sels before reimplantation. Repair of
conditions previously managed only

by nephrectomy has become feasible
employing autotransplantation as illus
trated in a patient who had malignant
hypertension due to an extensive dis
secting aneurysm associated with severe
stenosis of the renal artery. After ex
cision of the stenosis and repair of the
dissection the autotransplantation was
completed as a trifurcation anastomosis,
preserving a normal kidney and curing
the hypertension (Fig. 6).
Conclusion

In our experience autotransplantation
has proven to be a particularly effective
procedure for repairing renal artery
stenosis in patients with severe reno
vascular hypertension. Lesions of the
renal artery requiring extensive recon
struction may be Repaired by this tech
nique with greater safety to both the
patient and the kidney.
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Electrohydraulic Cystolitholapaxy
R.H.
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lithotrites utilize sophisticated fiberoptic
systems for visualization but still rely
on heavy, serrated, mechanical jaws to
crush the stone, and these may injure
the bladder mucosa during the proce
dure and the urethra during passage of
the instrument. The bladder may be
perforated during mechanical litho
tripsy necessitating appropriate repair
and drainage.3
Yutkin, a Russian engineer, reported
in 1950 that certain high voltage, low
amperage discharges in a liquid medi
um could fracture adjacent solid objects
(unpublished data). In 1959, Goldberg,
a Latvian urologist, reported the first
electrohydraulic transurethral lithotrip
sy.4 His instrument utilized physical
principles developed by Yutkin. Since
then, this technique has been used in
several European clinics and, more re
cently, in some North American cen
tres.5'7 This report describes our ex
perience with 36 electrohydraulic litho
tripsies performed over the past 31A
years at Sunnybrook Medical Centre in
Toronto.

The electrohydraulic lithotrite generates
high voltage discharges which, in a
liquid medium, are converted to
hydraulic shock waves capable of
fracturing bladder stones. Electro
hydraulic litholapaxy was successful in
treating 28 of 30 patients with bladder
stones. In nine patients other proce
dures were performed during the same
anesthetic. In one patient, a calculus
was removed from within a narrow
necked bladder diverticulum. Compared
with conventional mechanical lithotripsy
with serrated, jawed instruments,
electrohydraulic lithotripsy is a safe,
easy to learn and effective technique
for treating bladder stones.
Le lithotriteur electrohydraulique genere
des decharges de haut voltage qui,
dans un milieu liquide, sont converties
en ondes de choc hydrauliques capables
de briser les calculs vesicaux. La
litholapaxie electrohydraulique a ete
utilisee avec succes chez 28 patients
souffrant de calculs vesicaux sur 30.
Neuf patients ont subi d'autres inter
ventions au cours de la meme anesthesie.
Chez un patient, un calcul a ete retire
d’un diverticule vesical a petite
ouverture. Comparativement a la lithotripsie mecanique traditionnelle utilisant
des instruments a dents et a pinces,
la lithotripsie electrohydraulique est
une technique sure, simple a apprendre
et efficace de traiter les calculs
vesicaux.

Apparatus

The major component of the ap
paratus (Northgate Research Corp.,

Plattsburg, NY) (Fig. 1) is a cabinet
containing circuitry that generates
appropriate current from a standard
120-volt electrical wall outlet. Current
is carried along a special high voltage
extender cable to the lithotriptor elec
trode. The electrodes (no. 9 French in
diameter) pass easily through a no. 23
French cystoscope with a deflecting
bar. A foot control switch permits the
operator to control current discharges.
Surgical Technique

After the administration of a suitable
general, or regional anesthetic, a cysto
scope is inserted and the bladder par
tially filled with water. The lithotripsy
electrode is inserted through the cysto
scope using a deflectable catheter bridge
and positioned so that the tip of the
electrode just touches the calculus. Be
cause of the intense heat generated at
the electrode tip, it should be at least
1 cm away from the bladder wall and
0.5 cm away from the tip of the lens.
Fracturing of the stone is effected by
1- to 3-second applications of cur
rent, regulated by the foot switch.
Stone fragments are fractured until all
are small enough to be irrigated out
through the cystoscope sheath.

Review of the evolution of transurethral
surgery reveals that many ingenious
devices have been developed for treating
bladder stones. The first documented
transurethral litholapaxy was performed
by Civiale in Paris in 1824 using a blind
lithotrite.1 The development of the
cystoscope in the latter half of the 19th
century2 allowed the operator to see the
stone and bladder during the procedure
and reduced the large number of
bladder injuries associated with early
blind lithotripsy. Currently mechanical
From the division of urology,
Sunnybrook Medical Centre, and the
department of surgery, University of
Toronto, Toronto, Ont.

FIG. 1— Apparatus for electrohydraulic litholapaxy. (1) Cabinet with generator and
controls. (2) High voltage extender cable. (3) Lithotriptor electrode. Note electrode tip
protruding through end of cystoscope. (4) Cystoscope. (5) Light cable for cystoscope.
(6) Foot regulated control pedal. (7) Power cord for generator.

Reprint requests to: Dr. R.H. Comisarow,
1039-2075 Bayview A ve., Toronto, Ont.
M4N 3M5
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After removal of all the calculous
debris, an indwelling catheter may be
inserted if desired, but is not always
necessary. Other procedures such as
transurethral prostatectomy may be
done immediately after the litholapaxy.

Discussion

Patients

Thirty patients, ranging in age from
16 to 86 years (average 70 years) had
a total of 36 cystolitholapaxies. In 17
(57%) cases, stones had formed sec
ondary to the presence of a permanent
indwelling catheter, usually inserted for
the management of neurogenic disease.
In 12 (40%) patients, no catheter was
present but bladder outlet obstruction,
usually due to benign prostatic hyper
trophy, was present. In one patient
there was no obvious cause for the
stone. Half of the patients had multiple
calculi and half had solitary stones.
Some litholapaxies were performed
by staff urologists but most were car
ried out by residents under staff super
vision.
Results

Electrohydraulic cystolitholapaxy was
successful in 34 (94%) of 36
procedures. The first failure was due
to a burned out electrode which could
not be replaced. The second was caused
by a very hard uric acid stone which
could not be fractured by either elec
trohydraulic or mechanical lithotrites
and required cystotomy for removal.
The average operating time, in
cluding assembly of instruments, ir
rigation of fragments and additional
surgical procedures, was 21 minutes
(range 5 to 70 minutes). Slight eryth
ema and mild patchy edema of the
bladder mucosa were noted in some of
the patients but no serious bladder or
urethral trauma was recognized in any
patient.
In eight patients, transurethral pro
statectomy and, in one patient, transu
rethral resection of a large bladder
tumour were performed during the
same anesthetic. In one patient, a stone
(4 cm in diameter) within a narrow
necked bladder diverticulum was frac
tured and removed without incident.
Postoperative urine cultures grew
organisms in 11 (37%) patients; all
had indwelling catheters and cultures
had been positive preoperatively. In 10
(33%) patients who had positive cul
tures preoperatively there was no
growth after operation and 9 (30%)
had negative cultures before and after
the procedure. No patient with sterile
urine before litholapaxy, had urinary
infection. In 15 cases, the removed cal
culi were analysed; the frequency of
constituents was as follows: calcium
in 47% of the patients, phosphate in
67% , oxalate in 53%, carbonate in
526

53%, ammonia in 67%, magnesium
in 67% and uric acid in 60% of the
patients. None of the six patients with
stones that contained uric acid and in
whom urinary uric acid excretion was
measured had hyperuricosuria.
The electrohydraulic lithotrite has
several advantages over conventional
mechanical lithotrites. The electrohy
draulic procedure is easier to learn and
can be performed safely by residents
at a relatively early stage in their train
ing. Trauma to the bladder wall is
minor and bladder perforation, which
may occur with a mechanical instru
ment, has not been reported in the Eng
lish literature. Unlike many mechanical
lithotrites, in which serrated, thick jaws
encroach on the operator’s view, visual
ization is excellent since the entire
visual field of the telescope can be
used. The electrohydraulic lithotrite
may be used to fracture calculi within
a bladder diverticulum whose neck is
too narrow for safe entry of a mechan
ical instrument.
As with any operative procedure,
careful technique and attention to detail
are important. Most bladder calculi
can be disintegrated by a few brief ap
plications of current. If a very hard
stone does not fracture, higher voltage,
higher frequency current should be
used. More applications of current may
be needed. Soft, amorphous material
covering a hard calculus may interfere
with fracturing and must be penetrated
first by scraping the covering away with
the electrode tip or by application of a

few current discharges before the inner,
hard stone will fracture. Electrode tips
should be inspected frequently since the
concentric insulation separating the
coaxial electrodes wears away after 15
to 50 seconds of accumulated use.
Worn electrode tips (Fig. 2) allow shortcircuiting of current with loss of hy
draulic power and should be replaced.
The
electrohydraulic
lithotriptor
costs about one third more than a com
plete conventional mechanical lithotrite.
In addition, each lithotriptor lead costs
$42 and can be used for a cumulative
total of about 50 seconds, or for about
three cases. This increase in capital
cost is offset by the apparently lower
complication rate of the electrohy
draulic instrument. In addition, several
European clinics have carried out elec
trohydraulic lithotripsy with topical ure
thral anesthesia on an out-patient basis,8
further reducing total costs.
Several more advances in the non
mechanical fragmentation of urinary
tract calculi have recently been re
ported. Electrohydraulic fracturing of
calculi in the ureter9 and renal pelvis10
has been reported in laboratory- anim
als. With present techniques, the high
energy released when a stone is frag
mented in a small cavity (i.e., ureter,
renal pelvis) cannot be dissipated as
effectively as in the bladder, and injury
to these structures may occur. Further
refinements may, however, permit clin
ical application of electrohydraulic
lithotripsy to upper tract stones in the
future. Certainly at present, its role in
the treatment of bladder stones seems
well established.
References

1. D esnos E: Lithotripsy, in The History
of Urology, M urphy LJT (ed),
CC Thomas, Springfield, IL, 1972,
p 169
2. Idem: in Ibid, p 183
3. Smith RB: Complications of trans
urethral surgery, in Complications of
Urologic Surgery: Prevention and
Management, Smith RB, Skinner DG

4.
5.
6.
7.
8.

FIG. 2— Electrode tips, (a) Unused
electrode tip; i.s. are insulating sheaths
covering outer electrode (o.e.) and separ
ating it from inner electrode (i.e.). (b)
Used electrode tip. Note that insulating
sheaths have been burned back, exposing
electrode tips and permitting short-cir
cuiting of current between them.

VOLUME 22, NO. 6, NOVEMBER 1979

/

9.
10.

(eds), Saunders, Philadelphia, 1976,
p 301
G oldberg VV: On the history of the
electrohydraulic lithotripsy method
(E). Urol Nefrol (Mosk) 50: 90, 1974
E aton JM, M alin JM j r , G len JF:
Electrohydraulic lithotripsy. J Urol
108: 865, 1974
R aney AM: Electrohydraulic cystolithotripsy. Urology 7: 379, 1976
M itchell ME, K err WS j r : Ex
perience with the electrohydraulic
disintegrator. J Urol 117: 159, 1977
R ouvalis P: Electronic lithotripsy for
vesical calculus with “Urat-1”. An
experience of 100 cases and an ex
perimental application of the method
to stones in the upper urinary tract.
Br J Urol 42: 486, 1970
R aney AM: Electrohydraulic ureterolithotripsy. Preliminary report.
Urology 12: 284, 1978
R aney AM, H andler J: Electrohy
draulic nephrolithotripsy. Urology 6:
439, 1975

THE CANADIAN JOURNAL OF SURGERY

Studies of Crystalluria in Recurrent Calcium Lithiasis
P .O .

C r a s s w e l l e r , m d , f r c s [c ], FACS,* L. B randes , m d , t A .
AND D .G . OREOPOULOS, MD, PH D, FRCP[C]f

The authors have studied the distribution
and total volumes of large and small
crystals in the urine of healthy
individuals and of those who form
stones. Studies carried out on randomly
obtained specimens were as reliable in
identifying differences as were fasting
specimens. Stone forming individuals
had a greater number of large crystals
and a greater total volume of crystals
in the urine than had healthy persons.
The urine of stone forming patients
who had received treatment showed no
difference in crystal volume from that
of a similar group who had not been
treated, and the same was true of a
group of stone forming patients studied
before and 6 months after the start of
treatment.

products. We did identify a difference
between active “ stone formers” and
healthy control subjects with respect to
octocalcium phosphate (Fig. 2); the
mean value for control subjects was
somewhat below the saturation product
and that for active stone formers in
the metastable range was above the
saturation product. That crystal growth
and aggregation are not inevitable in

Les auteurs ont etudie la distribution et
les volumes totaux des cristaux petits
et gros retrouves dans I'urine de sujets
sains et dans celle de sujets producteurs
de calculs. Les etudes effectuees sur
des echantillons obtenus au hasard ont
ete aussi surs pour identifier les
differences que les echantillons pris
a jeun. Les sujets producteurs de calculs
avaient un plus grand nombre de gros
cristaux et un plus grand volume total
de cristaux dans I’urine que les
personnes saines. L’urine des patients
producteurs de calculs qui avaient ete
soumis a un traitement n'a montrS
aucune difference dans le volume des
cristaux par rapport au groupe qui
n’avait pas ete traite, et il en a ete de
meme pour un groupe de patients
producteurs de calculs etudie avant et
6 mois apres le debut du traitement.

all urines is due to the presence o f
inhibitors o f crystal growth and ag
gregation in the urine, and our studies1,2
(Fig. 3) indicated little difference be
tween the active stone form er and the
healthy control subject, with respect to
inhibition o f calcium phosphate crys
tallization.
We therefore studied the form ation
o f calcium crystals in the urine o f
individuals who were stone form ers and
those who were not, to try to identify
differences in crystal size between the
two groups. W e wished to determine
the conditions under which
urine
should be studied (in random samples
or in morning urine samples from
fasting patients), the pattern o f crystal
luria in healthy individuals and stone
formers, and whether or not treat
ment o f a recurrent stone form er in
fluenced the pattern o f crystalluria.
Methods

product in 24-hour urine samples o f
healthy individuals and stone forming
patients. There is no significant difference
between groups. FP = formation pro
duct, SP = saturation product, X =
mean.

The model T A Coulter counter
(Coulter Electronics Inc., Hialeah, FL)
was used to measure crystal volum e o f
particles from 5 to 40 fx in diameter
in urine samples immediately after the
subjects had voided. The samples were
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FIG. 2— Octocalcium phosphate activity
product in 24-hour urine samples o f
healthy individuals and stone forming
patients. Difference between two groups
is significant (P < 0.01).
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FIG. 3— Mean values o f inhibiting
units per day in healthy individuals and
stone form ing
patients.
Mean
urine
volume (m l/d ) ±
standard error was
1121 ±
109 for healthy subjects and
1685 ± 125 for stone forming patients.
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collected in thermos flasks and pre
filtered through a sieve with 74 fx mesh
to remove any large pieces of cellular
debris. They were then divided into
two aliquots: the first was incubated
for 20 minutes with physiologic saline
(25 ml urine and 25 ml saline). The
second aliquot was incubated for the
same period with 10% ethylenediaminotetraacetate (EDTA) solution (25 ml
urine, 20 ml saline and 5 ml EDTA
buffered at the pH of the urine). This
dissolved any calcium containing crys
tals present in the urine. The samples
were maintained at 37°C throughout
the procedure. The particle volume
counted in the second aliquot gave a
background count of cellular debris
left after dissolving the crystals and
this was substracted from the count for
the first aliquot. The final result was
a measure of the calcium crystals
present in the original urine sample.
The type of crystal can be character
ized by viewing the sediment of the
centrifuged sample under the micro
scope. Whenever the urine pH was
greater than 7.0, phosphate crystals
were the predominant type. The re
sults were expressed as either total
calcium crystals or small (<12 fx)
crystals and large (>12 /x) crystals.
Results
Random versus Fasting
Urine Samples

and large crystals and the total volume
of crystals for each of the 51 patients
attending the clinic. There was no
statistically significant difference be
tween the random and the fasting
samples. The mean specific gravity for
random samples was 1.017 (standard
error ± 0.006) and for fasting samples
was 1.019 (SE ± 0.005), but this dif
ference was not statistically significant.
We therefore used randomly obtained
urine samples for all subsequent studies.

the findings for small and large crystals
and the total volume of crystals in the
two groups. Significant differences
(P > 0.02) were observed in relation
to the total volume of crystals and the
presence of large crystals, stone form-

Healthy and Stone Forming
Subjects
Random urine samples for studying
crystalluria were collected from 23
healthy individuals (staff of the Toronto
Western Hospital) and 31 patients who
were recurrent calcium stone formers,
before treatment was initiated. Typical
distribution curves of crystal particle
size for the healthy persons and for the
stone forming patients are shown in
Figs. 5 and 6. Small crystals, less than
12 fx in size, predominate in the
healthy individual, even though the
volume may be high, as opposed to the
stone forming patients in whom part
icle size tends to be large.
In each group, a substantial number
of patients had no crystalluria at the
time of the study, and for this reason
statistical analysis was carried out
using the Wilcoxon ranking test rather
than Student’s r-test. Fig. 7 shows

In 51 patients attending the stone
clinic at the Toronto Western Hospital
a urine sample was collected during the
afternoon hours (random sample) for
each patient, and a 2-hour (08:00 to
10:00 hours) urine sample was collected
after the patient has fasted for 12 hours
(20:00 to 08:00 hours) (fasting sample).
In addition to crystal volume, urinary
pH and specific gravity of all the urine
samples were measured.
Fig. 4 shows the volumes of small

FIG. 7— Comparison of volumes of
small crystals and large crystals and total
volume of crystals in healthy subjects
and stone forming patients before start of
treatment.

FIG. 8— Comparison of volumes of
small crystals, large crystals and total
crystals between healthy persons and
stone forming patients who had been
taking medication.

FIG. 5— Pattern of distribution of
crystal size in healthy individual show
ing preponderance of small crystals.

F IG . 4— Comparison of volumes of
small crystals, large crystals and total
crystals in random specimens and those
of fasting patients. Difference is not sig
nificant. n = number of specimens.
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FIG. 6— Pattern of crystal distribution
in recurrent stone forming patient show
ing high volume of large crystals com
pared with healthy individuals.
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FIG. 9— Effect of medication on total
volume and volume of large crystals in
group of patients before start of treat
ment and same group after treatment for
6 months.
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unrecognized. It is also possible that
the salt and protein intake during the
day contributed to a relative increase
in specific gravity in the random sam
ples. Not only is the random sample
easier and more convenient for the
patient to obtain, but it has the addi
tional advantage of reflecting the effect
of diet and activity.

ing patient’s having a much greater
number of large crystals and a greater
total volume than healthy persons.
Fig. 8 shows the volume of small
and large crystals and the total volume
of crystals in another group of stone
forming patients who had already re
ceived treatment for crystalluria at the
time of the study. Once again, the
stone forming patients had a signifi
cantly (P > 0.02) higher mean value
for large crystals and total crystals
than did the healthy subjects, but there
was no statistically significant differ
ence between the treated patients and
the group of stone forming patients
studied before treatment was initiated.
To evaluate this finding, we further
compared a group of patients before
treatment and after 6 months of treat
ment (Fig. 9). There was no statistically
significant difference in the pattern of
crystalluria following treatment.

Conclusions

We have found that stone forming
patients have significantly more large
crystals in their urine than do healthy
control subjects. To date we have not
separately identified the crystals as cal
cium phosphate or calcium oxalate.
Probably the large crystal size, whether
oxalate or phosphate, is the determin
ing factor in nucleation and epitaxial
stone formation in association with al
terations in levels of saturation and in
urinary inhibitors. We were surprised
to find that treatment did not signifi
cantly alter crystal particle size and
total crystal volume.

Discussion

Our findings agree with previous ob
servations,3 that randomly obtained
samples give as reliable information as
do specimens obtained from fasting
patients, which tend to be more dif
ficult to interpret due to the presence
of both phosphate and oxalate crystals.
Our own results with regard to particle
size and total crystal volume indicate
that random samples are as useful as
samples from fasting patients and are
simpler to obtain. This may be because
our patients failed to achieve a higher
specific gravity in the fasting state.
This finding was not expected. Perhaps
there is a concentrating defect in stone
forming patients that was previously
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NOTICES
Kenzie—Ethicon Travel Fellowship of
the Royal College of Physicians and
Surgeons of Canada. The fellowship
will be for a period of 1 year and is
valued at $12,000. The first award
will be made in March 1980.
The late Dr. Walter C. MacKenzie,
as the first chairman of the committee
on awards from 1975 to 1978, worked
tirelessly to establish this fellowship.
The award, made possible through the
generosity of Ethicon Sutures Ltd., is
a tribute to the world-renowned
stature of Dr. Mackenzie.
The fellowship is open to practising
surgeons in Canada who are fellows in
the division of surgery. Application
forms and detailed terms of reference
may be obtained by writing to: Com
mittee on Awards, Royal College of
Physicians and Surgeons of Canada,
74 Stanley Ave., Ottawa, Ont. KIM 1P4.

Association des chirurgiens
de la province de Quebec
Cette association tiendra une journee scientifique, le 8 decembre 1979,
a I’hotel Bonaventure de Montreal.
Cette journee comprendra, entre autres, un exercice d’auto-evaluation et
des chirurgiens du Canada. Pour tous
renseignements veuillez communiquer
avec D. Bernard, md, Secretaire, Asso
ciation des chirurgiens generaux de la
province de Quebec, 5, Place Ville
Marie, Ste 714, Montreal, PQ H3B 2G2.
Walter C. MacKenzie— Ethicon
Travel Fellowship
The Royal College of Physicians and
Surgeons of Canada is pleased to an
nounce the institution of a major
travel fellowship in surgery. It is
to be known as the Walter C. MacVOLUME 22, NO. 6, NOVEMBER 1979
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In the treatment of shock
and its pulmonaiy
complications

Solu-Mednol
soon enough,
often enough,
in pharmacologic doses
Dosage and Administration:
In treating severe shock, there is a
tendency in current medical practice to
use massive (pharmacologic) doses of
corticosteroids. (The anti-inflammatory
activity of 1 mg of Solu-Medrol is equal
to 4 mg or more of hydrocortisone.)
The suggested dosage of Solu-Medrol
for severe shock is 30 mg/kg stat and
repeated in four hours, if necessary.
Therapy is initiated by administering
Solu-Medrol intravenously over a period
of at least ten minutes. In general,
therapy should be continued only until
the patient’s condition has stabilized —
usually not beyond 48 to 72 hours.
Solu-Medrol may be given by intrave
nous injection, by intravenous infusion,
or by intramuscular injection. The pre
ferred method for initial emergency use
is intravenous injection.
Cautions:
The general precautions and contra
indications to systemic corticosteroid
therapy should apply to the use of
Solu-Medrol. However, when used for
medical emergencies, or in shock-like
states, the possible lifesaving effects
must be weighed against the possible
undesired hormonal effects. In the treat
ment of shock, Solu-Medrol should be
adjunctive to conventional supportive
therapy such as fluid replacement, etc.
Although adverse effects associated
with high-dose short-term corticoid
therapy are uncommon, peptic ulcera
tion may occur.
Supplied:
As Solu-Medrol (methylprednisolone
sodium succinate) in 40 mg and 125 mg
Mix-O-Vials; 500-mg and 1g vials with
water for injection.
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whenshock
threatens the lung
helps reduce pulmonary
damage and increase
survival rates.

• preserves lysosome and cell membranes, thereby preventing the release o f destructive
lysosomal enzymes3
• preserves platelets thereby reducing the risk of intravascular coagulation1
• preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern o f deteriorating pul
monary function, com m only described as shock lung. This pulmonary insufficiency
progresses despite restoration of haemodynamic balance and apparent stabilization of
the acute episode.
Gnder conditions of prolonged shock, lack of oxygen at the cellular level causes
alterations in the oxygen-carbon dioxide exchange mechanism. T h ese
changes in cell metabolism lead ultimately to interstitial oedema and peri
vascular haemorrhage.1Polymorphonuclear leukocytes aggregate in
the pulmonary capillaries and obstruct the pulmonary vascular
bed. As these trapped cells break down, they release lysosomes, tiny subcellular particles containing proteolytic
enzymes.1These enzymes attack their host cell and
go on to damage or destroy other cells.2 The re
sulting tissue dam age may not readily repair
itself even if the shock patient survives.
When administered in conjunction with
standard therapeutic measures, SoluMedrol exerts a protective effect
on the lung and improves the
patient’s chance o f survival.
Prescribing information on page 529
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Hypospadias: a Review
P eter Wilkin,

md, J ames

Hypospadias is a common congenital
anomaly with a prevalence estimated
to be as high as 1 in 125 live male
births. Its etiology is not entirely
resolved but is embryologic in origin
and has been attributed to fusion defects.
Several authors believe it is a
manifestation of intersex. Experience to
date has produced a general consensus
with regard to indications, timing and
surgical principles for repair of the
hypospadiac meatus. While two-stage
procedures have been the mainstay of
therapy, successful single-stage
procedures have recently been
developed. The prevention and man
agement of the complications of
persistant chordee, fistula and stricture
make hypospadias repair one of the
more challenging urologic procedures.

L’hypospadias est une anomalie congenitale frequente dont revaluation de
la prevalence est aussi elevee que
1 sur toutes les 125 naissances males.
Son etiologie n'est pas entierement
resolue mais elle est d'origine
embryonnaire et elle a ete attribute
a un defaut de fusion. Plusieurs auteurs
croient qu'il s’agit la d'une manifestation
d'intersexualite. [.'experience acquise
a ce jour a degage un consensus general
en ce qui a trait aux indications, au
moment choisi et aux principes
chirurgicaux de la reparation du meat
dans les cas d’hypospadias. Bien qu'une
intervention en deux etapes ait ete la
norme du traitement, des operations
reussies en une seule etape ont
recemment ete mises au point. La
prevention et le traitement des
complications que represented la
persistance des coudures de la verge,
les fistules et les strictures font de la
reparation de I'hypospadias I’un des plus
grands defis des interventions
urologiques.

O. M etcalfe,

md, frcs[c ] and

William H. Lakey,

A review of the literature reveals that
virtually all aspects of hypospadias are
controversial. The fact that about
150 procedures have been proposed for
its correction attests not only to the
controversy but to the surgical chal
lenge of this common developmental
anomaly.
In hypospadias the urethral meatus
is located on the ventral aspect of the
penis proximal to its normal position
on the glans. In most cases the prepuce
is deficient on the ventral aspect and
forms a dorsal hood over the glans,
which is itself usually flattened with a
ventral groove representing the un
fused fossa navicularis. Hypospadias of
greater than coronal degree is usually
accompanied by a chordee deformity.
Sweet and colleagues,1 in a review
of the literature, found a prevalence of
hypospadias ranging from 1 in 1250
to 1 in 122 live male births. The figure
commonly stated is 1 in 300 to 1 in 400,
but a collaborative, prospective study
still in progress in the United States has
put the figure at 1 in 125,2 making hy
pospadias second only to congenital
heart disease in frequency of congenital
anomalies.3 There is a 5% to 10%
familial frequency which is higher than
that expected by chance alone.3
The genitourinary tract anomalies
commonly associated with hypospadias
include significant chordee (35% to
40%), meatal stenosis (about 15%)
and cryptorchidism (8% to 35%). The
association of upper urinary tract anom
alies is probably infrequent, indeed,
Felton4 suggested that there is no sta
tistically significant difference between
the hypospadiac and the normal indi
vidual in this regard.
Embryology

At 6 to 7 weeks’ gestation the gen
italia are in an undifferentiated state
consisting of genital tubercle, uro
genital slit and anal pit. The sex of
the fetus is determined by whether the
primordial germ cells of the germinal
From the division of urology, department ridge develop into testes or ovaries, and
of surgery, University of Alberta,
this in turn is determined by the pre
Edmonton, Alta.
sence or absence of the Y chromo
Reprint requests to: Dr. Peter Wilkin,
some.
In the presence of the Y chromo
Division of urology, Department of
surgery, 11-101 Clinical Sciences Building, some the gonads develop into testes.
The fetal testes secrete testosterone and
University of Alberta, Edmonton,
Alta. T6G 2G3
Mullerian inhibiting substance, a non
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steroidal compound which inhibits the
development of Mullerian duct struc
tures.
The testes exert these hormonal
effects between 4 and 8 weeks, and
under this stimulation the genital
tubercle assumes the normal penile
shape, a groove develops delineating
the glans, the urethral groove deepens
and the urethral folds become more
prominent. Before 12 weeks, the folds
begin to fuse from proximal to distal
penis, and mesenchymal tissue coal
esces around the forming tube to
develop into the corpus spongiosum
and its investing fascias. As the
urethral slit reaches the corona, the
glans enlarges and its urethral groove
deepens but does not fuse. At this time
a fold of skin forms around the corona
on either side of the urethra and be
comes the prepuce. Finally, the groove
of the glans fuses to become the fossa
navicularis and the development of the
external genitalia is complete by 12
weeks.
Etiology

The etiology of hypospadias is closely
related to embryologic deficiency.
There is no single known cause of this
anomaly and two theories exist. Camp
bell and Harrison5 and Howard6 con
tend that it is a manifestation of inter
sex, while others3 believe it to be a
fusion defect secondary to testo
sterone deficiency, or possibly an in
sensitivity of the end organ (urethral
folds) to the available testosterone. In
terms of genetics, a polygenic predis
position seems likely, as the observed
8% to 10% familial frequency is
higher than would be expected by
chance alone.3
Intersex

Fusion defects may explain lesser
degrees of hypospadias, but in the
more severe cases the possibility of
intersex as a causative factor must be
entertained. The frequency of intersex
in association with hypospadias and
cryptorchidism has been stated as 53%
of all cases, and as 27% when cases of
ambiguous genitalia were excluded.7
The concomitant occurrence of hypo
spadias and cryptorchidism should
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procedures for the transfer of the
meatus to the tip of the glans, but
have encountered difficulty with
stenosis of the tunnelled urethra.0

prompt suspicion of intersex. Culp
stated that for practical purposes inter
sex begins at the penoscrotal angle.8
However, it was his practice to get
buccal smears in all but the mildest
cases of hypospadias, and to do retro
grade urography and panendoscopy on
all patients with perineal hypospadias.8
Once the genetic sex is determined,
preferably in the newborn period, King
is of the opinion that the ability of the
abnormally small phallus to respond to
testosterone would be demonstrated by
application of 2.5% to 5% testosterone
cream to the genitalia for 3 weeks.
Failure to respond should lead to con
sideration of raising the infant as a
female.3
Panendoscopy of hypospadiacs will
occasionally reveal the presence of an
enlarged sinus pocularis. Since the
utricle represents the fused ends of the
Mullerian ducts, this finding, in com
bination with undescended or incom
pletely descended testicles, should alert
one to the possibility of intersex. For
practical purposes, these pouches can
be ignored in the repair of hypospa
dias, unless they are large enough to
cause difficulty with infection second
ary to stasis.8’8

Timing
There is probably no ideal time for
all hypospadias repairs, but it is gener
ally agreed that the repair should be
complete by school age. Two-stage re
pairs are started early in life (18
months to 3 years) to leave time for
induration to resolve before starting
the second stage, which is done be
tween 3 and 5'A years of age. With
regard to the time interval between
first and second stages, Spence and
associates8 stated that under no cir
cumstances should additional urethra
be constructed until the penis is
truly straight, the displaced meatus
is of adequate calibre and at least
6 months have elapsed since pre
vious surgery. The single-stage proce
dure should be done at the age of
about VA years to allow time for in
duration to resolve and any complica
tions to be managed before the child
goes to school.
General Considerations

Surgical Management

The desired result of hypospadias
repair is to ensure adequate voiding
and the ability to procreate, by cor
recting chordee and constructing a
urethra of adequate calibre, free of
hair, capable of growth and free of
scarring. Some basic principles have
evolved to aid in achieving this result.
Meatal stenosis must be corrected
before the neourethra is anastomosed,
and preservation of an adequate
original meatus prevents stricture.11
Hemostasis during the procedure
must be meticulous. This may be
achieved by infiltration with 1/100 000
epinephrine, use of fine ligatures, ac
curate minimal electrocoagulation or
use of sponges soaked in 1/100 000
epinephrine.
It is of utmost importance that all
components of the chordee be excised.
They may include skin, fascia, corpus
spongiosum and even segments of the
ventral surface of the corpora caver
nosa.8 It may be necessary to carry the
dissection proximal to the meatus and
to relocate the meatus proximally.
Suture lines should be placed so as
not to overlap, whenever possible, to
decrease the chance of fistula forma
tion.
Skin flaps should be fashioned with
attention to blood supply, maintenance
of full thickness and gentle handling
of tissues.
Circumcision should not be per
formed on a hypospadiac until pub

Indications
It is agreed that operation is indicated
for patients in whom the deformity will
cause difficulty with either voiding or
intercourse, but the validity of repair
for purely cosmetic reasons has been
questioned. Spence and associates8
seemed to express the general con
sensus in their philosophy that “it is
the inalienable right of all boys to be
pointers instead of sitters by the time
they start school,” and that “during or
shortly after puberty, he should be
able to write his name in the snow and
have it legible”.
The question arises as to whether
aglandular hypospadias, in the absence
of appreciable chordee or stenosis, re
quires surgical management (i.e., trans
fer to the tip of the glans). Most
authors, including Spence and associ
ates,8 Campbell and Harrison5 and Creevy,9 believe that a coronal meatus of
adequate calibre to permit easy void
ing, in the absence of chordee, should
be left alone. As such, it produces no
functional deficit, and procedures to
move it to the tip run the risk of serious
complications. Allen and Spence,10
more concerned with the psychologic
factors associated with hypospadias,
have developed a single-stage proce
dure for correction of chordee with a
coronal meatus. Russell, Young, Mayo,
Levi and Mays have all attempted
VOLUME 22, NO. 6, NOVEMBER 1979

/

erty. In the case of Jewish males,
religious law requires only that blood
be drawn during the ceremony.8'12
Suture material used by most work
ers at present is fine chromic catgut
(5-0 to 7-0) under the skin and mono
filament wire or nylon for skin to
prevent capillary spread of bacteria
and thereby to reduce the danger of
fistula formation. Polyglycolic acid or
polyglactin 910 will probably replace
chromic suture material in the future.
Drains used for a short time (1 to
3 days) may reduce the chance of
hematoma formation or of exudate
disrupting suture lines.
Urinary diversion, used by most
workers, is effected by a catheter placed
either suprapubically or through a
proximal perineal urethrotomy. The
fenestrated catheter of Turner-Warwick may be helpful when the entire
urethra is splinted.
Dressings vary from the application
of Telfa (Kendall Canada, Hospital
products division, Toronto, Ont.) only
to eliminate a constricting bandage,
which may compromise blood supply,
to compression dressings to minimize
edema, thereby aiding blood supply.
When compression bandages are used
the glans should be checked frequently
to make sure that the circulation is
adequate.
Specific Corrective Procedures

Chordee without Hypospadias
A small number of patients present
with this isolated deformity. Devine
and Horton13 described three classes
of chordee:
1. Absence of spongiosum with a
very thin urethra and a thickened band
dorsal to the urethra. Correction is
achieved by elevating the urethra and
excising the band. Because of the
delicacy of the urethral tissues, the
procedure may be technically difficult.
2. Normal urethra with the chordee
maintained by Buck’s fascia and the
dartos fascia. This is corrected by
freeing the urethra from the corpora
and the fascial layers.
3. Normal urethra with the chordee
maintained, in the absence of dartos
fascia, by skin adherent to the urethra.
Correction requires freeing of the skin
only. The ventral defect left by ex
cision of skin may be repaired by Zplasty or ventral transposition of
dorsal skin. The latter method is essen
tially that of Allen and Spence.10
If straightening cannot be accom
plished without transection of the
urethra, transection should be done in
the mid-shaft followed in 6 months by
a Johanson procedure to reconstitute
the urethra.
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Chordee with Glandular
Hypospadias
The accepted method of correction
used to be resection of the chordee
with subsequent urethroplasty, but
recently Horton and Devine'2 devel
oped a one-stage repair which takes
the meatus to the tip of the glans.
When there is only skin tethering the
chordee, an Allen-Spence procedure
may be used.10
Glandular or Coronal Hypospadias
with Meatal Stenosis and
without Chordee
Several procedures are applicable to
this situation, the oldest being the
Denis Browne meatotomy, in which
the tissue between the stenosed meatus
and the distal dimple is crushed and
excised (Fig. 1, a and b) allowing con
tinuity of the meatus with the ventral
groove (Fig. lc). A more recent proce
dure is the advancing V-flap meato
tomy with circumcision used by Horton
and Devine.12 A V-flap is cut from the
glans (Fig. 2, a and b) and a Y-V
plasty procedure done on the meatus
on the dorsal aspect (Fig. 2c). A cir
cumcision is then performed.

ventral longitudinal incision in addi
tion if the meatus is in a more proxi
mal position (Fig. 4b). In both instances
a longitudinal closure is used (Fig. 4c).
Second Stage Repairs

Following any of the first stage pro
cedures, a period of 6 to 18 months will
allow induration to resolve. Then, any
one of a number of second stage
urethroplasties can be performed.
Denis Browne Procedure
This makes use of the ability of a
buried skin strip to form a tube and
is probably one of the most common
second stage techniques used today.
The first stage is done when the child
is about 18 months old and the second
stage at 4 to 5 years of age. A perineal
urethrostomy is established, a Ushaped incision is made around the
meatus, and the arms of the incision
are carried to the glans where a small
triangle of glans is denuded on either
side (Fig. 5a). To allow closure, the
strip is made about 1 cm wide in
children, and 1.5 to 2 cm wide in
adults. The strip itself is not under-

mined, but the lateral flaps are widely
undermined and brought together
without tension over the strip (Fig. 5,
b and d). A relaxing incision may be
necessary on the dorsum of the penis
and this must be longer than the ventral
closure. It should not extend onto the
abdominal wall, as this will cause con
tracture of the scar (Fig. 5c). A penile
incision gives a flat pliable scar. The
original skin closure of “double stop”
beads and tubing on wire resulted in a
high frequency of fistula formation,
and many modifications of skin closure
have since been introduced (Fig. 5e).
This procedure is advocated by Culp
for use in perineal and scrotal hypo
spadias. He encountered some diffi-

First Stage Repairs

The first stage in all cases involves
correction of the chordee and mani
pulation of available skin to facilitate
the second stage urethroplasty. Regard
less of which procedure is performed,
it is essential to excise the entire chor
dee structure. Two of the more com
mon procedures, used with various
modifications are Byar’s procedure and
procedures of the Heineke-Mikulicz
type.

FIG. 1—Denis Browne dorsal meato
tomy.
c

Byar’s Procedure
The ventral midline incision starting
just distal to the meatus is carried
distally and dorsally to encircle the
glans. Skin is then freed from sub
cutaneous tissue and the entire chordee
excised. A wedge of tissue excised
from the ventral midline of the glans
will allow a more distal position of
the meatus in the second stage. The
dorsal preputial hood is unfolded (Fig.
3a) and divided into two flaps (Fig.
3b) which are transposed ventrally
and closed in the midline (Fig. 3c).

FIG. 4— Heineke-Mikulicz
stage repair.

d
type

first

FIG. 2—Horton-Devine advancing Vflap meatotomy.

Heineke-Mikulicz Type Procedures
All modifications of this procedure
make use of the basic principle of
transverse incision and longitudinal
closure. The procedure as used by Culp
(Fig. 4a) employs a simple transverse
incision for distal hypospadias and a
534
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FIG. 5—Denis Browne second stage re
pair.
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culty with a patulous urethral meatus
which required subsequent urethro
plasty.11
Byar’s Procedure
The first stage of Byar’s procedure
(Fig. 3) is done when the child is 3
years of age and the second at 5 years.
In the second stage a perineal urethro
stomy is established, a median strip is
isolated to include the meatus (Fig. 6a)
and the strip sufficiently undermined
to allow closure over a catheter of
appropriate size (Fig. 6b). The lateral
flaps are widely elevated and closed
over the neourethra (Fig. 6c). The
moulding catheter is removed at the
end of the procedure and the urethro
stomy removed 7 to 10 days later.
Culp Modification of
Cecil Procedure12
The first stage of this procedure is
carried out when the child is 18
months old, the second at about 5
years of age. A midline tube is fash
ioned as in the preceding methods, but
the catheter is left in place (Fig. 7, a
and b). A longitudinal incision is made
in the scrotum, subcutaneous tissue is
sewn to the corpora cavernosa and
penile skin is sutured to scrotal skin
(Fig. 7, b and c). The catheter is re
moved in 7 days. After 2 months the

FIG. 6—Byar’s second stage repair.

FIG. 7—Culp modification of Cecil
repair, second stage.
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penis and scrotum are separated allow
ing ample scrotal skin for closure (Fig.
7, d and e). The scrotal incision is
closed over a Penrose drain, which is
removed 3 days later (Fig. 7f).
One-Stage Repairs

onal degrees of hypospadias. With this
technique Horton and Devine have had
primary healing in 75% of cases, the
remaining 25% having had only small
fistulas. Meatal stenosis has not been
a problem with the use of the V-flap.
Hodgson Procedure

King Procedure

The procedure described by Kelalis,
King and Belman3 is useful for hypo
spadias of the mid-shaft, or more distally, associated with mild to moderate
chordee which is maintained by skin
only (Fig. 8a). A skin strip including
the meatus is marked and isolated with
an incision that extends dorsally at the
corona to encircle the penis (Fig. 8, b
and c). The width of the isolated strip
in millimetres should equal the size of
the original meatus in French units.
Skin is then freed from deep tissues to
a level proximal to the penoscrotal
junction, thus freeing the entire chor
dee (Fig. 8d). The skin strip is ex
tended distally onto the glans to ensure
a glandular meatus (Fig. 8e) and is
“tubularized” to form the neourethra
(Fig. 8f). The dorsal preputial flap is
then partially separated to preserve
the blood supply (Fig. 8, g and h) and
the two dorsal flaps are transposed
ventrally to complete the procedure
(Fig. 8i).

Since it was first described in 197014
this procedure has been used exten
sively by both Hodgson14 and Engel.15,13
A circumferential incision is made
below the coronal sulcus and the
meatus circumscribed with a triangular
incision (Fig. 10a). The skin is freed
and the entire chordee is excised,
mobilizing the urethra if necessary
(Fig. 10b). A midline skin island is
then formed on the ventral aspect of
the hood of the prepuce, using in
cisions of cutis depth to avoid com
promising the blood supply (Fig. 10c).
The usual width is approximately 2
cm, but a wider island is used for
children over 4 years of age. The
length of the island is adjusted to
cover the distance from the meatus to

the glans. The remaining deep pre
putial layer is excised, the prepuce
freed dorsally and a buttonhole made
through which the glans is pulled (Fig.
lOd). A neourethra is then fashioned
by creating a tube from the preputial
island and this is anastomosed to the
original meatus (Fig. 10, e and f).
Wedge incisions in the glans receive the
sutures from the distal anastomosis,
thus bringing the meatus distally (Fig.
lOf). The ventral skin flap is sutured
in place and redundant tissue is ex
cised (Fig. lOg). Skin sutures and the
urethral catheter are removed on the
10th day after the operation and the
urethrostomy catheter on the following
day.
Complications
Hematoma

Interposition of blood between a
flap and its bed can cause severe
secondary scarring and fibrosis. This
can be prevented by meticulous intra
operative hemostasis, the short-term

Horton-Devine Procedure

This operation12 makes use of a free
graft of preputial skin. Skin incisions
are made as shown in Fig. 9a and the
entire chordee is excised (Fig. 9b). A
ventral incision is made in the meatus
to allow an elliptical anastomosis with
the neourethra. The prepuce is un
folded and a graft of appropriate size
is measured and removed from the pre
putial flap (Fig. 9, c and d). This free
graft is then shaped into a tube around
a catheter and the ends are fashioned
to allow an elliptical anastomosis
proximally and a V-flap distally (Fig.
9e). Three triangular flaps are elevated
on the glans (Fig. 9f), the lateral flaps
being full thickness and the distal one
thinned. The proximal elliptical incision
is completed, the distal V-flap is
sutured to the new urethra, and the
lateral glandular flaps are closed to
form a meatus at the tip of a conical
glans (Fig. 9, g and h). The ventral
defect is then covered with dorsal pre
puce transposed ventrally using the
buttonhole technique (Fig. 9, i and j).
The splinting catheter is removed 7
days after operation and the diverting
perineal urethrostomy catheter 3 days
later. A urinary antiseptic is used while
the catheters are in place.
Modifications of this one-stage proce
dure are used for both perineal and cor
536
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use of subcutaneous drains, and pres
sure dessings. Once established, a
hematoma must be drained.

nical details as the tension placed on
sutures, the thickness required to en
sure adequate blood supply to skin
flaps and preventing overlap of suture
lines will help to decrease the fre
quency of fistulas.
If a fistula develops, it is essential
to rule out distal obstruction before
the fistula is repaired. Once an ade
quate distal passage is achieved, tiny
fistulas can be successfully treated by
coagulation, with either silver nitrate
or electrocautery. Larger fistulas re
quire surgical management of varying
magnitude. Freshly formed fistulas
with no sign of infection can be closed
by sutures placed with the patient
under local anesthetic, while larger
ones may be managed by circumscrib
ing the fistula and closing in layers.
Skin flaps may be useful in treating
fistulas of moderate degree. More
serious fistulas may require closure by
a variant of the Cecil urethroplasty or
by a Johanson repair. To avoid missing
minute fistulas at the time of repair,
Creevy9 has injected indigo carmine
under pressure into the urethra.

Infection
The presence of infection may cause
necrosis of flaps and breakdown of
suture lines with subsequent fistula
formation. Horton and Devine12 have
recommended that broad spectrum
antibiotics not be given intraoperatively,
and that antibiotic-impregnated dress
ings be used, together with a urinary
antiseptic while catheters are in place,
and that rubbings be frequent to clean
the suture line. They12 allow granulation
and secondary closure if dehiscence
occurs.
Late Complications

Persistent Chordee
This complication can be avoided
only by initial excision of the entire
chordee. If this requirement is not ful
filled, the entire procedure may have
to be repeated.
Fistula

Stricture

Many factors have been implicated
as the cause of this common complica
tion. Careful attention to such tech-

Stricture may follow contraction of
a neourethra made too small, use of
skin flaps too thin or infection. Stric
tures at the site of the original meatus
are amongst the most difficult to treat.
They respond poorly to dilation or in
ternal urethrotomy, and exteriorization
or opening of the urethra with second
ary closure is often required. Meatal
stenosis can be managed in the usual
manner. Free tube grafts should be
allowed 3 to 4 months to soften and
assume their final state before a stric
ture repair is attempted.12 Retraction
of the meatus occurs most often with
the Cecil repair. Its correction requires
creation of a new distal urethra in the
second stage.
Diverticula
These often follow postoperative
infections or meatal stenosis and
frequently occur at the site of the
proximal anastomosis. They should be
suspected when there is persistent in
fection, post-void dribble and urethral
bulge during voiding. Management is
by excision and maintenance of an
adequate distal passage.
Urethral Stones
Stones may form on any hair
present in the urethra. Preoperative
epilation by fulguration of hair follicles
on skin to be buried should be carried
out. Hairs that grow postoperatively
may be fulgurated transurethrally.
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Summary

The repair of hypospadias has
proved to be one of the most chal
lenging reconstructive procedures in
urologic surgery, demanding strict ad
herence to principles which have
evolved over the years. While the twostage procedures continue to provide
a reliable result when performed by a
surgeon experienced in such proce
dures, considerable attention has re
cently been given to the development
of safe single-stage repairs, free of the
distressing complications of persistent
chordee, fistula and urethral stricture.
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Ever since ‘opium ’ fell into disfa vour,
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the search for a potent analgesic, without
narcotic liabilities, has been endless.
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of relief from moderate
to severe pain,
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• As effective in relieving pain as morphine
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• Analgesia during balanced anaesthesia.
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degree of analgesic efficacy.
• Increasfng STADOL doses yield greater
analgesic effect, in contrast to morphine,
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liability for respiratory depression.
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prompt onset of analgesia which is main
tained for 3-4 hours.
• Has low physical-dependence liability,
limited respiratory depressant effect, with
sedation being the most frequent reaction,
less frequent reactions are nausea,
vomiting and C.N.S. effects.
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Should not be used in patients physically
dependent on narcotics or with significant
previous narcotic experience, since it
will induce withdrawal reactions unless
detoxification is accomplished prior to use.
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and can also specifically reverse the major pharmacodynamic actions of narcotic
drugs (antagonist action). These opposing actions are dose-dependent; the
agonist properties being produced at lower doses. The exact mechanism of
action of butorphanol is unknown at this time, however, it is thought to exert
its analgesic effect via the central nervous system, possibly blocking the action
of the hydrolysis of acetylthiocholine.
The analgesic activity of 2 mg of butorphanol tartrate administered parenterally
is approximately equivalent to 10 mg morphine sulfate, 80 mg meperidine hydro
chloride or 40 mg pentazocine. In normal volunteers the same doses of these
drugs produce nearly equivalent respiratory depression. Butorphanol, in contrast
to morphine or meperidine produces respiratory depression in a limited dose
range, reaching a plateau at approximately 4 mg.
The onset time for analgesia with STADOL is within 10 minutes after intramuscular
administration and within one minute following intravenous administration. The
duration of analgesia at doses of 1-4 mg is generally 3-4 hours with a peak
activity at 30 minutes following intramuscular injection and 4-5 minutes following
intravenous injection. The mean plasma half-life of butorphanol is 3.9 hours
after a 1 mg intravenous administration and 4.9 hours after a 2 mg intramuscular
administration. The main route of excretion is via the urine, in vitro studies
show that butorphanol is about 80% bound to plasma proteins over the range of
concentrations found in human plasma after therapeutic doses.
INDICATIONS: STADOL (butorphanol tartrate) is indicated for the relief of moderate
to severe pain, including prepartum, preoperative, and postoperative pain, and
renal colic. STADOL is also indicated for analgesia during balanced anesthesia.
CONTRAINDICATIONS: STADOL (butorphanol tartrate) should not be administered
to patients who have been shown to be hypersensitive to it or its ingredients.
USE IN PREGNANCY: The use of STADOL is women of childbearing potential
requires that the expected benefit of the drug be weighed against the potential
risk to the mother and fetus.
USE IN CHILDREN: Clinical experience in children under 12 years of age is
limited, therefore, use of STADOL is not recommended in this age group.
WARNINGS: Because of the antagonist properties of STADOL (butorphanol
tartrate), patients who are physically dependent upon narcotics may experience
withdrawal symptoms and therefore, should not be given STADOL.
DRUG DEPENDENCE: STADOL has not been used clinically for a sufficient time
to fully evaluate the physical dependence liability, but it is felt to be lower than
typical narcotic agonists (e.g. morphine or meperidine). Nevertheless, STADOL
should be administered cautiously to patients who are emotionally unstable or
who have a history of drug misuse.
In patients with an elevated cerebrospinal fluid pressure, caused by head injury
or intracranial lesions, STADOL should not be used since it can produce miosis,
which may obscure the clinical course of the patient.
PRECAUTIONS: Some patients receiving therapeutic doses of STADOL (butorphanol
tartrate) have experienced hallucinations (usually visual), disorientation and
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The Abdominal Surgeon and the Ureter
G. B eland ,

Iatrogenic ureteral injuries are not
common but may occur whenever the
retroperitoneum is opened. The best time
to treat these injuries is when they
occur. The abdominal surgeon is
responsible for the immediate treatment
of ureteral injuries that he causes and
should be able to take care of most
of them. The author describes methods
for preventing and managing ureteral
puncture, crushing injury, kinking and
ligation of the ureter, partial and
complete transection of ureters, excision
of both short and long segments of the
ureter and ureteral devascularization.
Les lesions ureterales iatrogenes ne
sont pas frequentes mais elles peuvent
survenir chaque fois qu'il y a ouverture
retroperitoneale. Le meilleur temps
pour traiter ces lesions est lorsqu'elles
surviennent. Le specialiste en chirurgie
abdominale est responsable du
traitement immediat des lesions
ureterales qu’il cause et il devrait etre
capable de veiller a la plupart d'entre
elles. L'auteur decrit les moyens de
prevention et de traitement des
perforations ureterales, des lesions par
ecrasement, des coudures et ligatures
de I'uretere, des dissections transversales partielles et completes des
ureteres, de I'excision de segments
courts ou longs de I’uretere et d’une
devascularisation ureterale.

The surgeon who performs abdominal
operations faces the possibility of in
juring the ureter either accidentally or
intentionally, such as when abdominal
masses are removed. A consensus has
been reached about the management of
these injuries. One important point that
has been made is the need for imme
diate diagnosis and definitive treatment.
Over the years I have had the oppor
tunity to treat many iatrogenic ureteral
injuries,1’2 and in this paper I discuss
briefly my experience in the preven
tion, diagnosis and immediate treat
ment of such injuries. I shall review

From the department of surgery, division
of urology, University of Montreal
School of Medicine, Montreal, PQ
Reprint requests to: Dr. G. Beland, Head,
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what every surgeon should know who
ventures into the retroperitoneum and
who may cause ureteral injuries.
Prevention
It is fundamental that the surgeon
should know the normal anatomy of
the ureter. There are particular points
to be borne in mind which predispose
count for many of them: the ureter is
to iatrogenic ureteral injuries and acadherent to the posterior peritoneum
and follows it whenever it is elevated;
this is important to remember when dis
secting the colon and when closing the
posterior peritoneum of the pelvis. Dur
ing gynecologic operations the proxi
mity of the ureter to the uterine artery
and cervix must be kept in mind. The
lower extremity of the ureter is separ
ated from the vagina by only a small
amount of connective tissue. The rec
tum is also very close to the lower
ureter.
The vasculature of the ureter comes
from many arteries and one or many
of them may be sacrificed with im
punity. On the other hand the intrinsic
blood supply of the ureter is much
more precarious. There is a vascular
anastomotic network in the ureteral
adventitia which cannot be suppressed
for more than 2 cm without risking
ureteral necrosis. This length is still
shorter when the ureter has been irra
diated. On the other hand when the
adventitia is respected the ureter may
be mobilized for a considerable dis
tance without consequence.3
Knowledge of the ureteral anatomy
of the individual patient is also very
important. Intravenous pyelography
should be carried out on all patients
who undergo operation in which there
is a possibility of penetration of the
retroperitoneum. This rule is now
widely accepted and operating on the
colon and rectum, the internal female
genitalia or the major abdominal vessels
without first obtaining an intravenous
pyelogram cannot be justified. Of
course a more complete urologic evalu
ation should be carried out if the pye
logram is abnormal.
Prevention of ureteral injury cannot
be discussed without reference to the
use of ureteral catheters during the
operation. In the past these were used
frequently when an abdominal mass was

VOLUME 22, NO. 6, NOVEMBER 1979

/

removed. Today many consider that
they give a false sense of security
Although they may occasionally be
helpful they more often cause prob
lems. A ureteral catheter may intro
duce infection and if it is too tightly in
place can cause ischemia of the ure
teral wall with ensuing stenosis. The
presence of a catheter in the ureter
sometimes facilitates its dissection but
generally renders it more rigid and
predisposes to injury. In some cases the
ureter has been divided with a ureteral
catheter within it.4 We believe that it
is preferable to identify the ureter well
visually rather than with the help of a
ureteral catheter. Those who may still
desire to use a ureteral catheter should
remember that illuminated catheter
are available today and may provide
additional help.
Attention to points of technique can
help prevent ureteral injuries. As al
ready noted, preservation of the ad
ventitia with its vasculature is para
mount. This means that all manipula
tions of the ureter must be carried out
with great care. The ureter should not
be held with forceps. Tapes and sponges
should not be passed around the ureter
because they do not slide well and can
damage the blood vessels in the adven
titia. If ureteral retraction is necessary,
he use of a Penrose drain which slides
well is preferable. When there is bleed
ing close to the ureter, blind hemostasis
must not be performed and the use of
mass ligatures should be avoided.5 The
ureter can easily be caught in a ligature
or be kinked when ligating the periure
teral tissues. Such bleeding should be
controlled temporarily with compres
sion and time must be taken to define
and dissect the ureter completely. The
ureter can also be ligated or kinked
when closing the posterior peritoneum
if the ureter is not clearly seen it is
more advisable to leave the peritoneum
open. During hysterectomy, the ureter
sometimes becomes ligated during
vaginal closure; if the bladder is not
well separated from the vagina and re
tracted anteriorly the intramural por
tion of the ureter may be included in
the closure.
Urologic surgery more than any
other field of surgery predisposes to
ureteral injuries. Pyelolithotomy and
ureterolithotomy are the most common
operations performed on the upper
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urinary tract by nonurologists. When
the ureter is completely obstructed it is
edematous and friable. It must be
manipulated as little as possible and
with great caution. Injuries can occur
at all levels of the ureter, but avulsion
at the ureteropelvic junction is most
common when traction is exerted on
the ureter in order to reach the pelvis
of the kidney. A similar avulsion can
be produced at the lower end of the
ureter where it is less accessible. In
short, when performing ureteral surgery
for stones no traction should be exerted
on the ureter; instead there should be
longer incisions, better retraction of
surrounding tissues and direct exposure
over the calculus.
Some general surgeons also do open
prostatectomies, mostly suprapubic.
Because of the shape of an enlarged
prostate the ureteral orifices are some
times located near the bladder neck. In
these cases securing hemostasis around
the bladder neck with sutures becomes
hazardous because the end of the ureter
may be included. When such sutures
have been placed, the surgeon must
make sure that the ureters are still open
by observing the efflux of urine or by
passing a small ureteral catheter.
Endoscopic manipulation of ureteral
stones is a hazardous procedure which
is fraught with danger even in the
hands of a trained urologist. Those who
are less well trained should not embark
upon this kind of operation. Amongst
other things, the lower ureter may be
avulsed.
Diagnosis of Ureteral Injuries
during Operation

In most cases injury to the ureter will
be obvious at the time of operation.
When a ureteral injury is suspected a
more thorough dissection of the ureter
should be carried out. When a partial
or complete transection of the ureter is
feared, a dye such as indigo carmine
or methylene blue can be injected in
travenously and seen in the operative
field. If doubt still persists a longi
tudinal ureterotomy can be made and a
ureteral catheter passed. For those who
are unwilling to do a ureterotomy when
working through a suprapubic incision,
retrograde ureteral catheterization can
easily be carried out through a bladder
incision. If doubt still persists uretero
graphy can be done on the operating
table by injecting a radiopaque sub
stance into the ureter. The important
point is that the abdomen must never
be closed if there is a ureteral injury or
when such an injury is possible. The
best time to treat a ureteral injury is at
the time of the operation and not later.
At that time the tissues are normal and
lend themselves to an adequate repair.
VOLUME 22, NO. 6, NOVEMBER 1979 /

Nature of Injuries and
Their Treatment

In this section we review all possible
injuries of the ureter, including simple
ones about which questions are some
times asked, and suggest appropriate
treatment in each case.
Ureteral Puncture
Penetration of the ureter by a needle
if of no consequence and no treatment
is required. Any bleeding is arrested.
Crushing Injury
When the ureter is accidentally
crushed in a clamp, the clamp is re
moved and the operation continued. In
most instances, after an interval, the
ureter appears normal; sometimes the
crushed segment is not even visible and
ureteral peristalsis is normal. However,
if a segment is obviously devascularized
it should be excised and treated as
for excision of a short segment.
Kinking
When the ureter is kinked releasing
it sufficiently to remove all compression
is usually all that is required.
Ligation
The ureter may be included in a mass
ligature or ligated separately. Removal
of the suture material is usually suffi
cient. If the ureter does not appear
normal the involved segment should be
removed.
Partial Transection
When a partial transection of the
ureter involves less than one third of
its circumference, a water-tight closure
of the gap can be made with interrupted
4-0 or 5-0 chromic catgut, suturing the
whole thickness of the ureter except
the mucosa. Normal healing occurs.
When the transection involves more
than one third of the circumference of
the ureter the transection should be
completed and treated as such.
Complete Transection or Excision
of a Short Segment of Ureter
When the ureter has been completely
severed, continuity can be re-established
either by an end-to-end ureteral an
astomosis or by reimplantation of the
ureter into the bladder. The former pro
cedure should be done when the injury
is too far from the bladder for reim
plantation even though the likelihood
of a stricture developing is greater. The
latter procedure is simpler and rarely
presents complications; its only draw
back is a vesicoureteral reflux if an
adequate tunnel has not been formed.
However, such reflux is generally well

tolerated by patients with normal
bladders.
Since it is the aim of this paper to
give practical suggestions, let me briefly
point out, without discussion, the im
portant steps of these two procedures.
The technique is simple but must be
performed with great care and precision
in order to obtain good results. The
important steps of a ureteroureter
ostomy are as follows:
Debridement.—All necrotic tissue
should be removed from both ends of
the ureter which must present normal
vascularity.
Spatulation.— Both ends are bevelled
in order that an oblique anastomosis
may be done. This avoids stricture with
retraction of the scar as occurs fre
quently with a transverse anastomosis.
Mobilization.—The ureter must be
mobilized proximally and distally with
out disrupting its vasculature, so that
an anastomosis can be made without
tension.
Water-tight
suturing.—The
an
astomosis is made with interrupted 4-0
or 5-0 chromic catgut or Dexon sutures
taking the whole thickness of the ure
teral wall except the mucosa. Suture
material within the lumen of the ureter
may encourage infection and formation
of calculi. Enough sutures are used to
obtain a water-tight closure; excessive
suture material may interfere with nor
mal healing.
Covering the anastomosis with fat.—
The anastomosis should not rest on
aponeurosis but be covered with fat.
Urinary diversion and splinting.—
These are not indicated when repairing
injury to an otherwise normal ureter.
Drainage.— A Penrose drain is left
near the anastomosis to prevent collec
tion of urine or blood that could inter
fere with normal healing.
A simple ureteroneocystostomy can
be performed in the following manner
when the proximal end of the cut ure
ter can reach the bladder without ten
sion: The distal end is sutured. The
bladder is opened anteriorly. Another
incision is made in the lateral wall of
the bladder the same size as the ureter
at a point that the ureter reaches with
out tension. The ureter is introduced
into the bladder through this incision.
The end of the ureter is incised longi
tudinally on opposite sides and the two
ureteral flaps are sutured to the bladder
mucosa with interrupted 4-0 chromic
catgut. This can be reinforced by
suturing the outer layer of the ureter
to that of the bladder. The bladder is
then closed with a cystostomy tube in
the usual manner.

THE CANADIAN JOURNAL OF SURGERY

541

ADJUNCTIVE TO REST
AND PHYSICAL THERAPY FOR THE
RELIEF OF MUSCLE SPASM
OF LOCAL ORIGIN ASSOCIATED
WITH ACUTE, PAINFUL
MUSCULOSKELETAL CONDITIONS

FLEXERIL
[CYCLOBENZAPRINE HYDROCHLORIDE TABLETS)

Relieves spasm without
interfering with muscle
function
Usually patients can be relieved o f muscle spasm and not
experience general muscle weakness.
FLEXERIL" is not recom mended for spasticity due to central
nervous system disease.

Prompt onset of action
Clinical improvement has been observed as early as the first
day of therapy in some patients. The full therapeutic response
often can be expected during the first week of therapy.

Simple dosage regim en

MERCK
SHARP
&DOHME
CANADA LIMITED

HIGHLY EFFECTIVE SKELETAL MUSCLE RELAXANT
z lm n a r l/

FLEXERIL

Excision o f a Long Segment
o f Ureter

SKELETAL M U SC LE RELAXANT

INDICATIONS

This is a very unusual situation and
constitutes a serious problem which
can be managed properly only by a
urologist. This type of injury as well
as the others is best repaired when it
occurs. If no urologist is available the
responsible surgeon may perform a
nephrectomy if the patient has a short
life expectancy and a normal kidney
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ureter, doing a nephrostomy and refer
ring the patient to a urologist.
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I have reviewed the factors that
might favour the occurrence of ureteral
injuries and the steps to follow in order
to avoid most of them. I have also
described the types of injuries and their
appropriate treatment according to
present knowledge. These procedures
are simple and must be known by all
surgeons who operate in the abdomen.
Ureteral injuries are not common but
can occur at any time during abdominal
operations and the surgeon must be
ready to cope with them. Their imme
diate definitive repair is a prerequisite
for the patient’s smooth recovery. Ure
teral injuries are the responsibility of
the operating surgeon and he should be
able to manage most cases because a
urologist is not always available.
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shunted away from hepatocytes before
the operation because of anatomic
changes in the liver microcirculation.

None u
preoperative predictors of
encephalopathy proposed so far to
evaluate the risk of portacaval shunting
in cirrhotic patients has been of value.
The authors have found, in preliminary
studies, that measurement of the
hepatic extraction of indocyanine green
(ICG), which correlates highly with the
“functional" portal blood supply, could
be of prognostic value: cirrhotic patients
with a near-normal value for ICG
extraction often have encephalopathy
after portacaval shunting whereas those
with a low ICG extraction value seldom
have encephalopathy. These preliminary
data suggest that cirrhotic patients
with markedly decreased ICG extraction
have a lesser risk of encephalopathy
since their portal blood supply is already

Dans 1’evaluation preoperatoire des
malades cirrhotiques devant subir une
anastomose porto-cave, aucun element
pronostique n’a vraiment permis, jusqu’a
maintenant, de predire I’apparition
d'encephalopathie post-operatoire. Nos
observations preliminaires nous
indiquent que la mesure de I'extraction
hepatique de ITCG, un parametre
hautement correle avec la mesure du
debit portal “fonctionnel”, pourrait
servir d’indice pronostique: les cirrho
tiques avec une extraction d'ICG a peu
pres normale tendent a presenter de
I'encephalopathie post-operatoire alors
que ceux qui ont une faible extraction
d'ICG n’en presentent pas. Ces donnees
preliminaires suggerent que chez les
cirrhotiques dont I’extraction de ITCG
est tres diminuee, le risque d'encephaiopathie post-operatoire est moindre
parce que le sang portal est peu ou pas
en contact avec les hepatocytes a la
suite des remaniements anatomiques
de la microcirculation hepatique.

From the clinical research centre and
departments of medicine and surgery,
Hopital Saint-Luc and University de
Montreal, Montreal, PQ
Presented at the 48th annual meeting
of the Royal College of Physicians
and Surgeons of Canada by the
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Prospective controlled studies of the
efficacy of therapeutic portacaval
shunts in cirrhosis1'4 have shown that
shunted patients fall into two distinct
groups according to their clinical re
sponse: one group (70% to 80% of pa
tients) that tolerates well the total di
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version of portal flow and a second
group (20% to 30% of patients) in
which hepatic encephalopathy results.
Because a portacaval shunt sometimes
has a notable effect on the quality of
life of cirrhotic patients, surgeons and
hepatologists managing these patients
should be able to answer the following
basic question: Can the postoperative
outcome and occurrence of hepatic
encephalopathy be predicted for a given
cirrhotic patient with recurrent bleed
ing varices for whom a therapeutic
portacaval shunt is clearly indicated?
These two groups of cirrhotic pa
tients which have undergone portacaval
shunting appear to have similar clinical
and chemical features. Serum bilirubin
and albumin concentrations and pro
thrombin time of these patients were
similar so that their long-term prog
nosis could not be predicted before
operation.2 It has also been reported
that the occurrence of encephalopathy
cannot be predicted when patients are
classified according to Child’s criteria
before surgery.5,6
Portacaval shunts not only shut off
all (or part) of the portal blood that
flows to the liver, which contains
various nutrients and the so-called hepatotropic factors such as insulin and
glucagon,7 but also divert into the sys
temic circulation nitrogenous com
pounds implicated in the pathogenesis
of hepatic encephalopathy.8,9 Therefore
preoperative methods of hemodynamic
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or metabolic assessment, or both, must
be developed so that these two ap
parently similar groups can be differen
tiated from one another, making it
possible to predict the postoperative
course of the patient.
Initially two relatively simple hemo
dynamic measurements were consi
dered: wedged hepatic venous pressure
and estimated hepatic blood flow. In
1970, Reynolds10 clearly showed that
there was no predictable relationship
between these two preoperative meas
urements and the postoperative course.
Recently, however, in a preliminary
report, Zimmon and Kessler11 suggested
that the intrahepatic venous pressure
might have prognostic value: there were
fewer postoperative deaths and instan
ces of encephalopathy in patients with
an intrahepatic venous pressure greater
than 25 cm H20 than in those with in
trahepatic venous pressure of less than
25 cm H20 . These data have yet to
be confirmed and are in conflict with
those of previously reported studies.1012
Since portacaval shunting induces a
sudden diversion of portal blood flow
from the liver, Warren and associates13
suggested that the clinical response of
cirrhotic patients to operation depends
on the preoperative magnitude of the
portal blood flow. However, because of
the relative inaccessibility of the portal
vein, absolute portal blood flow (or
even the portal fraction of hepatic
blood flow) is difficult to measure preoperatively in many patients. Therefore
indirect measurements were first ob
tained in order to approximate the true
flow through the portal vein. Various
measurements of pressures and pres
sure differences, using a clamp occlud
ing the portal vein during operation,
have been proposed as useful indirect
estimates of portal flow.13-14 These in
direct estimates (maximum perfusion
pressure and portal perfusion pressure)
have also been proposed as useful in
dices peroperatively for predicting post
operative complications.13 Two recent
studies12,15 clearly demonstrated that
these variables have no value in the
preoperative predictability of postoper
ative outcome. Moreover, Burchell and
associates15 proved that these indirect
estimates of portal blood flow did not
correlate with the true flow through the
portal vein measured by flowmeters.
Other important data were also ob
tained from Burchell’s study: neither
the absolute portal blood flow nor the
portal fraction of hepatic blood flow
correlated with the postoperative
course. However, the flowmeter meas
urements were obtained during laparo
tomy after dissection of hepatic vessels
and while the patients were anesthe
tized. Anesthesia reduces hepatic blood
flow and, presumably, the portal blood
546

flow10 and it has been found that dis
section of hepatic artery and portal
vein may modify the portal fraction
of hepatic blood flow in anesthetized
dogs (Huet P-M: McGill University,
PhD thesis, 1973).
We reported a method for estimating
the portal fraction of hepatic blood
flow in unanesthetized patients by cannulating the umbilicoportal vein.17 In
dicator dilution curves were obtained
from the portal vein and one hepatic
vein after injection into the superior
mesenteric artery of a bolus of red
blood cells labelled with chromium-51.
The portal fraction of hepatic blood
flow can be calculated from compari
son of the two curves. In 10 patients
with alcoholic cirrhosis who subse
quently underwent an end-to-side port
acaval shunt, the occurrence of ence
phalopathy could not be predicted from
the preoperative determination of the
portal fraction of hepatic blood flow
(range 14% to 87.3%) (Huet P-M: Un
published data, 1978).
Such findings should dampen the
enthusiasm for using complex ap
proaches in the selection of patients
who should undergo portacaval shunt
ing. However, another hemodynamic
feature should be considered: the he
patic artery response to the diversion
of portal flow. Normally blood flow to
the hepatic artery increases when the
portal vein is clamped and may com
pensate for the hepatic blood flow.18
Burchell and associates19 recently pro
posed a direct evaluation of the hepatic
artery response by measuring its flow
before and after completion of porta
caval shunting. Their results suggested
that patients with an increase in the
hepatic artery flow of less than 100 ml/
min had poorer clinical results than
patients with an increase in flow of
more than 100 ml/min. Unfortunately,
these data can only be obtained after
surgery. In 1973, Zimmon and Kessler2’

suggested that changes in the wedged
hepatic venous pressure following
pumping of blood from the portal vein
through an umbilicoportal catheter
might be useful in predicting postoper
ative outcome. They hypothesized that
the wedged hepatic venous pressure
should remain stable in cirrhotic pa
tients if the hepatic artery is able to
compensate for the reduced portal in
flow. For such patients a better prog
nosis was suggested than for patients in
whom the pressure decreases. In an
other preliminary study they recorded
changes in the portal venous pressure
that occurred following administration
of intravenous vasopressin and deduced
from the observed changes the ability
of the hepatic artery to increase or
decrease its flow.21 Cirrhotic patients
with a decrease in portal venous pres
sure of less than 6 mm Hg appeared to
do better after portacaval shunting than
did patients with a greater decrease.
These procedures are too complex for
routine use and the results have not
been verified experimentally or con
firmed clinically by prospective studies.
The key value in predicting the oc
currence of encephalopathy postoperatively may not be the absolute portal
flow or even the hepatic artery response
but could be the “functional” portal
blood supply—portal venous blood ef
fectively in contact with hepatic cells
along the sinusoids. The concept of
functional blood supply was pro
posed in 1962 by Shaldon and as
sociates22 when they found that the
extraction by the liver of heat-denatured
albumin was decreased in cirrhotic
patients.
In cirrhosis, anatomic changes in the
liver microcirculation occur in the re
generative nodules: (a) the central veins
are displaced eccentrically in fibrous
septa and anastomoses develop with
the portal venules (intrahepatic portohepatic shunts)23-24 and (b) there is a

RIG- 1— Dilution curves of red blood cells labelled with chromium-51 (5,Cr
RBC) and albumin microaggregates labelled with iodine-125 (125I-AMA) obtained from
one hepatic vein after single injection into portal vein in two patients with alcoholic
cirrhosis. E ‘“ I-AMA = percentage of hepatic uptake of m I-AMA.
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FIG. 2— Correlation between hepatic
extraction of 125I-AMA and of indocyanine
green (E-ICG) in 29 cirrhotic patients
(closed circles) and 5 patients with non
cirrhotic presinusoidal portal hypertension
(open circles) (r = 0.952, P < 0.001).

therapeutic portacaval shunting using
the preoperative hepatic extraction of
ICG as an index of the functional
portal blood supply.29 Clinically and
biochemically the 20 patients appeared
to be quite similar as did the severity
of their portal hypertension. However,
these patients showed a wide range of
hepatic extraction of ICG (3.3% to
43.8%) before surgery. Nineteen pa
tients were followed up from 1.5 to 64
months (416 patient-months). Ence
phalopathy occurred in seven patients
and was associated with progressive
liver failure in one patient. In these 7
patients the preoperative hepatic ex
traction of ICG was only slightly de
creased (range 21.1% to 43.8%, mean
33.7%). By contrast, the 12 other pa
tients who did not experience encepha
lopathy or liver failure, had markedly
decreased preoperative hepatic extrac
tion of ICG (range 3.3% to 18.2%,
mean 11.1%). A highly significant dif
ference (P < 0.001) existed between the
hepatic extraction of ICG of patients
who had encephalopathy and of pa
tients who did not (Fig. 3).
These preliminary data suggest that
cirrhotic patients with markedly de
creased functional, portal blood supply
as evaluated by the hepatic extraction
of ICG are at less risk of encephalo
pathy after portacaval shunting than
patients with slightly decreased values
(Fig. 4). In patients with substantially
reduced extraction, portal blood is ap
parently already shunted away from
hepatocytes before operation because
of the existing anatomic changes of
the liver microcirculation; therefore, in
such patients the surgical interruption
of portal flow should induce only minor
changes in the microcirculation of re
generative nodules.
This hypothesis is currently being
investigated prospectively in our hos
pital. If this hypothesis is confirmed,
CIRRHOTICS WITH
the preoperative evaluation of the he
BLEEDING VARICES
patic extraction of ICG may prove
E-ICG ± +
E-ICG 4+1
useful in selecting cirrhotic patients for
siightly decreased
markedly decreased
portacaval shunting and in their prog
functional P B S
functional P B S
nosis. Hepatic extraction of ICG is a
relatively simple value to obtain and
can be made available in most hospi
SURGERY
tals. Eventually, portacaval shunting
could be reserved for patients whose
functional portal blood supply is sub
stantially reduced. In patients with a
near-normal functional portal blood
supply distal splenorenal shunting may
preserve portal flow while controlling
ENCEPHALOPATHY
variceal
hemorrhage.30
Portacaval
WELL
AND/OR
shunting associated with hepatic arLIVER FAILURE
terialization might be an alternative
procedure which would preserve hepa
FIG. 4— Schematic diagram of proposed
tic blood flow.31

capillarization of the sinusoids with
collagen deposits in the Disse space.*5
These anatomic changes limit the
access of portal blood to, or contact
with, hepatocytes and Kupffer cells. In
1976, our group26 described a method
for simultaneously measuring the hepa
tic extractions of indocyanine green
(ICG) by the hepatocytes and albumin
microaggregates labelled with iodine125 (125I-AMA) by the Kupffer cells in
unanesthetized patients. The hepatic
extraction of ICG was calculated using
a continuous infusion of ICG and
sampling from one hepatic vein and the
portal vein (or one peripheral artery).27
The hepatic uptake of 125I-AMA during
one passage through the liver was cal
culated using portal or hepatic vein
multiple indicator dilution curves, or
both26’28 (Fig. 1). In 34 patients, with
or without cirrhosis, a highly significant
correlation (P < 0.001, using Pearson’s
coefficient of correlation r = 0.952)
was found between the extraction of
these two substances, removed by two
different cell populations and measured
by different methods (Fig. 2). Such a
correlation strongly suggests that in
cirrhosis the alteration of both extrac
tions is explained by the anatomic
changes described in the liver microcirculation. Therefore either extraction
may effectively be used as an index
of the functional portal blood supply
to the liver in cirrhotic patients.
Recently, we hypothesized that the
clinical response of cirrhotic patients
to portacaval shunting could depend
mainly on the value of their preoper
ative “functional” portal blood supply,
irrespective of the absolute portal blood
flow.29 To test this hypothesis, we
studied, retrospectively, 20 patients with
alcoholic cirrhosis who underwent

++

+

o

FIG. 3— Presence ( + ) or absence (O)
of encephalopathy in 19 patients after
portacaval shunting related to percentage
preoperative E -IC G (N = normal value
in our laboratory).
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hypothesis based on E-ICG as evaluation
of “functional” portal blood supply (PBS)
in cirrhotic patients before portacaval
shunting.
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SESAP II Question
Items 643-644
A 10-month-old infant appears to have pain on urination. He voids frequently and in small volumes. A tender,
indistinct lower abdominal mass is defined by palpation.
643. The most likely diagnosis is
(A)
(B)
(C)
(D)
(E)

cystitis
hypospadias
urethral valve
diverticulum of the bladder
persistent urachal cyst

644. Which of the following would be most useful in establishing the diagnosis?
(A)
(B)
(C)
(D)
(E)

Urinalysis
Quantitative urine culture with determination of antibiotic sensitivities
Intravenous pyelography with a voiding cystourethrogram
Cystoscopy
Cystometric studies

For the incomplete statement and the question above select one completion for each that is best of the five given.
F or the critique of Items 643 and 644 see page 561 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education
and Self-assessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program
No. 3, please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Emergency Treatment of Variceal Hemorrhage
M.J. O r l o f f , MD, FACS*

The cirrhotic patient with acute bleeding
from esophageal varices has less than
a 5 0 % chance of leaving the hospital
alive; the outlook for survival is so poor
that even desperate measures are
worthwhile. Som e traditional nonsurgical
methods for the control of the bleeding
are either ineffective at worst or
temporary at best. Balloon tamponade
is not recommended at all, but intra
venously administered vasopressin may
be helpful in allowing the necessary
diagnostic investigations to be completed.
M ost important at this stage are the
measures necessary to improve the
general status of the patient—
restoration of blood volume with fresh
blood, prevention of ammonia intoxi
cation, support of the liver, correction,
of metabolic alkalosis and treatment of
the hyperdynamic state with digitalis
and cardiotonic drugs. Controlling the
bleeding is not the greatest problem—
the greatest problem is achieving
survival of a critically ill patient who
undergoes a formidable operation
(e.g., variceal ligation stops the bleeding,
but is itself an operation of consider
able magnitude). In our hands
emergency shunting is the best
treatment providing a definitive
procedure with the highest 10-year
survival rate and the lowest complication
rate.
Le patient cirrhotique souffrant
d'hemorragie aigue de varices
oesophagiennes a moins de 5 0 %
de chances de quitter I'hopital en vie;
les chances de survie sont si minces
que meme les mesure heroiques
sont indiquees. Certaines methodes
traditionnelles non chirurgicales
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M.J. Orloff, Department of surgery,
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destinees a juguler I'hemorragie sont
inefficaces au pire ou temporaires
au mieux. La tamponnade par ballonnet
n'est absolument pas recommandee
m ais I’injection intraveineuse
de vasopressine peut utilement
permettre de completer les etudes
de diagnostic necessaires. A ce stade,
les mesures les plus importantes
consistent a ameliorer I'etat general
du malade par la correction du volume
sanguin a I'aide de sang frais,
la prevention de I’intoxication par
I'ammoniac, ['assistance hepatique,
la correction de I'alcalose metabolique
et le traitement de I’etat hyperdynamique
par la digitale et les cardiotoniques.
Le plus gros probleme n’est toutefois
pas d’arreter I'hemorragie mais plutot
d'assurer la survie d’un patient
dangereusement malade qui subit une
formidable operation (la ligature
d'une veine varioueuse arrete
I'hemorragie mais, c’est en soi une
operation d'une importance conside
rable). Pour nous, I’operation de
pontage pratiquee en urgence est le
meilleur traitement: c’est une
intervention definitive offrant le meilleur
indice de survie apres 10 ans et le plus
taux de complication.

There are three circumstances in which
surgical therapy has been used in pa
tients with esophageal varices— as
prophylactic treatment, as elective
therapy and as emergency treatment.
Each circumstance is different and in
volves different patients, so that it is
fallacious to compare them with each
other or to group them together in
evaluating the results of treatment.
Prophylactic surgery is clearly of no

value. Three groups have shown its
ineffectiveness in well-designed pro
spective studies. We have never per
formed a shunt for prophylaxis.
Elective surgery is still controversial.
There is no question that by carefully
selecting patients for elective thera
peutic shunting, the operation can be
done with a mortality of less than 10%
and a 5-year survival rate of 50% to
60%. However, I must emphasize that
the elective treatment of bleeding
varices is only a small part of the
problem and that our concentration on
this aspect of portal hypertension
during the past three decades has been
seriously misplaced.
The cirrhotic patient who enters the
hospital with his first episode of
variceal hemorrhage has less than a
50% chance of leaving the hospital
alive. The immediate mortality of the
first bleeding episode has averaged
about 70% during each of the past four
decades (Table I). Moreover, only 10%
to 15% of bleeding cirrhotic patients
have become eligible for elective ther
apy. In the recently reported study of
therapeutic portacaval shunting by the
Boston Interhospital Liver Group,
only 75 (9%) of 832 patients with
bleeding varices underwent portacaval
shunting electively. Evidence indicates
that the traditional approach of using
temporary, nonsurgical emergency
measures in the hope of permitting
deliberate, methodical preparation of
patients for elective surgery has had
very little influence on the overall sur
vival of cirrhotic patients with variceal
hemorrhage.
It is apparent from the statistics
that emergency treatment of bleeding
esophageal varices is unquestionably

Table I— Reported Mortality of First Variceal Hemorrhage in Cirrhotic Patients

Authors, yr reported
Ratnoff and Patek, 1942
Higgins, 1947
Atik and Simeone, 1954
Nachlas and associates 1955
Cohn and Blaisdell, 1958
Taylor and Jontz, 1959
Merigan and associates, 1960
Orloff, 1962

Type of
hospital
5 private teaching
City indigent
City indigent
City indigent
City indigent
Veterans
City indigent
City indigent

No. of
patients

Mortality,

106
45
59
102
456
102
74
87

40
76
83
59
74
45
76
84
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the single most important factor in
treating portal hypertension. Our ef
forts must be directed to the prompt
and definitive control of the initial
bleeding episode if the survival rate of
patients with variceal hemorrhage is to
be improved. Therefore, during the past
20 years, we have focused our atten
tion on emergency therapy.
Diagnosis

In almost all patients, the diagnosis
can be made within 2 to 4 hours of
admission to the hospital by means of
an organized plan which includes the
following steps:
• History and physical examination
will usually elicit a background of
alcohol consumption and typical find
ing of chronic liver disease. Gastric
intubation and aspiration are essential
to confirm and monitor upper gastro
intestinal bleeding.
• Blood studies should include a
complete blood count and tests of liver
function including measurement of
serum bilirubin, alkaline phosphatase
and glutamic oxaloacetic transaminase,
bromsulfalein retention and blood gases,
and coagulation studies.
• Esophagogastroduodenoscopy with
the flexible fiberoptic endoscope can
be done in almost every patient in the
emergency room shortly after admis
sion and is the single most useful
diagnostic procedure.
• An upper gastrointestinal series
with barium as the contrast medium
should be obtained when the patient’s
condition has been stabilized. It is
emphasized that radiologic studies
are directed at determining the pre
sence not only of esophageal varices
but also of other lesions such as a duo
denal ulcer, gastric ulcer or hiatus
hernia. In our experience, emergency
radiologic studies can be performed
safely in most patients and have accur
ately demonstrated esophageal varices
at the time of bleeding in 95% of
cases.
• Determination of wedged hepatic
venous pressure by catheterization of
the hepatic veins through a groin or
arm approach provides definitive evi
dence of the presence or absence of
portal hypertension in alcoholic cir
rhosis and is extremely helpful when
other findings are equivocal.

1. Prompt restoration of the blood
volume with fresh blood if possible.
This is important because the coagula
tion defects associated with liver dis
ease are compounded by those result
ing from multiple transfusions of
stored blood. Substantial evidence in
dicates that cirrhotics are deficient in
2,3-diphosphoglycerate, the enzyme
that facilitates the unloading of oxygen
to the tissues, and that fresh blood
corrects this deficiency while bank
blood does not.
2. Prevention of hepatic coma by
thorough and repeated cleansing of the
intestine, both from above and below,
and the instillation of antibiotics into
the intestine.
3. Support of the failing liver by the
administration of concentrated glucose
solutions and vitamins parenterally.
4. Frequent monitoring of vital
functions including central venous
pressure.
5. Correction of the hypokalemic
metabolic alkalosis that is almost
always present preoperatively or im
mediately postoperatively by infusion
of large quantities of potassium chlor
ide supplemented, occasionally, by
parenteral administration of an acidify
ing agent such as ammonium chloride
or arginine hydrochloride.
6. Treatment of the hyperdynamic
state with digitalis and cardiotonic
drugs.
Nonsurgical Treatment

A number of emergency nonsurgical
measures are presently used specifically
to stop variceal bleeding. They include
the use of esophageal balloon tampon
ade, the intravenous administration of
vasopressin systemically and infusion
of vasopressin into a mesenteric artery.
Although each measure is capable of
temporarily controlling bleeding, it has
been our experience that as a group
they have not substantially influenced
the mortality in cirrhotic patients with
variceal hemorrhage.
Balloon Tamponade
There is no doubt that balloon tam
ponade has stopped variceal bleeding
in many cirrhotic patients (Table II).

The disheartening aspect of this form
of management has been that in many
patients the bleeding resumed when the
balloon was deflated. Moreover, in
our experience and that o f' others,
tamponade has been associated with a
high frequency of complications, in
cluding perforation of the esophagus,
asphyxiation from regurgitation of the
balloon into the pharynx and aspira
tion pneumonia. Finally, and most im
portant, balloon tamponade has failed
to influence measurably the mortality
associated with bleeding esophageal
varices during the three decades it has
been in use.
Systemic Vasopressin
From our experience and that of
others, it is apparent that the intra
venous administration of vasopressin
promptly lowers portal pressure and
stops the hemorrhage in many pa
tients. Most of these patients, how
ever, resume bleeding, usually with
in several hours of receiving the
drug. Vasopressin alone, therefore, is
not a definitive form of treatment but
may be valuable in buying time while
other measures are being considered
or the patient is being prepared for
operation. At present, all our patients
receive vasopressin soon after admis
sion as a bolus of 20 units of Pituitrin®,
and this measure has largely replaced
balloon tamponade as a means of ob
taining immediate control of hemor
rhage.
Mesenteric Intra-arterial
Vasopressin
Selective infusion of vasopressin into
the superior mesenteric artery through
an indwelling catheter was introduced
in 1967 by Nusbaum and associates,
and was followed by a number of
enthusiastic claims about its efficacy.
However, within the last few years
several studies have shown that this
measure is no more effective in con
trolling hemorrhage than vasopressin
given intravenously and is associated
with similar systemic toxicity and an
increased frequency of local complica
tions. Consequently, most centres have
abandoned this form of treatment of
variceal hemorrhage.

Table II— Results of Balloon Tamponade in Bleeding Cirrhotic Patients

Principles of Treatment
Authors, yr reported

No. of
patients

Initial
control,
%

Once the diagnosis of bleeding
esophageal varices has been made, there
are six general principles of treatment
which apply to all patients regardless
of the specific therapeutic measures
used to control the hemorrhage. These
are:

Reynolds and associates, 1952 32
20
Hamilton, 1955
58
Ludington, 1958
50
C onn,1958
38
Read and associates, 1960
Orloff, 1962
45
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66
45
75
70
84
55.5

Ultimate
control,
%

Mortality,
%

—

47
75

43

—

50
—

24
20

82
74
82
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Em ergency Surgical Treatment

A number of surgical procedures
have been employed to control bleed
ing esophageal varices, but, currently,
two procedures are used in the United
States for emergency surgical treat
ment. These are transesophageal liga
tion of varices and the emergency
portacaval shunt. It should be noted
that controlling the bleeding, although
a formidable task, has not been the
greatest problem. Rather, the greatest
difficulty has been that of obtaining
survival in critically ill patients with
severely damaged livers who are sub
jected to operations.
Reported experience with trans
esophageal ligation of varices is meagre,
and it has been difficult to assess the
results. Because of this, and our poor
survival rates with medical therapy, we
undertook a prospective evaluation of
this procedure some years ago. Every
cirrhotic patient admitted to the hos
pital with bleeding varices was included
in the study. The patients were as
signed, by blindly drawing a card, to
one of two groups— ligation or nonsurgical treatment. The diagnosis in all
patients was completed within 6 hours
of admission to the hospital and oper
ation was performed within 8 hours.
The study group was made up entirely
of chronic alcoholics with moderate
to advanced cirrhosis and massive
variceal hemorrhage; 50% had ascites,
52% had jaundice and 25% had
hepatic encephalopathy in addition to
bleeding varices. All operations were
done through a transthoracic approach
which is clearly superior to the ab
dominal approach.
The results of the study are shown
in Table III. The survival rate in the
group of patients with medical treat
ment was only 17% and esophageal
balloon tamponade ultimately con
trolled the bleeding in only 29% of
the patients. These results were almost
identical to the survival rate of 18%
obtained in a larger prestudy group of

Table I I I — Comparison of Emergency Transesopahageal Ligation of Varices and Medical
Therapy in Unselected Patients w ith
Cirrhosis
Medical
Variceal
treatm ent ligation
( n = 59) (n = 28)
Mean liv e r index
P atients w ith
ja u n d ic e, %
P atients w ith ascites,
%
Patients w ith encephalopathy, %
Early su rvival, %
5-y ea r su rvival, %
10-year su rvival, %

552

2.8

2.8

42

57

41

50

25
17
3
0

25
54
21
11

45 bleeding cirrhotic patients, all of
whom received identical modern med
ical therapy. (The study and prestudy
medical treatment groups are combined
in Table III.) In contrast, 54% of the
patients subjected to transesophageal
variceal ligation survived the opera
tion; the bleeding was controlled in
every patient and the invariable cause
of death was hepatic decompensation
and coma.
Experience has shown that trans
esophageal ligation of varices is not a
dependable procedure for the prolonged
control of variceal bleeding. Accord
ingly, all survivors were urged to
undergo elective portacaval shunting
during the same period of hospitaliza
tion. All the survivors who refused a
second operation ultimately rebled and
died.
From our experience with variceal
ligation, some conclusions are war
ranted. First, the procedure is uni
formly effective in stopping the bleed
ing. Second, it results in the immediate
survival of four times as many patients
as does nonsurgical treatment. As with
medical therapy it has the disad
vantage of not being a definitive pro
cedure but must be considered the first
of two stages in treatment, the second
stage of which is portacaval shunting.
Therefore, the operative mortality must
include the mortality of the subsequent
shunt procedure. Moreover, trans
esophageal variceal ligation is just as
serious as portacaval shunting.
The other surgical procedure cur
rently being used for treatment of
bleeding esophageal varices is the
emergency portacaval shunt. The ad
vantage of the venous shunt operation
is that it is the definitive treatment for
portal hypertension and bleeding eso
phageal varices. If it can be success
fully accomplished during the bleeding
episode, there is every reason to expect
that it will permanently solve the
problem of bleeding in the majority of
patients. The question is: Can cirrhotic
patients tolerate an operation of this
magnitude when it is performed as an
emergency in the presence of bleeding?
To answer this question, we have been
involved for the past 14 years in a
prospective study of emergency shunt

ing, identical in nature to our study of
variceal ligation.
Important features of the study
program are that it has been prospec
tive and has involved all patients with
variceal bleeding, regardless of their
condition. An extensive diagnostic in
vestigation is completed within 7 hours
of admission, operation is undertaken
within 8 hours, and a program of life
long follow-up is conducted in our
portal hypertension clinic so that the
current status of 97.3% of the patients
is known.
We have now performed emergency
portacaval shunting in 255 unselected,
consecutive patients; 146 were oper
ated on before June 1975 and have
a minimum of 3 years follow-up. All
146 patients were chronic alcoholics
and examination of the liver biopsy
specimen confirmed that they had
alcoholic cirrhosis. On admission 53%
had ascites, 47% were clinically
jaundiced and 20% had frank ence
phalopathy or hepatic coma. The sys
temic intravenous administration of
Pituitrin® temporarily controlled the
variceal bleeding in 95% and allowed
sufficient time for the diagnostic in
vestigations to be completed. Emer
gency portacaval shunting promptly
and permanently stopped the hemor
rhage in 97% of the patients. The
amount of blood needed for transfusion
before and during operation averaged
5100 ml.
A side-to-side portacaval shunt was
performed in 114 patients, end-to-side
shunt in 29, and another type of shunt
in 3. There was no difference in the
survival rate between those with sideto-side anastomosis and those with an
end-to-side anastomosis. The operating
time averaged 4.2 hours.
All patients had portal hypertension
with corrected free portal pressures
(obtained by subtracting the inferior
vena caval pressure) that averaged 267
mm of saline. The portacaval anasto
mosis reduced the portal pressure to
normal in all but one patient.
One of the most important questions
about portacaval shunting concerns the
effect of portal diversion on liver
function and, in turn, on survival and
the development of encephalopathy. It

Table IV— Influence of Maximum Perfusion Pressure (M P P ) before Shuntingon Survival Rate and
Frequency of Encephalopathy afte r Shunting*
MPP, mm saline
(SOPP - HOPP)

No. of
patients

<100
101 - 200
201 - 300
>300

65
35
23
17

Survival, %
46
63
52
71

Encephalopathy
in survivors, %
30
23
17
17

‘ Differences in rates of survival and of encephalopathy w ere not statistically significant.
S 0 P P = splanchnic occluded portal pressure, HOPP = hepatic occluded portal pressure.
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has been proposed that patients with
a large prograde portal blood flow
will tolerate a portacaval shunt poorly,
while those with a small prograde flow
already have most of their portal
blood diverted away from the liver and
will not suffer ill effects from a shunt.
Furthermore, it has been proposed that
measurement of the maximum perfu
sion pressure (MPP) is an accurate
indicator of prograde portal blood
flow. The uncertainty in this attractive
hypothesis is related to the capacity of
hepatic artery flow to compensate for
diversion of portal flow, a critical
factor that is unknown or difficult to
predict. Table IV shows the relation
ship of MPP to the rate of survival
and frequency of encephalopathy in
survivors. Contrary to the hypothesis,
the patients with the lowest MPP
before shunting had the lowest sur
vival rate. In contrast, patients with
the highest MPP, who might be ex
pected to suffer serious consequences
from portal diversion, had the highest
survival rate and the lowest rate of
encephalopathy. Clearly factors other
than the MPP or the magnitude of
portal flow diversion play an im
portant role in determining survival
and in the development of encephalo
pathy. Our results have been confirmed
by the studies of three other groups,
and particularly by the elegant studies
of Burchell, and colleagues who clearly
found no correlation between portal
blood flow and the response to porta
caval shunting.
Seventy-eight of our 146 patients
survived the operation, an early sur
vival rate of 53.4% in unselected
patients. The survivors have been fol
lowed up for from 3.5 to 15 years.
The predicted 10-year survival rate by
the life-table method is 30% of the
original group of 146. The actual 10year survival rate of the 30 patients
who were operated on 10 or more
years ago is 37%.
Of the 78 survivors 20 (26%) have
had encephalopathy requiring dietary
protein restriction at one time or an
other. Long-term shunt patency has
been demonstrated by angiography,
performed annually, in 90% of the
patients. The two thrombosed shunts
were of the end-to-side type. Forty-six
(59%) of the 78 survivors have not
consumed alcohol at any time during
the follow-up period and their survival
rate is 84%, compared with 58% for
those who resumed drinking. The gen
eral status of the survivors is excellent
or good in 57%, fair in 33% and poor
in 10%, and all but one of those
doing poorly have resumed heavy
drinking. Fifty-seven per cent are gain
fully employed or doing full-time
housework.
VOLUME 22, NO. 6, NOVEMBER 1979

Only three preoperative factors had
a statistically significant adverse effect
on survival. One was the presence of
ascites at the time of admission. The
second was a serum glutamic oxaloacetic
transaminase value of 100 IU/m l or
greater, which usually reflected acute
liver damage by alcohol and correlated
with the demonstration of alcoholic
hepatitis in the liver biopsy specimen.
The third was a requirement for 5000
ml or more of blood transfusion, which
reflected the magnitude of the variceal
hemorrhage. Although all three of
these factors substantially decreased
the survival rate, their presence was still
associated with an acceptable survival
rate of about 40%, so they cannot be
considered contraindications to oper
ation.
Fig. 1 shows the cumulative survival
curves resulting from the three types
of emergency therapy. The differences
between the results are highly signif
icant (P < 0.001). We conclude from
our prospective study of unselected
patients that emergency portacaval
shunting is the most effective treatment
currently available for bleeding eso
phageal varices associated with alco
holic cirrhosis. This conclusion should
not be interpreted as advocacy of
emergency shunting for all cirrhotic pa
tients with bleeding varices. Rather, it
should be emphasized that, except in ob
viously terminal patients with ascites,
jaundice, encephalopathy and severe
muscle wasting, we do not yet have a
sound basis for predicting which pa
tients have no hope of survival, even
with shunting. Criteria for exclusion
of those patients who are unlikely to
benefit from shunting still remain to be
defined.

order to improve the overall survival
of patients with this disease.
In most patients the correct diag
nosis can be reached within 4 to 5
hours of admission to the hospital by
means of the history and physical
examination, liver function tests, esophagogastroduodenoscopy, an upper
gastrointestinal series of roentgeno
grams and measurements of wedged
hepatic venous pressure.
General measures which should be
employed in all cases include prompt
restoration of blood volume with fresh
blood, prevention of ammonia in
toxication, support of the liver with
vitamins and glucose, frequent moni
toring of vital functions, correction of
metabolic alkalosis and treatment of
the hyperdynamic state with digitalis
and cardiotonic drugs.
Specific nonsurgical measures to
control bleeding, such as balloon tam
ponade, systemic intravenous adminis
tration of vasopressin and selective
administration of vasopressin into a
mesenteric artery do not consistently
achieve hemostasis. Balloon tamponade
has been particularly disappointing and
has failed to influence the high mortal
ity rate.
Regarding emergency surgical proce
dures, comparison of the results of
medical treatment, variceal ligation and
emergency shunting in a prospective
study involving 233 unselected patients
shows that the 10-year survival rate is
far better following operation and is
best in patients treated by emergency
shunting.
The only contraindication to emer
gency shunting is the presence of
ascites, jaundice, encephalopathy and
severe wasting at the time of the pa
tient’s admission to hospital.

Summary and Conclusions

Bleeding esophageal varices in pa
tients with cirrhosis carries a high
mortality. Efforts should be concen
trated on the emergency treatment in

FIG. 1— Cumulative survival rates after
three types of emergency treatment.
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Nutrition for the Cancer Patient
The diet, nutrition and cancer program
and the division of cancer treatment of
the National Cancer Institute are
sponsoring a symposium on the nutri
tion of the cancer patient. The sym
posium will be held on Jan. 10 and 11,
1980 at the National Institutes of
Health, Building 10, Masur Audito
rium, Bethesda, Maryland. Basic and
clinical presentations will relate to an
orexia, host and tumour metabolism
and nutritional support for the cancer
patient. For further information and
registration contact: Jean Cook, Capital
Systems Group, 6110 Executive Blvd.,
Rockville, MD, USA 20852 (telephone:
301-881-9400).
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Elective Management of the Patient Who Has Bled
from Esophageal Varices
B. L anger , m d , FACS, frcs [c ], L.E. R otstein , m d , frcs [c ] and P.D. G reig , md

Variceal hemorrhage can be controlled
by nonsurgical means in over 50% of
patients. As a result, their general
hepatic status can often be improved
by preoperative preparation for the
elective procedure. The major problem
following elective end-to-side portacaval
shunting is encephalopathy; it occurs
in up to one half of patients who
undergo this shunting procedure. Mesocaval shunting has been proposed as a
better operation because of the lower
frequency of encephalopathy; however,
the authors' experience has not
confirmed this. Distal splenorenal
shunting, as shown by the results of a
prospective controlled trial, does have
a lower frequency of encephalopathy,
but the initial morbidity and mortality
are higher and an improvement in the
duration of survival is not yet evident.
Chez plus de 50% des patients,
I’hemorragie variqueuse peut etre
jugulee par des moyens non chirurgicaux.
En consequence, leur etat hepatique
general peut souvent etre ameliore par
une preparation preoperatoire en vue
d’une intervention non urgente.
L'encephalopathie est le probleme
majeur consecutif a une anastomose
porto-cave distale-laterale; elle apparait
chez jusqu'a la moitie des patients qui
subissent cette operation. II a ete
suggere que I’anastomose meso-cave
etait une intervention superieure grace
a une frequence moindre d'encephalopathie; neanmoins, I'experience des
auteurs ne confirme pas ces dires.
Tel que les resultats d'une etude
prospective controlee I’ont demontre,
I’anastomose spleno-renale distale
comporte effectivement une frequence
d'encephalopathie moins elevee, mais

From the department of surgery, Toronto
General Hospital, and the University of
Toronto, Toronto, Ont.
Presented at the 48th annual meeting of
the Royal College of Physicians and
Surgeons of Canada by the Royal College
in cooperation with the Canadian
Association of General Surgeons and the
Canadian Association of Gastroenterology,
Montreal, PQ, Feb. 8, 1979
Reprint requests to: Dr. B. Langer,
1-127 University Wing, Toronto General
Hospital, 101 College St., Toronto, Ont.
M5G 1L7
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la morbidity et mortality initiales sont
plus grandes et une amelioration de la
duree de survie n’est pas encore
evidente.

Between 50% and 65% of patients
who are admitted to hospital with
bleeding varices will stop bleeding
either spontaneously or as a result of
conservative measures including the use
of vasopressin and balloon tamponade.
Such patients are at risk of death fol
lowing recurrent bleeding, the incidence
being at least 60% in the first year. To
avoid this hazard, elective portosystemic
shunting is commonly recommended in
an effort to increase the duration of
survival.
Four prospective randomized trials
have been carried out to assess the
value of portacaval shunting.1-4 Three
of the trials have shown that it is ad
vantageous; in each trial the results fell
just short of statistical significance. This
evidence supporting elective shunting
is not particularly strong; however,
there were two factors built into these
trials which may have made it difficult
to show marked differences in survival.
First, the trials were generally restricted
to patients with good hepatic function,
who tolerated recurrent bleeding well
and therefore were least likely to be
helped by shunting. Second, the trials
all included an escape clause which
allowed shunting for recurrent bleeding
in medically treated patients, thus giv
ing patients in that group the benefit
of both medical and surgical therapy.
Therefore the prospective randomized
trials appeared to show a slight advan
tage for shunting over persistent con
servative treatment in the patient who
had bled and stopped bleeding, but the
differences were not great enough to
allow complacency about portacaval
shunting as the operation of choice.
Previous trials of portacaval shunting
as a prophylactic procedure in cirrhotic
patients with varices which have not
bled failed to show any advantage over
conservative treatment.
The problem with the standard por
tacaval anastomosis used in both the
therapeutic and prophylactic shunt
trials was that even though there was
a marked decrease in the frequency of
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bleeding in patients who underwent
portacaval shunting, there was an in
crease in the frequency of encephalo
pathy after shunting and of late hepatic
failure. These changes were almost cer
tainly the result of diverting portal flow
and decreasing total hepatic blood flow.
It is interesting to speculate why all
patients who have total portal diver
sion do not have some deterioration of
hepatic function and some degree of
encephalopathy. It may be that in some
cirrhotic patients a major reduction in
portal flow has already occurred and
total diversion produces little change
in their hemodynamic status. Also,
there is evidence5 that in some patients
portal diversion is followed by a large
compensatory hepatic artery inflow so
that total hepatic flow is not greatly
changed and the liver does not suffer
injury.
In practice, however, the problem of
encephalopathy and hepatic failure
after portacaval shunting still exists,
and the solution lies in the ability to
accomplish either one of two object
ives: (a) to develop a reliable predictive
test that would identify patients who
were at risk of encephalopathy after the
shunting procedure so that they could
be excluded; or (b) to develop an oper
ation that is not associated with the
problems of encephalopathy and late
hepatic failure.
Attempts to develop predictors of
post-shunting encephalopathy have not
been successful.6’7 Clinical staging, liver
function tests and pre- and intraoper
ative studies of blood flow have not
helped to identify patients in whom
encephalopathy will develop.
With regard to alternative operations,
here are two procedures that have re
ceived considerable attention and have
been proposed as improvements over
portacaval shunting in terms of the
development of post-shunt encephalo
pathy and hepatic decompensation.
The mesocaval shunt was first used
in children with obstruction of the
portal vein.8 A modification of this
operation using an interposition graft
of synthetic material was reported by
Drapanas in 19729 to be associated with
a longer survival and a lower rate of en
cephalopathy. It should be noted that
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there has been no report of a prospect
ive randomized trial comparing this
operation with the standard portacaval
shunting procedure. Drapanas also
claimed that the interposition mesocaval
shunt afforded selective decompression
of the portal system while allowing con
tinued perfusion of the liver; he attri
buted the low frequency of encephalo
pathy to this preservation of portal
flow.
At the Toronto General Hospital, 35
mesocaval shunting procedures were
done between 1968 and 1978; 23 of
these were emergency operations. The
operative mortality was 23% (eight pa
tients). Post-shunt angiography was
done on 23 patients and early shunt
patency was confirmed in 22 of them.
Differential flow was studied by select
ive splenic and superior mesenteric in
jection in 16 patients. Preservation of
some portal flow was seen in only
three and was thought to be associated
with narrowing of the shunt. The other
13 patients had total diversion of portal
flow. We have therefore been unable to
confirm the suggestion that the meso
caval shunting preserves portal flow
o the liver.
Twenty-four of our 35 patients were
followed up for periods ranging from
3 months to 42 months; 12 patients
had encephalopathy and in 3 it
was severe. This frequency of ence
phalopathy is the same as in our
experience of portacaval shunting
and, although the patients were
studied in a random fashion, there
is no suggestion of an advantage for
mesocaval shunting over the stand
ard portacaval shunt procedure with
respect to the frequency and degree of
encephalopathy. In some patients it is
technically easier to create a mesocaval
than a portacaval shunt, and in such
patients mesocaval shunting may be a
suitable alternative in an emergency
situation. It is also the preferred shunt
in cases of demonstrated reversal of
portal flow or in cases of intractable
ascites.
The distal splenorenal shunt on the
other hand has been designed specific

ally to preserve portal venous inflow.
This operation as described by Warren,
Zeppa and Fomon10 includes division
of the splenic vein, ligation of its
proximal portion and anastomosis of
the distal portion to the renal vein, as
well as ligation of the coronary veins
and other collateral veins around the
stomach, allowing decompression of the
gastroesophageal region, which is the
region of bleeding, while preserving
portal inflow to the liver. We have
done angiography in 42 patients after
distal splenorenal shunting; 39 had
patent shunts and preservation of portal
inflow was demonstrated in 38.
To study the role of the distal spleno
renal shunt properly, we initiated a
prospective randomized trial of this
operation in 1971, comparing it to endto-side portacaval anastomosis.11 Our
results are summarized in Table I. The
operative mortality resulting from distal
splenorenal shunting was significantly
(P < 0.05, Fisher’s exact test) higher
than after portacaval anastomosis, but
most of the deaths occurred in the
early part of the study. There was a
significant (P < 0.05) decrease in the
incidence of post-shunt encephalopathy
following distal, splenorenal shunting;
this difference has also been shown by
Galambos and coworkers.12The expected
improvement in duration of survival
associated with this decrease in ence
phalopathy is as yet not apparent, but
in our experience the mean survival
of patients leaving hospital was longer
in the group of patients who under
went distal splenorenal shunting than
those who had portacaval shunting al
though this difference is not yet statis
tically significant. The survival results
are the most critical part of the trial,
so we shall continue to enter patients
into the study until this question has
' een resolved.
Conclusions

The risk of rebleeding after a patient
has survived a variceal hemorrhage is
high and is associated with a high
mortality. Controlled trials of elective
portacaval shunting have shown a slight

Table 1— Results of Prospective T ria l (1971 to 1978) of Distal Splenorenal Shunting Compared
with Those of Portacaval Shunting
Type of shunt
Porta cava
No. of patients
No. of operative deaths
No. of patients w ith post-shunt encephalopathy
Mild
Severe
No. of late deaths/no. of operative survivors
Mean late survival, mo

28
0
14
9
5
9/28
28.2

*P < 0.05.
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Distal splenorenal
27
5*
3*
3
0
4/22
43

improvement in the length of survival
for good-risk patients but a substantially
increased frequency of encephalopathy
Our current policy is to reserve emer
gency shunting for patients whose
bleeding cannot be controlled early with
conservative measures. All other pa
tients except those with marked nutri
tional impairment, severe encephalo
pathy or severe coagulopathy undergo
elective shunting.
There is no known advantage of me
socaval shunting over portacaval shunt
ing performed electively except per
haps in patients who have reversal of
portal flow or in those with intractable
ascites.
Electively performed distal spleno
renal shunting is associated with a
marked decrease in encephalopathy
compared with the standard portacaval
procedure. It promises to be the best
operation for elective shunting, but as
yet the data are insufficient to demon
strate significantly prolonged survival
compared with standard portacaval an
astomosis.
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Current Status of the Peritoneovenous Shunt for the
Management of Intractable Ascites
P .D . F ry, md, frcs ( i ), frcs [c],* R . H allgren, R N and M .E . R obertson , b sc

reponse initiate a la derivation ait
ete excellente chez 53% des patients,
la permeabilite a long terme (de plus
de 3 mois) a ete obtenue chez 43%
seulement, mais elle a considerablement
ameliore la qualite de la vie chez ces
patients.
Les indications de ('operation de
pontage, les complications, les resultats
et les taux cumulatifs de permeabilite
sont discutes.

Renewed interest in the management
of intractable ascites has led to the
use of a peritoneovenous shunt for its
control. Analysis of Canadian experience
with this technique in the last 2 years
has demonstrated that there are
problems associated with it that have
not been reported in the surgical
literature. A group of 60 patients who
underwent peritoneovenous shunting
at several Canadian centres was
analysed. The operative mortality was
20% but was related to the underlying
disease rather than to the operative
procedure. Although the initial response
to shunting was excellent in 53%, long
term patency (more than 3 months)
was achieved in only 43%, but the
procedure greatly improved the quality
of life in those patients.
The indications for shunting, the
complications, results and cumulative
patency rates are discussed.

For many years, physicians and sur
geons have been frustrated by the lack
of a successful means of treating al
coholics with intractable ascites second
ary to liver disease. O f the numerous
modalities employed in the past, the
most successful has been the judicious
use of diuretics coupled with dietary,
fluid and salt restriction. However,
there are a few patients who remain
resistant to diuretic therapy and who
can be truly said to have intractable
ascites. It is in this group of patients
that peritoneovenous shunting has been
used with some success.
The aim of this study was to assess
the indications for shunting currently
in vogue and the long-term patency,
since little information is available
concerning these aspects.
We did not attempt to review the
etiology, physiology or surgical tech
nique of placing the peritoneovenous
shunt since these aspects have already
been well documented in the medical
literature.

Le regain d'interet envers le traitement
de I'ascite rebelle a conduit a I’emploi
de la derivation peritoneoveineuse
pour son controle. L’analyse de
I'experience canadienne de cette
technique au cours des 2 dernieres
annees a demontre qu'il existe certains
problemes qui lui sont relies qui n’ont
pas ete signales dans la litterature
chirurgicale. Un groupe de 60 patients
qui ont subi un pontage peritoneoveineux dans plusieurs centres
canadiens sont analyses. La mortalite
operatoire a ete de 20% mais elle etait
reliee a la maladie sous-jacente plutot
qu'a (’intervention meme. Bien que la

Patients and Results

From the department o f surgery,
faculty o f medicine, University of
British Columbia, Vancouver, BC

The data for this analysis were ob
tained from questionnaires on 60 pa
tients (39 men, 21 women) returned by
surgeons across Canada who employed
this technique. Fifty-three (8 8 % ) of
the 60 patients fitted the description
of intractable, symptomatic ascites re
fractory to diuretics and long-term
medical treatment. The medical treat
ment in these 60 patients included diet
and salt restriction, and diuretics, in
cluding spironolactone. In 22 (3 5 % )
of the 60 patients, repeated para
centesis had also been performed. The
longest follow-up was 2 years.

Presented at the 48th annual meeting of
the Royal College o f Physicians and
Surgeons o f Canada by the Royal College
in cooperation with the Canadian
Association of General Surgeons and the
Canadian Association o f
Gastroenterology, Montreal, PQ,
Feb. 8, 1979
* Assistant clinical professor of surgery,
University of British Columbia
Reprint requests to: Dr. P.D. Fry,
Department of surgery, University of
British Columbia, 700 West 10th Ave.,
Vancouver, BC V5Z 1L5
VOLUME 22, NO. 6, NOVEMBER 1979

/

The age distribution was typical; it
ranged from 19 to 75 years (mean 50
years). The disease profile also was
typical; 46 (7 4 % ) patients had alcoholinduced cirrhosis, 3 had hepatitis, 3
had the Budd-Chiari syndrome, 5 had
neoplastic disease and 3 had other
forms of liver disease.
We graded the initial response to
peritoneovenous shunting as excellent,
moderate or poor. Excellent implied
that the response to placement of the
shunt was good and diuretic therapy
or dietary restrictions were not needed.
Moderate implied that the shunt was
obviously functioning but that the pa
tient still required some diuretic ther
apy. Poor indicated no response to the
shunting procedure.
Although 32 (5 3 % ) patients had an
excellent initial response and 22 (3 7 % )
had a moderate response, these rather
impressive figures did not reflect the
long-term success of the procedure. Our
definition of a successful outcome was
a shunt that remained patent for longer
than 3 months. O f the 32 patients who
had an excellent initial response, early
complications occurred in 16 (5 0 % ).
There were 10 (3 1 % ) early failures. At
3 months 8 (2 5 % ) patients no longer
had patent shunts and within 18
months 12 (3 8 % ) patients had died.
Six patients had a poor initial result.
The mortality of 43% (Table I) over
the study period appears exceptionally
high but reflects the underlying disease
process. The operative mortality (within
30 days of shunting) of 20% was ac
counted for in half the patients by a
coexisting hepatorenal syndrome (Table
II). Of the patients with overt (14 pa
tients) or coexisting (6 patients) hepa
torenal syndrome, 10 died within 3

T a b le

1— D e a t h s R e s u l t i n g f r o m
v e n o u s S h u n t in g

No
T im e o f d e a t h
O v e r a l l s t u d y p e r io d
O p e r a tiv e d e a t h s ( < 30 d )
L a te d e a t h s *

P e r it o n e o -

o f p a tie n ts
(a n d % )
26 (4 3 )
12 (2 0 )
14 ( 2 3 )

* M e a n s u r v i v a l 5.6 m o .
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Table II— Nonfatal Postoperative
Complications

Complication
Occluded shunt
Hemorrhage
Dissem inated intravascular
coagulopathy
Sepsis

No. of patients
(and % )
20 (33)
3(5)
8 (1 2 )
5(8)

months of the shunting procedure;
the other 10 had an excellent or moder
ately good response at 3 months.
Nonfatal complications were com
mon (Table II). The majority were oc
cluded shunts from various causes.
Disseminated intravascular coagulo
pathy occurred in 12% of the patients
who underwent this procedure and in
many of them the shunt had to be re
moved.
In attempting to evaluate the role
that peritoneovenous shunting plays in
improving the patient’s quality of life,
we looked at the relatively long-term
clinical response as assessed by the
surgeon providing the data. We divided
the patients into four groups. In pa
tients of group A, the procedure was
considered by the clinician to have
been invaluable; it provided an ex
cellent response and the shunt remained
patent longer than 3 months; 26 (43%)
patients were in this group and had a
marked improvement in the quality of
their life. In group B were 15 (25%)
patients having an excellent initial re
sponse whose shunts failed within 3
months. The effect of this group is re
flected in Fig. 1 which shows the cumu
lative patency rate for the 60 patients.
Group C consisted of seven (12%)
patients who derived some benefit from
the procedure but whose shunts failed
within 3 months. Group D included 12
(20%) patients in whom the procedure
was considered to be of no benefit.

subject.1-4 The purpose of this paper
was not to assess the various modalities
of treatment but to look critically at
the patient response to a particular
procedure, the peritoneovenous (LeVeen) shunt. Long-term published re
sults have tended to be anecdotal and
overly optimistic with few reported
complications.5,6
It is difficult to be objective when
considering this problem. On the one
hand some patients have an excellent
response to treatment (Fig. 2) and on
the other hand, the operative period is
associated with a high mortality.
It is essential to recognize that most
patients with intractable ascites re
fractory to diuretics represent the endstage of liver disease. The 20% mor
tality for peritoneovenous shunting in
this series was not from the operative
procedure itself, which is considered a
minor one, but because the patients
selected were often preterminal as a re
sult of their severe liver disease.
This aspect is further illustrated by
the patients with hepatorenal syndrome
who accounted for half of the patients
who died.7,8 By excluding patients with

hepatorenal syndrome, one could re
duce the operative mortality from 50%
to 27.5 % for patients who did not have
hepatorenal syndrome. However, the
response to shunting in patients with
hepatorenal syndrome who survived
was excellent. Such a policy would
therefore deprive them of the chance of
survival and improved quality of life.
The identification of hepatorenal
syndrome in this study must be con
sidered tenuous, considering that no
detailed biochemical or renal function
data were available. It is possible that
some patients were in renal failure
because of a volume deficit induced by
other causes and did not have true
hepatorenal syndrome.
Before inserting the LeVeen shunt,
we perform several autotransfusions to
assess the patient’s response to a volume
load both on cardiopulmonary and
renal systems. We have found this a
useful predictor of the success of the
shunting procedure if the patient re
sponds with a diuresis.
Patients with intractable ascites
are unquestionably preterminal with
respect to their underlying liver

4

The management of intractable
ascites has always been controversial
’ as demonstrated by the voluminous
medical and surgical literature on the

— —
Fig. 2b

Fig. 2a
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Discussion

FIG. 1— Cumulative patency o f peri
toneovenous shunting.

4

FIG. 2— (a) Preoperative view of 57-year-old man with intractable ascites who un
derwent peritoneovenous shunting, (b) Postoperative view.
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answer the questionnaire we sent out on
peritoneovenous shunting.

disease. Untreated and treated patients
tend to die relatively quickly as can be
seen by the 38% mortality of our ex
cellent response group within 18 months.
Long-term meaningful results are
difficult to obtain although we have
attempted to provide some index of
cumulative patency for this group of
patients. Nevertheless it seems clear
that nearly 50% of patients having this
procedure can expect significantly im
proved quality of life and in some cases
survival is prolonged. There are now
many documented cases of patients re
turning to a productive life after peritoneovenous shunting.
Surgeons will continue to see the type
of patients we have described and will re
serve this procedure for those with endstage cirrhosis in whom other modal
ities of treatment have been exhausted.
Provided it is recognized that the
duration of survival will probably not
be extended we believe that peritoneovenous shunting is worthwhile in the
small number of well-selected patients
for whom it is applicable and that it
will substantially improve the quality
of life for many of them.
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1980 DAVIS & GECK SURGICAL ESSAY AWARD
FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical resident submitting
the best paper on a surgical topic to the Canadian Journal of Surgery. This
award is intended to promote scientific and literary excellence among
Canadian surgeons in training. In the event that there is no paper of
sufficiently high calibre, the award will not be made.
The conditions of entry for the 1980 award are the following:—
1. Candidates shall currently be engaged in a recognized surgical residency
program leading to eligibility for Fellowship of the Royal College
of Physicians and Surgeons of Canada in one of the surgical specialties
(cardiovascular and thoracic surgery, general surgery, neurosurgery,
obstetrics and gynecology, ophthamology, otolaryngology, orthopedic
surgery, plastic surgery and urology).
2. The material to be submitted shall be in the form of a manuscript
relating to work in which a surgical resident is or has been the prime
or major investigator. Prior oral presentation at a Royal College meeting
or a surgical forum meeting will not be a disqualification, but prior
publication as a formal paper in a journal will. The paper should relate
to any field of surgical interest. The manuscript must conform to the
style requirements of the Journal and must not exceed 3000 words of
text and six tables and/or six figures. Coauthors are permitted on the
understanding that the candidate shall be the first author and that only
the first author shall be eligible for the award.
3. Entries must be received in the office of the Journal no later than
June 30, 1980. Each entry must be submitted to the editorial office of
the Canadian Journal of Surgery, PO Box 8650, Ottawa, Ont. K1G 0G8
with a letter stating that the paper is being submitted as an entry for
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property of the Canadian Journal of
Surgery unless returned to the author without publication.
All papers submitted will be judged by an independent committee com
prising at least one member of the editorial advisory board of the Journal,
one fellow of the Royal College of Physicians and Surgeons of Canada and
one representative of the Canadian Medical Association, together with other
fellows invited to serve at the discretion of the three permanent members
of the committee. For the purpose of judging, the candidates will be
anonymous. The judges’ decision shall be final.
The name of the successful candidate and the title of the paper will be
announced in the November 1980 issue of the Journal.
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Toute com m u nica tion in itia te d o it e tre
adressee aux coredacteurs, CP 8650,
Ottawa, Ont. K1G 0G8 sous la m en tion :

“Le journal canadien de chirurgie”.
Les te xte s o rig in a u x des a rtic le s e t des
autres com m u nica tion s y co m p ris un
nombre Iim ite de rap po rts sur des cas
speciaux d o iv e n t e tre rediges en double
exem plaire, en fra n ca is ou en anglais, et
accompagnes d ’une le ttre dem andant
leur p u b lica tio n dans le Journal. V euillez
les da ctylo g ra p h ie r sur une seu le face
d'une fe u ille non reglee avec double
in te rlig n e e t grandes marges.
Les p rin cip a le s u n ite s de m esure d o ive n t
etre exprim ees selon le S ystem e in te r
national d 'u n ite s s i c 'e s t possible.
Les illu s tra tio n s te lle s que des ph oto
graphies d'a p p a re ils cliniques, des radiographies, des p h otom icrogra ph ies, des
graphiques et des diagram m es d o ive n t
etre fou rn ie s sous la form e d'ep reu ves
sur papier glace sans montage, le s bordures in ta ctes, d un form at ne depassant
pas 20 X 25 cm. Chaque illu s tra tio n d o it
etre m unie d'une legende dactylographiee sur une page separee du te x te de
I'a rticle . S ’il s 'a g it de radiographie, en
voy ez une copie e t non / ’o rig in a l. S 'il
s ’agit d'une ph otom icrogra ph ie, indiquez
le con tra ste e t I'e c h e lle de I'agrandissement. Les le ttre s qu i serve nt a id e n tifie r
les elem e nts d 'un e illu s tra tio n d o ive n t
e tre d'une dim e n sio n s u ffis a n te a fin de
dem eurer v is ib le s lo rsqu e le s ne ce ssite s
de /'im p re ssio n im p o se n t une re d u ctio n
de I'im age fou rn ie .
II ne fau t pas qu'on puisse id e n tifie r un
patient grace a une illu s tra tio n a m oins
qu it n'y a it exp resse m ent c o n se n ti par
e crit; faute de p e rm issio n le s tra its de
sa physionom ie d o iv e n t e tre o b lite re s.
Les illu s tra tio n s en couleur ne se ro n t
publiees qu'aux fra is de I'a uteu r. Si
/'illu s tra tio n p ro v ie n t d'une a u tre source,
il convient d 'o b te n ir tant de I'a u te u r que
de I'e d ite u r de I ’ouvrage d o n t e lle e st
tiree, I'a u to ris a tio n de s'en s e rv ir aux
fins de la p u blicatio n.

II faut que le s tableaux soien t con form es
au fo rm a t re cta n g u fa ire du Journal e t
rediges su r des fe u ille s separees du
texte, un tableau pa r feu ille .

Les refere nce s d o iv e n t e tre c ite e s dans
le texte au m oyen d'un c h iffre e t groupees dans I ’o rd re a la fin de I'a rtic le
selon la m aniere de fa ire adoptee par
ce Journal. Les re fe re n ce s a des periodiques d o iv e n t e tre con form es a ce lle s
qu’adopte /’Index Medicus.

Un resum e q u i ne d o it pas depa sser 125
mots d o it accom pagner chaque a rtic le
sur une fe u ille separee.

A titre d'approbation, un e xe m plaire du
m anuscrit red ig e sera envoye a I'a u te u r
mais non le s epreuves.
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Panel Discussion
C h a ir m a n : B . L a n g er
P a n e l is t s : P.D. F r y , P-M. H u e t and M.J. O r l o f f

The papers presented by our speakers
have focused on some of the current
problems in the management of portal
hypertension. Dr. Huet has reviewed
the attempts of his group to rationalize
the selection of patients for surgery,
recognizing the shortcomings of current
surgical therapy and the variability of
the patient population. Dr. Orloff has
emphasized the special problems of
management of the patient during the
acute hemorrhage and continues to
promote an aggressive definitive sur
gical approach. 1 have presented the
case for seeking a better operation than
the standard portacaval shunt to treat
the patient who has bled and has
stopped bleeding, and for continued
controlled studies in this area. Dr. Fry
has reviewed his own and the Canadian
experience with the LeVeen shunt in
an attempt to place this new method
of therapy for intractable hepatic
ascites in its proper perspective. These
presentations inevitably raise as many
questions as they provide answers, and
we will now allow our audience the
opportunity to ask some of these
questions.
Question (Dr. Kent Grant, Charlotte
town): Would the panelists comment on
the experience of the Japanese with the
esophageal and gastric devasculariza
tion procedures?
Dr. Orloff: In about 1954 the Japanese
lost interest in portacaval shunting and
by 1964, for the most part, had switched
to nonshunting procedures in which the
area of the esophageal varices was devascularized externally and often a
transection was made across the eso
phagus or upper stomach. I must point
out that in all previous reported experi
ence with transection, including the
Tanner operation, and esophageal variPresented at the 48th annual meeting of
the Royal College of Physicians and
Surgeons of Canada by the Royal College
in cooperation with the Canadian
Association of General Surgeons and the
Canadian Association of Gastroenterology,
Montreal, PQ, Feb. 8, 1979
Reprint requests to: Editorial office,
Canadian Journal of Surgery, PO Box
8650, Ottawa, Ont. K1G 0G8
560

ceal ligation, there has been consistent
failure in the long term. All the pa
tients inexorably reformed varices and
bled again. These procedures, it is
claimed by the Japanese, are not asso
ciated with rebleeding. That experience
is incompatible with anything else I
know anywhere else in the world and
cannot be duplicated.
Question (Dr. Mortimer Levy, Mont
real): Would Dr. Fry tell us whether
results he classified as excellent were in
patients free of detectable ascites, or
did some of them have small amounts
of ascites?
Dr. Fry: Clinically there was no evi
dence of ascites in the group of patients
with excellent results.
Question (Dr. Levy): For those patients
who had no clinical evidence of ascites
what proportion could eat as much salt
as they liked and did not require diure
tics?
Dr Fry: That’s a good question. It is
a difficult one to answer exactly be
cause many of our patients are un
available for regular follow-up and
come back only when in serious
trouble. I can tell you there are some
who have gone on unrestricted diets,
which unfortunately may also include
alcohol.
Question (Dr. Levy): Do you have re
sults of sodium balance studies on
these patients? Dr. M.J. Wexler and I
have found that dogs with experi
mentally induced cirrhosis, who have
a functioning LeVeen shunt that con
trols the ascites and in whom the aldo
sterone and renin values have returned
to normal, cannot handle an orally ad
ministered salt load and retain salt.
This suggests that the maintenance of
salt retention in cirrhosis has nothing
to do with the sequestration of a third
space but is due to other factors.
Dr. Langer: In response to this ques
tion, we have placed LeVeen shunts in
22 patients and have done sodium
balance studies on 10 of them. One
patient has some detectable ascites, but

VOLUME 22, NO. 6, NOVEMBER 1979

/

clinically this is not a disability. Some
patients do require salt restriction for
persistent salt retention, and on follow
up sodium balance studies they cannot
tolerate a sodium load, so what you
have observed in the dog also occurs
in humans. From the clinical therapeu
tic point of view, however, the patients
are improved. Those who do well do
very well; patients who do poorly
usually die.
Dr. Orloff: I have not commented on
the LeVeen shunt but I would like to
do so now. I am somewhat offended by
the publicity given to the LeVeen shunt
and that makes me a little sceptical
about it. My experience with this shunt
has come largely from removing it. I
have now removed LeVeen shunts from
18 patients because of complications
that include erosion of the abdominal
wall by the prosthesis, local and sys
temic sepsis, disseminated intravascular
coagulation, thrombosis or nonfunc
tion of the valve, and pulmonary em
bolism. I would point out, therefore,
that it is not an innocuous or minor
procedure. The other aspect of this is
that the 3 months of relief that Dr. Fry
has reported is not particularly com
mendable and I would really urge that
a critical look be taken what in
tractability of ascites is and at the effec
tiveness of a regimen of diuretic ther
apy. I predict that the number of pa
tients who qualify for a LeVeen shunt
would not be large, and even then the
surgeon ought to think twice about
performing the procedure.
Question (Dr. Paul A. Jordon, Ottawa):
Dr. Orloff, would you comment on how
often you would have to use percu
taneous transhepatic embolization for
acute variceal bleeding?
Dr. Orloff: Never!
Question (Dr. Jordon): My second ques
tion is addressed to Dr. Langer, who I
know does use this procedure. Would
you comment on the same aspect?
Also, what is your own approach to
emergency portacaval shunting in vari
ceal bleeding?
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Dr. Langer: I would like to take the
questions in reverse order and com
ment first on the San Diego approach
to the actively bleeding patient which,
as described, is to operate on every
patient within 8 hours of admission.
There are very few diseases in medicine
in which a single form of therapy can
be applied indiscriminately to all pa
tients, and I think we all recognize that
there is considerable variety in the con
dition of patients who are admitted to
hospital with variceal bleeding. It is
therefore hard for me to accept that
there is one method of treatment that
is best for every patient with bleeding
varices. The proof of that is not yet in.
Marshall Orloff’s studies have con
vinced me that it is better to operate
on every patient with a variceal hemor
rhage who arrives in the emergency
department than to operate on none
of them, but I think we would do even
better if we operated on some and de
ferred operation on others. This is our
own approach. We recognize that there
are patients whose clinical condition
and hepatic function can be improved
if the bleeding can be stopped, and in
more than half of our patients this can
be done. There are some patients who
are found to have a marked degree of
alcoholic hepatitis, on biopsy, who
have a very high mortality if operated
on immediately, but who do better if
operation can be deferred. So our ap
proach to actively bleeding patients
is to treat them vigorously by conser
vative means, and that includes giving

vasopressin and performing balloon
tamponade. The patients who do not
stop bleeding after about 48 hours un
dergo shunting, except for the worst of
the patients classified as Child’s class C,
that is, those with ascites, jaundice and
encephalopathy. The patients who con
tinue to bleed and in whom shunting
cannot be carried out are those in
whom we have used transhepatic em
bolization. We have done 12 of these
procedures, and in this very seriously
ill group of patients three have survived
and have been discharged from hos
pital. So I think that there is a role for
this form of therapy. Some centres are
now using this as the primary method
of management for variceal hemor
rhage; the preliminary reports suggest
that although it is moderately success
ful in early control of bleeding, the rate
of rebleeding is quite high.
Dr. Orloff: I would like an opportunity
to respond. I don’t fundamentally disa
gree with what has been said, but I
would like to be clear on one point: I
am not sure that operating on every
patient within 8 hours of admission is
the best way to go. What I am sure is
that I cannot predict which patient will
survive without a shunt long enough to
be prepared for elective surgery. If I
try to make that prediction by the
“seat-of-the-pants” method that has
been universally applied, many patients
will fall by the wayside. I agree that
some patients should not be operated
on and some should, but at the moment

there is no scientific way of selecting
those patients. In fact, trying to make
that prediction has resulted in the loss
of many patients over the years. So,
when Dr. Langer or Dr. Huet finds a
way of making the prediction, I will
cheer and select the appropriate pa
tients for elective operation.
Dr. Langer: lust to clarify what the
difference of opinion is: if the patient
stops bleeding within 48 hours, and
many do stop bleeding, that patient
gives you an opportunity of doing an
elective operation. I don’t think that
any predictor will allow me to prejudge
who will get encephalopathy and who
will get hepatic failure. The question is
whether or not some patients should
have an elective operation rather than
an emergency operation. I think that
question can be answered by a clinical
trial and I think Dr. Orloff that you
have the patient volume to do such a
trial.
Dr. Orloff: But the problem really is,
that the patient stops bleeding and then
starts again, and the surgeon is called
to see the patient when he is on his
22nd unit of blood, 72 hours later. I
maintain that the patient has an appre
ciably smaller chance of surviving an
emergency operation at that point than
if he is operated on initially.
Question (Dr. Harry Himal, Montreal):
Dr. Orloff, of all your patients, how
many were in Child’s class C and what

Critique of Items 643 and 644 (SESAP II)
643 —Although many congenital abnormalities of the genitourinary tract may insidiously produce renal insuf

ficiency, unexplained fevers, and recurrent urinary tract infections, in a male infant the symptom complex of
abnormal voiding pattern and a lower midline mass consistent with an enlarged bladder suggests urethral
obstruction. Posterior urethral valves are the most likely cause of these findings (C). Urachal cysts and
bladder diverticula are rarely palpable, and they do not cause frequent, painful voiding.
----644— Urine studies may show infection. Infant cystoscopy, especially in males, is difficult and often inconclusive.
In contrast, an intravenous pyelogram with voiding cystourethrogram characteristically shows hydronephrosis,
bladder enlargement, and cylindrical dilation of the prostatic urethra where valves may be seen. Therefore,
intravenous pyelography with a voiding cystourethrogram describes the most useful method in establishing the
diagnosis.
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643-644/ 1. Gross RE: The Surgery of Infancy and Childhood. Philadelphia, WB Saunders Co, 1953, pp 730-731
643-644/ 2. Lattimer JK, Uson AC: Abnormalities of the lower urinary tract, in Mustard WT, Ravitch MM,
Snyder WH Jr, et al: Pediatric Surgery, ed 2. Chicago, Year Book Medical Publishers Inc, 1969, vol. 2,
pp 1158-1161
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was the operative mortality in that
subgroup?
Dr. Orloff: Around 60% of our pa
tients are in the Child’s C group. Less
than 10% of the patients in our study
group are class A, so the largest group
is the Child’s C. I can’t, off the top
of my head, give you the mortality
figure for those in Child’s class C.
Question: First, what is today’s mor
tality of patients whose first episode
of bleeding is treated medically, and
what is the substantiation for Dr.
Orloff’s figure of 50% to 70%, re
corded in the past? Second, Dr. Roy
from Spain, has suggested that death
occurs rapidly in patients with “in
tractable ascites” in whom the glome
rular filtration rate has fallen below
about 50 ml/min. I wonder if any
panelist has experience in selecting
such patients for LeVeen shunt to see
if the mortality and survival rate could
be improved.
Dr. Huet: I think the mortality of pa

tients whose first episode of bleeding
is treated medically is still about 50%,
as Dr. Orloff has said, and in our hos
pital we have had difficulty in getting
patients prepared for elective surgery.
In the last 3 years only about 20 out
of 50 such patients could be operated

on electively. The others were either
operated on as emergencies within 3
to 4 days or died of uncontrollable
bleeding before any operation could be
performed. I would like to comment on
the patients with intractable ascites. I
think that the rate of blood flow in
the portal vein should be considered in
these patients because, most of the
time, those with true intractable ascites
have stagnant portal flow or even re
versed portal flow, in which case sideto-side shunting can be performed with
out damage to the liver, and such a
shunt is much better than the LeVeen
shunt in this situation.
Dr. Langer: Dr. Fry, do you have any

information on the use of the glome
rular filtration rate in predicting who
should have a LeVeen shunt and who
should not?

ated intravascular coagulation is likely
to develop.
Question (Dr. Jordon, Ottawa): Dr.
Orloff, are you able to separate out, by
liver biopsy at the time of operation,
those who have the entity we call alco
holic hepatitis and do you have any
correlation of your results in operating
on patients with this condition?
Dr. Orloff: Yes, we have found that

the patients who have alcoholic hepati
tis do have a worse prognosis. Their
operative mortality is about 20%
higher than those who don’t have the
condition, but of course their survival
without the operation is poor so we
don’t consider the presence of alcoholic
hepatitis a contraindication to opera
tion.
Dr. Langer: I would now like to ask

Dr. Fry: Not specifically. The only

predictor that we have used is a rapid
autotransfusion of 1000 or 2000 ml
of ascitic fluid while assessing renal
function by measuring the values of
blood urea nitrogen, serum creatinine
and urinary sodium, and urine volume.
If patients respond well to this autotrans
fusion, they seem to respond well to a
LeVeen shunt. The other advantage to
this technique is that it may allow
screening of patients in whom dissemin

each of the speakers to give us a
brief wise word in conclusion.
Dr. Huet: I’m very happy to participate
in this panel with Drs. Orloff, Langer
and Fry. Dr. Orloff has for many years
been the defender of emergency sur
gical treatment and has converted more
and more surgeons to this approach.
In the area of preoperative predictors,
I hope that our studies of functional
blood flow will eventually allow more

Surgical patients don’t always eat
what they get.
Surgical patients are at nutritional risk,
and picking at their food is only one of the
factors involved. Fasting before surgery,
restricted post-op diets, latent
deficiencies and illness are other causes
which can put surgical patients under
severe nutritional stress.

Patients may need more than ‘diet as
tolerated’ when they’re about to undergo
surgery, or during convalescence from
surgery. They need a food that’s
complete, easy to take, easy to serve, and
flexible enough to be used in all surgical
situations.

4

4

rational selection of patients and of
operations.
*
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Dr. Fry: I’d just like to say that I’m
glad to hear Dr. Orloffs comments on
the LeVeen shunt. If you look at the
literature, particularly from the origin
ators of the shunt, the results appear to
be fantastic. In my own practice and in
the rest of Canada we just cannot re
produce these results. In discussing
this panel with Dr. Langer earlier this
year we decided that a cross-Canada
survey would give a better picture of
the unselected results in the general
surgical community. This survey
showed that other surgeons across Can
ada were having similar problems and
Dr. Orloffs experience with failed
shunts emphasizes this. I still feel that
it is a worthwhile procedure for some
patients but the patients must be care
fully selected.
Dr. Orloff: I’ll make two final com
ments. The first is that our study of
emergency shunting followed our pro
spective unselected trial of variceal
ligation versus medical therapy, and
to be scientifically valid, a prospec
tive randomized trial of emergency
surgery versus medical therapy, per
formed concurrently needs to be
done. We are now involved in such
a trial which I hope will settle that
question once and for all. The second

comment that I would like to make
concerns the Warren shunt. I per
sonally am not doing this operation.
My reason is that its value has not been
proven. The studies such as those that
Dr. Langer and Dr. Warren and several
others are doing are of great interest to
me and when they finally reach a con
clusion, I’ll make my decision on the
basis of the evidence. But you must re
member that the Warren procedure is
applicable to only one segment of the
bleeding cirrhotic population, those
good-risk patients who can be prepared
for an elective procedure. It does not
have, in my opinion, broad applicability
even if it does prove to be a very good
procedure. I think there is no question
that it will prove to be associated with
a lower frequency of encephalopathy
than other procedures; however, in
our experience the frequency of ence
phalopathy after portacaval shunting is
not as high as some reports indicate.
The ultimate determinant will be sur
vival and those results are not in yet.
Dr. Langer: I think after the wise words
of the panelists I will let the conten
tious issues rest for a while. I thank
the speakers for their presentations and
discussion and the audience for their
questions and comments. We all have
more work to do to settle some of these
troublesome outstanding questions.
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^ With Ensure, they get the complete ^
. nutrition they need in a delicious drink.
ENSURE is a delicious ready-to-serve
liquid that delivers complete nutrition to
surgical patients. On the tray or as a
snack, ENSURE supplies quality protein,
fat, carbohydrate, essential vitamins and
minerals in a way that no hi-cal beverage
or milk-shake can match.

ENSURE is ideal for surgical patients. It
has low osmolality, low solute load, and
low residue. And ENSURE is always
ready to use, by mouth or by tube, as a
supplement or as total meal replacement.
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ORIGINAL CONTRIBUTIONS

Osteosarcoma in Manitoba: Review of 95 Patients
H.T. H u e b er t ,

A retrospective review of all recorded
cases of osteosarcoma diagnosed and
treated in Manitoba from 1930 to 1977
was carried out. There were 95 patients
(64 males, 31 females). The peak age
was 10 to 19 years. The most common
sites of osteosarcoma were the femur
(38 patients), tibia (14 patients), humerus
(13 patients) and pelvis (9 patients).
The survival rate (excluding parosteal and periosteal types) was
28% at 2 years and 16% at 5 years.
Patients who were operated upon
had a somewhat better prognosis
than those who had radiotherapy.
Initial results of chemotherapy are
encouraging. Patients with distal limb
tumours had a better prognosis than
those with more proximal neoplasms.
Patients with tumour secondary to
Paget's disease and to irradiation did
poorly, those with parosteal and
periosteal osteosarcoma did better.
Thirteen patients had 31 thoracotomies
for pulmonary metastases; their
average duration of survival after this
procedure was 9.3 months.

m d , fr c s [c ]

I’humerus (13 patients) et le bassin
(9 patients). Le taux de survie
(excluant les types parosteaux et
periostiques) a ete de 28% apres
2 ans et de 16% apres 5 ans. Les
patients qui ont ete operes ont eu un
pronostic quelque peu meilleur que
ceux qui ont recu de la radiotherapie.
Les resultats initiaux de la chimiotherapie sont encourageants. Les
patients porteurs d’une tumeur de la
partie distale des extremites ont
eu un meilleur pronostic que ceux
qui avaient une neoplasie plus proximale. Les patients ayant une tumeur
secondaire a une maladie de Paget
et a I'irradiation ont eu une evolution
mediocre; ceux qui avaient un
osteosarcome parosteal et periostique
cnt eu un meilleur pronostic.
Treize patients ont subi 31 thoraco
tomies pour metastases pulmonaires;
leur duree moyenne de survie apres
I'intervention a ete de 9.3 mois.

All cases of osteosarcoma diagnosed
and treated in Manitoba from 1930 to
1977 were studied retrospectively.
Several patients residing outside the
On a procede a une etude retrospec
province were included, but Manitoba
tive de tous les cas enregistres
residents whose condition was diag
d’osteosarcomes diagnostiques et
nosed or treated elsewhere were ex
traites au Manitoba de 1930 a 1977.
cluded. Biopsy and pathology reports
On a releve 95 patients (64 males
were available in each case and were
et 31 fem m es). L'age le plus commun
often confirmed by experts from other
etait compris entre 10 et 19 ans.
North American centres. The popula
Les localisations les plus frequentes
tion base was roughly 1 million, ap
de I’osteosarcome ont ete le femur
proximately 50% being urban.
(38 patients), le tibia (14 patients),
The purpose of this study was to
tabulate as accurately as possible the
From the section of orthopedics,
University of Manitoba, Winnipeg, Man, results of previous treatment in pa
tients with osteosarcoma, thereby pro
Reprint requests to: Dr. H.T. Huebert, viding
a baseline by which to judge
Winnipeg Clinic, Department of
any new treatment.
orthopedics, 425 St. Mary Ave.,
Winnipeg, Man. R3C 0N2
During the study period osteo
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sarcoma was diagnosed in 95 pa
tients (Table I). Price and associates'
calculated that the average incidence
of osteosarcoma was two to three
cases per million population annu
ally; the Manitoba incidence during
the last 10 years was 3.5 per million
annually.
T a b le

1— Typ es o f O s te o s a rc o m a Seen
M a n ito b a b e tw e e n 1930 an d 1977

Typ e

in

N o. o f p a tie n ts

P rim a ry
S econdary to P a g e t's
disease
E xtrao sseou s
S econdary to ir r a d ia tio n
S econdary to b e n ig n le s io n s
P a ro ste a l
P e rio s te a l

12
6
4
2
4
2

T o ta l

95

Ta b le

I I — S k e le ta l

S ite

65

D is tr ib u tio n

N o. o f tu m o u rs

L o n g bones
F e m ur
T ib ia
H um e rus
F ib u la
U ln a

38
14
13
4
2

A x ia l bones
P e lv is
Spine
M a x illa
Scapula
Ribs
C ra n iu m
M a n d ib le

9
4
2
2
1
1
1

E xtrao sseou s
T o ta l (2 m u ltic e n tr ic )

71

20

6
97

VOLUME 22, NO. 6, NOVEMBER 1979 / THE CANADIAN JOURNAL OF SURGERY

Treatment (Table III)

Patients in the Manitoba series were
treated initially by many different phy
sicians, most commonly orthopedic
surgeons. Methods of treatment have
changed during the study period.
Definitive surgery consisted of abla
tive procedures with amputation in
most cases (54) and wide excision in
the others (15).
Radiation therapy, in the form of
deep x-rays, was given as early as
1935. No primary tumour was irra
diated after the last recorded treatment
with cobalt in 1973.
The use of chemotherapy was ex
tremely variable. Few patients were
treated by chemotherapy before 1970.
One patient received mechlorethamine
(Mustargen®), which was given locally
into the pleural cavity, for pulmonary
metastases. Two had local perfusion
of the tumour area with methotrexate.
In 1976 a national protocol instituted
by the National Cancer Institute of
Canada was initiated in Manitoba:
Regimen I consists of six courses of
doxorubicin (Adriamycin®) and metho
trexate with citrovorum factor rescue
given concurrently, followed by metho
trexate at 3-week intervals for the re
mainder of 1 year. Regimen II patients
are treated by six courses of doxoru
bicin only, followed by methotrexate
for the remainder of the year. In a
random selection, six patients were
treated according to regimen I and
one according to regimen II. None of
the patients in our series received
chemotherapy alone.
No patient was treated by immuno
therapy. Four patients received no
definitive treatment for the primary
tumour; in two of these the diagnosis
was made at autopsy, a third patient
had decompressive laminectomy alone,
and the last patient had Kiintscher
nailing of a pathologic fracture of the
femur.

_» N> W -f*
o o o o

NUMBER

The distribution of osteosarcoma in
the skeleton was roughly the same as
that quoted in most series (Table II).
Two patients with Paget’s disease had
multicentric tumours. The age of our
patients at the time of diagnosis was
also similar to that noted in most
large series (Fig. 1). The peak age
in both male and female patients was
between 10 and 19 years, although there
was a much higher percentage of males
in this age group (43.7% of males,
but only 25.8% of females). In our
series there were 64 males and 31
females.
Scranton and colleagues2 noted that
the peak frequency of long bone osteo
sarcoma in females occurred 1.7 years
earlier than in males. The occurrence
is thought to be highest when the
growth rate of long bones is greatest.
In our series there was no obvious
difference in the average age at the
time of diagnosis, although the most
common year of diagnosis for females
was 16 and for males 18 years of age.

___ ~~l—
— i
10 2 0 3 0 4 0 5 0 6 0 7 0 8 0 9 0
A G E , yr

FIG. 1—Age of patients at time of
diagnosis of osteosarcoma.

Table Ill-T r e a tm e n t of Osteosarcoma
Treatm ent
D efinitive surgery
Surgery only
Radiotherapy
Radiotherapy only
Preoperative
radiotherapy
Chemotherapy
Chemotherapy only
No definitive treatm ent

No. of patients
69
30
43
21
6
22

Results and Discussion

0
4

In analysing results of treatment,
both parosteal and periosteal osteo

sarcomas were excluded from the sta
tistics, leaving a total of 89 patients
to be considered. Follow-up was ob
tained on all patients. Statistics record
survival only and do not necessarily
reflect a disease free state, although
this is most likely in long-term sur
vivors. No correction for attrition
due to other causes of death has been
made, since most of the patients were
young and it is unlikely that a large
number of deaths were due to other
causes.
Overall, the 2-year survival rate was
28% and the 5-year rate was 16%
(Table IV).
Patients who were treated surgically
had a better outcome than those who
were not, with 39% surviving 2 years
and 25% surviving 5 years. It is pos
sible that these patients had been
selected to some degree, since those
with more advanced disease likely did
not undergo operation.
Patients receiving radiation therapy
had a 2-vear survival rate of 22%
and a 5-year survival of 13%; of those
receiving radiotherapy alone, none sur
vived 5 years. Allen and Stevens3 found
no histologic evidence of tumour in the
limbs of six of seven patients who re
ceived radiotherapy before amputation.
Others have not found this treatment
mode as effective. Of the six. patients
in our series who received preoperative
radiotherapy, two survived 5 years.
Of all the patients who had chemo
therapy, 23% survived 2 years and
none 5 years. The 6-, 12- and 18month survival rates, however, were
somewhat better than the overall aver
age. Initial results in patients on the
chemotherapy protocol are encourag
ing: of the seven patients treated in
1976 and 1977, three died 9, 23 and
31 months from the time of diagnosis,
while four are alive from 26 to 33
months after the diagnosis was made.
Douglass and associates4 found that
patients treated by chemotherapy gen
erally survived 1 year longer than
those not so treated. Cortes and asso
ciates,5 Jaffe and colleagues,6'7 Pratt
and coworkers8 and Fornasier9 have
found that Adriamycin®, vincristine,
methotrexate and cyclophosphamide

Table IV — Percentage Survival of Patients w ith Osteosarcoma (Excluding Parosteal and Periosteal Osteosarcom a) w ith D ifferent Types of T rea tm en t
Length of s u rv iva l, mo
6

12

18

24

30

36

42

48

60

120

88
77
78
71
83
95
80

68
54
41
19
50
89
54

49
46
29
14
33
50
38

39
42
22
10
33
23
28

32
31
17
5
33
22
22

29
27
17
5
33
13
20

28
27
15
5
33
13
19

26
27
15
5
33
0
18

25
27
13
0
33
0
16

14
18
3
0
17
0
9

Treatm ent
Surgery (n = 63)
Surgery only (n = 26)
Radiotherapy (n = 41)
Radiotherapy only (n = 21)
Preoperative radiotherapy (n = 6)
A djunctive chemotherapy (n = 22)
Overall survival (n = 89)
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have delayed or decreased the fre
quency of gross metastases. Some sur
geons believe that with chemotherapy
less radical procedures may be used.
Rosen and colleagues10 and Marcove11
have described en bloc bone or joint
resections done in conjunction with
preoperative chemotherapy. We have
no experience of this method of treat
ment.

Osteosarcoma in Paget’s Disease

Twelve patients in the Manitoba
series had osteosarcoma secondary to
Paget’s disease. Two patients had two
sites of tumour (both sites proven by
biopsy). One patient had tumour in
the humerus and ilium, the other in
the scapula and ilium. The average
age at diagnosis was 71 years (range
59 to 87 years). There were 9 men and
3 women. Sites affected were femur
(five patients), humerus (four patients),
pelvis (two patients), spine (one pa
tient), scapula (one patient) and tibia
(one patient).
Three patients presented with patho
logic fractures of the femur due to
osteosarcoma secondary to Paget’s
disease. Three tumours were diag
nosed at autopsy. Three of the 12
patients received no active treat
ment for the tumour, 3 had major
amputations, 5 had biopsy followed by
irradiation, and 1 received radiation
therapy for a month, then died, and
the tumour was found at autopsy.
Six of the 12 patients died less than
6 months after the diagnosis was made,
while 10 died within 12 months. The
remaining two patients survived 48 and
59 months respectively.
Dahlin and Coventry12 found 20
cases of osteosarcoma secondary to

Douglass and colleagues4 found a
slightly better prognosis when the
tumour was located distally in the
limb. Dahlin and Coventry12 had an
overall 5-year survival rate of 20.3%
and in tumours distal to the elbow
or knee the survival rate was 35.8%.
In the Manitoba series, patients with
tumours in the distal part of the limb
had a 5-year survival rate of 25%
compared with 13% for those with
proximal limb tumours and 12% for
those with tumours of the axial skel
eton (Fig. 2).
In their series, Scranton and asso
ciates2 found that females survived
substantially longer than males. There
seemed to be a slightly more favour
able outlook for females in the Mani
toba series in the 12- to 24-month
period although long-term follow-up
showed no appreciable difference
(Table V).

Paget’s disease out of their series of
600. The age of these 20 patients
ranged from 32 to 70 years. Five pa
tients had involvement of the femur
and five of the humerus. They found
that 3 of the 20 patients were long
term survivors.
Extraosseous Osteosarcoma

Fine and Stout13 found 34 cases of
extraosseous osteosarcoma in the liter
ature; they added 12 of their own. Of
these 46 patients, 25 were over 30
years of age. Thirty-two had involve
ment of the extremities. Allen and
Soule14 reviewed the Mayo Clinic ex
perience. They found 26 cases. Twen
ty-four cases involved the limbs or
limb girdle, with the thigh area being
the most commonly affected. No pa
tient was in the first or second decade
of life. Four were treated by excision
alone, 11 by local excision and irra
diation and 3 by primary amputation.
Twenty-one patients had died at the
time of their review; of the 5 living
patients 2 were long-term survivors (8
and 12 years).
Six patients in the Manitoba series
were found to have extraosseous
osteosarcoma. Five were males, one
was female. The average age at the
time of diagnosis was 51 years (range
12 to 88 years). Sites included the
thigh (three patients), groin (one pa
tient), axilla (one patient) and ankle
area (one patient). Treatment consisted
of wide excision in all instances and
one patient underwent groin dissection
as well. Four patients received addi
tional radiotherapy. Four patients died
at 14, 24, 27 and 33 months, respec
tively, after the diagnosis was made.
Two were alive and apparently well
at 102 and 162 months.
Postirradiation Osteosarcoma

FIG. 2—Survival of patients with osteosarcoma according to site of tumour.

In the series reported by Dahlin and
Coventry12 16 of the 600 patients, had
postirradiation osteosarcoma. Three of
the tumours occurred after irradia
tion for carcinoma of the breast; no
patient with postirradiation osteosar
coma survived more than 3 years.
In Manitoba four patients had post
irradiation osteosarcoma 6, 6, 7 and 8
years, respectively, after irradiation
for other tumours. Bones involved
were the scapula, mandible, femur and

Table V— Percentage Survival by Sex (Excluding Parosteal and Periosteal Ostoesarcomas)
Length of survival, mo
Sex
Male (n = 61)
Female (n = 28)
All patients (n = 89)

566

6

12

18

24

30

/ 36

42

48

60

120

78
83
80

50
63
54

33
48
38

26
33
28

23
20
22

20
20
20

18
20
19

17
20
18

15
17
16

11
6
9

VOLUME 22, NO. 6, NOVEMBER 1979

/

THE CANADIAN JOURNAL OF SURGERY

sacrum. Two patients were men and
two were women; their ages ranged
from 32 to 70 years. They were treat
ed by radical excision or amputation,
and one patient received postoperative
irradiation. The patients died at 7, 8,
8 and 19 months, respectively, after
diagnosis of this second tumour.
Alpert, Abaci and Werthamer15 des
cribed a radiation-induced extraskeletal
osteosarcoma. No such tumour was
found in our series.
Osteosarcoma of the Maxilla
Harris, Muller and Greenberg16 re
viewed 37 cases of osteosarcoma of the
maxilla appearing in the world liter
ature before 1963 and added two cases
of their own. Peak age incidence was
in the third decade, with equal distribu
tion between male and female patients.
Seven patients survived 5 years and
four patients survived 10 years. Of 359
tumours of the nose and paranasal
sinuses, Eggston17 found only 2 os
teosarcomas. In Cade’s18 series, 3 of
133 cases of osteosarcoma arose in the
maxilla.
In Manitoba, a 54-year-old man un
derwent maxillectomy followed by co
balt irradiation for osteosarcoma of
the maxilla; he died 65 months after
initial treatment. A 26-year-old man
had similar treatment followed by
regional perfusion with methotrexate;
he died 14 months after the diagnosis
was made.
Parosteal Osteosarcoma
Unni19'20 reviewed the pathology of
parosteal osteosarcoma. Radiologically, there is no involvement of the me
dulla at the time of initial presentation;
histologically the tumour is well dif
ferentiated and is characterized by
well-formed osteoid trabeculae within
a spindle cell stroma. In the 79 pa
tients Unni19 reviewed, parosteal os
teosarcoma occurred more frequently
in females than in males, and the tu
mour was most commonly seen in pa
tients in the second to the fourth de
cades of life. In 54 (68%) of the 79
patients, the posterior aspect of the
femur was involved. Prognosis was
usually good, with only 4 of the 27
patients who had amputation initially
having pulmonary metastases.
In Manitoba, there were four pa
tients with parosteal osteosarcoma.
Their ages were 15, 15, 24 and 37
years, respectively, at the time the
diagnosis was made. Two were males,
two were females. Three of the lesions
were in the femur and one was in the
tibia. Treatment consisted of wide ex
cision in one patient and amputation
of the limb in three. One patient, who
VOLUME 22, NO. 6, NOVEMBER 1979 /

had a lesion of the proximal femur,
died 9 months after operation. Two pa
tients are alive at 59 and 91 months,
respectively, and one died of osteosar
coma at 17 years. While the Manitoba
experience is limited, the prognosis for
patients with parosteal osteosarcoma
seems to be better than for those with
the common form of osteosarcoma.
Periosteal Osteosarcoma
Unni20,21 has also reviewed the
clinicopathologic entity of periosteal
osteosarcoma. This tumour most often
occurs in young people and usually
involves the upper tibial metaphysis.
Radiologically, a small radiolucent
mass is seen beyond the confines of
the bone and histologically the lesion
is moderately undifferentiated and of
ten predominantly chondroblastic.
Unni21 described 23 cases of perios
teal osteosarcoma of which 14 were
in the upper tibia and 7 in the femur.
The prognosis was much the same as
that of parosteal osteosarcoma; 4 of
the 23 patients died of metastases.
In Manitoba, a 20-year-old woman
had a periosteal osteosarcoma of the
humerus locally excised three times
and then finally had a shoulder disar
ticulation. She is alive and well 31
years after the original diagnosis was
made. An 18-year-old man who had
a periosteal osteosarcoma of the frontal
bone excised, remains alive and well
12 years later.
Thompson, Patterson and Parsons22
found 11 cases of osteosarcoma of the
skull; 6 were secondary to Paget’s
disease, 3 secondary to irradiation and
2 were spontaneous. Only one patient
was alive at the time of writing, and
that patient had a spontaneous osteo
sarcoma. Goodman and McMaster23
reviewed 32 cases of osteosarcoma and
found that the survival rate of patients
with cranial osteosarcoma was the
same as that of ordinary osteosarcoma.
Our one case of cranial osteosarcoma
followed the more benign course of
periosteal osteosarcoma, rather than
that of the common form of osteosar
coma.
Tumour Spread
Generally, radical ablative surgery
is recommended for osteogenic sarco
ma in the absence of obvious metatases. The hope is that cure may be
effected in spite of the knowledge that
a large percentage of patients have
undetectable metastases at the time of
diagnosis. There is considerable con
troversy about the extent of excision
required; some surgeons now advocate
en bloc excision, others transmedullary
amputation and others believe that the
entire involved bone should be in

cluded in the amputation. All of these
surgical procedures are accompanied
by chemotherapy in the hope that micrometastases might be destroyed and
larger, though perhaps undiagnosed
metastases controlled.
In the Manitoba series a 15-year-old
boy with an osteosarcoma of the distal
fibula was treated by knee disarticula
tion. A skip lesion was found in the
middle one third of the shaft of the
fibula. This lesion had not been de
tected preoperatively by either roent
genography or bone scanning. Pul
monary metastases in the right lung
were excised 1 week later. Despite
three lung resections and extensive
chemotherapy, the patient died 14
months after the diagnosis was made.
Enneking; and Kagan24 studied 40
cases in which there was no evidence of
multifocal disease or of pulmonary me
tastases. Ten of these had skip lesions,
two lesions being obvious on the roent
genograms. Four were discovered on
gross examination and four on micro
scopic examination only. Five skip le
sions were transarticular and five in
traosseous; seven were proximal to the
primary tumour and three were distal.
At 24 months, 20 of the 30 patients
who had no obvious skip lesions were
disease free. Ablative surgery includ
ing the entire bone involved would
include some but not all of skip le
sions as described by Enneking. In the
one Manitoba case, the skip lesion was
included in the amputation, but metas
tases were already present.
The expected extent of direct intra
medullary spread is another factor in
deciding the site of surgical resection.
In the Manitoba series, roentgenog
raphy and bone scanning localized tu
mour to the distal end of the femur
in one 16-year-old patient. A hip dis
articulation was performed; gross ex
amination of the specimen showed tu
mour spread up the medulla to the
level of the lesser trochanter, at least
20 cm further than expected.
Lewis and Lotz“ studied 20 amputa
tion specimens and found a good cor
relation between roentgenograms and
gross spread; in 18 of 20 patients there
was no microscopic spread beyond
that seen grossly, while in 2 patients the
maximal spread was 2 cm. Goldman
and colleagues26 found a good correla
tion between the appearance of the
gross specimen, the bone scan and the
roentgenograms. The one Manitoba
case would seem to be an exception
to the findings of these two authors.
In Manitoba, there has been no con
sistent policy about the extent of the
ablative surgery. In 19 tumours of
the distal femur which were treated
by ablative surgery there were 11 hip
disarticulations and 8 transfemoral re-
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sections. There was no significant dif
ference in the prognosis between these
two groups.

promising (Table VI), although at the
time of writing, no patient had lived
beyond 44 months.

Pulmonary Metastases

initial diagnosis to thoracotomy aver
aged 10.7 months, while the subse
quent duration of survival averaged
9.3 months.

Summary and Conclusions

During the period 1930 to 1977, 95
With improved efficacy of chemo
therapy, it may be possible to prolong patients (64 male, 31 female) with
life in patients with pulmonary metas osteosarcoma whose disease was diag
tases, perhaps even to cure some pa nosed and treated in Manitoba were
tients by removing these lesions sur studied. The incidence of this tumour
in Manitoba is approximately 3.5/1
gically.
Jaffe and coworkers27 reported re million people annually.
The bones most commonly involved
gression of pulmonary metastases in
patients treated with methotrexate. were, in order, the femur, tibia, hu
Beattie, Martini and Rosen28 recom merus and pelvis. The peak age at the
mended combined surgery and chemo time of diagnosis was from 10 to
19 years.
therapy in children with metastatic
The principal forms of treatment
osteosarcoma, and were encouraged by
were ablative surgery, radiotherapy and
the results in 10 cases.
In the series of Spanos and asso chemotherapy. The overall survival
ciates29 30 patients with pulmonary rate (excluding parosteal and periosteal
osteosarcoma) was 28% at 2 years and
metastases were studied. Patients had
16% at 5 years. Patients who had sur
one to four thoracotomies; the 5-year
survival rate was 28%. Adverse fac gery only had a somewhat better prog
tors affecting survival were a short nosis, while those who had radio
initial tumour-free interval and the therapy had a worse prognosis. The
chemotherapy protocol has not been
multicentricity of tumours.
Marcove, Martini and Rosen30 re in use sufficiently long to draw firm
ported 22 patients who collectively had conclusions, but the initial results are
59 thoracotomies. Patients with pul encouraging.
Patients with tumours in the distal
monary metastases who did not have a
thoracotomy had a 3-year survival rate limb had a somewhat better prognosis
of 5%, and 5-year survival rate of than those with proximal limb or axial
2%. In patients who had a thoracoto tumours. The 5-year survival rate for
males and females was approximately
my the 3-year survival rate was 45%
and the 5-year survival rate was 31%. the same, although the survival rate
In Manitoba, 13 patients had a total at the 12- to 24-month period was
of 31 thoracotomies for removal of slightly better for females.
Twelve patients had osteosarcoma
pulmonary metastases. Lobectomy was
carried out for such metastases in secondary to Paget’s disease. Their
1948, 1959 and 1964 and wedge re average age at the time of diagnosis
section was adopted in 1972. Twenty- was 71 years; 10 were dead within
12 months of diagnosis. Six patients
eight wedge resections were done, with
up to 11 wedges being excised; the had extraosseous osteosarcoma, and
number of thoracotomies per patient two of them were long-term survivors.
varied from 1 to 11. All patients who Four patients had postirradiation osteo
had wedge resection also received sarcoma 6 to 8 years after irradiation
of another tumour. They all died
chemotherapy.
The average time from initial diag within 19 months of diagnosis. Four
nosis to thoracotomy was 10.7 months patients had parosteal and two had
(range 1 week to 33 months). The periosteal osteosaroma. The prognosis
average duration of survival after the for these types of tumours is relative
ly good. In our series, one patient
first thoracotomy was 9.3 months.
Four patients who had wedge resec had a skip lesion and one had exten
tion were still alive 5, 7, 24 and 44 sive unexpected intramedullary spread
months, respectively, after initial diag of the tumour.
Thirteen patients had a total of 31
nosis; all had definite or presumed
evidence of further metastases. The thoracotomies for varying numbers of
results at 12 and 18 months appear pulmonary metastases. The time from
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In the past, penicillins were not considered as products of first choice in the treatment of anaerobic infections, such as
bacteroides, and consequently, other potentially more toxic therapeutic agents were used.
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effective dry or moistened with thrombin solution, isotonic
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:

stimulates natural clotting and healing of disrupted tissue
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Gelfoam and Gelfilm are simple to use, and with conscientious observance of certain precau
tions satisfactory results may generally be expected where their use is indicated.
1. Gelfoam should be used discriminately in arterial bleeding because of the intra-arterial pres
sure. It is advisable to suture and reinforce where possible.
2. Although Gelfoam generally serves its purpose well in the presence of haemorrhagic blood
dyscrasias, it should not be relied upon as the sole method of haemostasis in such conditions.
3. Gelfoam should not be used to stop menstrual bleeding. In postpartum and menorrhagic
bleeding it serves only as a temporary vaginal tampon.
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material.
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Hemoccult® Test as a Routine Screening Procedure
for Colorectal Disease in the Private Clinic Setting
H .L . St e w a r t , m d , f r c s [c ] and E. W ie n s , m d , f r c s [ c ]

Increased attention is being focused
on the earlier detection of malignant
and premalignant colorectal lesions in
an attem pt to increase the survival rate
of patients with these diseases.
This study evaluates
Hemoccult® test as a
procedure in a private
for its implementation

the use of the
screening
clinic. A protocol
is presented.

Of the 631 patients entered into the
study, 514 (81.5%) returned completed
slides. In 14 (2.7%) of these 514
patients, the slides gave positive results,
and 10 of the 14 patients underwent
thorough investigation.
No malignant tumours were found
as a result of the test. Six (1.2% ) of
the 514 patients had one or more
benign polyps.

From the Baker Clinic, Edmonton, Alta.
Supported by a grant from the Cross
Cancer Institute research fund,
Edmonton, Alta.
Reprint requests to: Dr. E. Wiens,
Department of surgery, Royal Alexandra
Hospital, 10240 Kingsway, Edmonton,
Alta. T5H 3V9
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Une attention accrue est accordee
a la detection de plus en plus precoce
des lesions malignes et pre-malignes
du colon et du rectum dans une
tentative pour ameliorer la survie des
patients attaints de ces maladies.
Cette etude evalue I’epreuve
Hemoccult® utilisee comme procedure
de depistage en clinique privee. On
decrit un protocole destine a son
application.
Des 631 patients entres dans I’etude,
514 (81.5%) retournerent leurs lamelles
d'Hemoccult®. Les lames donnerent
des resultats positifs chez 14 (2.7%)
de ces 514 patients, et 10 des 14
subirent des etudes approfondies.
Aucune tumeur maligne occulte n'a
ete trouvee. Six (1.2% ) des 514 patients
avaient un ou plusieurs polypes benins.

Epidemiologic studies have shown that
the survival rate following a diagnosis
of colorectal cancer has remained
static for the past two decades.1 Increas
ing interest is therefore being directed
towards earlier detection of the disease
in an attempt to improve these statistics.
Methods employed to date for the
detection of colorectal cancers in the
general population have been: (a)
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taking a history and carrying out a
physical examination, including digital
rectal examination, (b) periodic sig
moidoscopy and (c) stool testing for
occult blood (Hemoccult® test, SmithKline Diagnostics, Sunnyvale, CA).
Hemoccult® testing is gaining in pop
ularity because it is practical and effec
tive in detecting colorectal pathologic
conditions.2-7 Most reports of this tech
nique have been from mass screening5.«.8 An element of preselection is
unavoidable in such studies. Our ob
jective was to introduce stool occult
blood testing into a private clinic set
ting to evaluate: (a) patient acceptance
and compliance, (b) physician accept
ance, (c) the number of pathologic condi
tions diagnosed by this method, (d)
cost of the test and (e) the feasibility
of incorporating it into a complete
medical examination as a routine
procedure.
M ethod

All patients over 40 years of age
who underwent a complete medical
examination were given the opportunity
to participate in a cancer screening
research project. There were few re
fusals. Those Who entered the project

THE CANADIAN JOURNAL OF SURGERY

were informed of the rationale for the
testing, were instructed in the method
of stool sample collection and the diet
to be followed during this period and
were told about further procedures to
be carried out should the test results
prove positive. The test material and
printed instructions were provided.
Each patient was given three slides
which, when returned, were tested by
the authors according to the manufac
turer’s instructions. Patients with neg
ative results were informed by means
of a form lett', emphasizing that the
test was not a complete cancer check
up and that any bowel symptoms
should be reported to their doctor. Pa
tients with one or more positive samples
were seen again. They were questioned
regarding adherence to the test diet
and more thoroughly about symptoms
and past history of bowel disease.
Roentgenography after a barium enema
and colonoscopic examination were
carried out. If these investigations re
vealed no pathologic condition to ac
count for the occult blood in the stool,
they were referred back to their
physician. Bowel abnormalities detected
were managed according to our cur
rent practices.
Those patients who did not return
the test slides within 3 weeks were
sent a reminder letter.
Results

Six hundred and thirty-one patients
(266 men and 365 women) entered the
study and 514 (81.5%) returned the
completed slides. Approximately 10%
returned the slides after the reminder
letter had been sent.
Of the patients returning slides, 500
had negative results and in 14 one or
more stool samples was positive for
occult blood. Ten of the 14 made ap
pointments for follow-up. One patient
could not be contacted for further
follow-up. In two patients the results
were negative on retesting. False

positive results had been produced be
cause of thick stool smears in one case
and by the ingestion of horseradish in
the other. One patient with hemor
rhoids had noted frank blood and re
fused further investigation.
Table I shows the results obtained
from the 10 patients with positive slide
findings who underwent follow-up in
terviews, roentgenographic examination
after a barium enema and colonoscopic
examination. All polyps were removed
by colonoscopic snare polypectomy
without incident and with the excep
tion of case 6, all polyps were exam
ined microscopically. The polyp in
case 6 could not be retrieved. Appro
priate medical management was ad
vised for the other conditions diagnosed.
Only 4 of 14 patients with a stool
specimen that was positive for occult
blood had noted the passage of blood
per rectum. This included one patient
who was not followed up and cases 6,
7 and 9 in Table I.
The reasons for the complete med
ical check-up are shown in Table II.
T a b le I I — Reason fo r M ed ical C he c k -u p in
514 P a tie n ts

Reason
R o u tin e m edical
G a s tro in te s tin a l com plaint
M uscu loskeletal com plaint
C ardio vascular com plaint
N euro logic com plaint
R esp ira to ry c om plaint
G y n ecologic/urologic co m p la in t
M iscellaneous

P ercen tag e
of p a tie n ts
69.5
8.2
6.3
5.5
4.0
1.6
1.4
3.5

Discussion
The 81.5% return rate of test slides
by the study population who were
regular clinic patients but were not
otherwise preselected or preadvised of
the nature of the test indicates a high
degree of patient cooperation, similar
to that of programs in which subjects
actively chose to participate.5*6'9 More
over, the many favourable comments
by patients regarding the test, both to
the interviewers and to their own physi
cians, indicates good acceptance of
such testing. That 10% of the patients
returned their samples only after being
sent a reminder letter indicates the
value of such a simple adjunctive
measure.
Physician acceptance of the screen
ing program was satisfactory overall.
While some had reservations about
how productive such testing might be,
most encouraged its introduction as a
regular part of the complete medical
examination.
The 2.7% frequency of occult blood
in the stool is within the range reported
by others.5*8*9 This confirms that a
substantial number of patients with
stools positive for occult blood can be
discovered in the adult population. The
over-40 age group to be tested was
chosen simply on the basis of the age
incidence of colorectal carcinoma. The
age distribution of the patients entered,
into the study is shown in Fig. 1. This
clearly indicates that most patients
screened were in the 45 to 65-year age
group, the age at particular risk for
colorectal carcinoma.

T a b le 1— Diagnosis in P a tie n ts w ith Occult
Blood in th e Stool
Case
no.
i
2
3
4
5
6
7
8
9
10

D iagnosis
Functional bowel disease
A c e ty lsa lic y lic acid in g e s tio n , up to
3.9 g /d
A denom atous polyp, rectum
Functional bowel disease
Adenom atous polyp, descending colon
Adenom atous polyp, sigm oid colon,
and hem orrhoids
Tw o adenom atous polyps, transverse
colon
In fla m m a to ry polyp w ith e p ith e lia l
dysplasia, descending colon
D iv e rtic u la r disease, sigm oid colon
A denom atous polyp, sigm oid colon

FIG. 1—Age distribution of patients who underwent Hemoccult® test.
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The patient questionnaire was aimed
at detecting other patient-related fac
tors that might help select subpopulaions in which screening would be better
indicated. Obviously, the total number
of patients screened, the number of
positive results and the number with
colonic disease were too small to dis
criminate
significant
epidemiologic
factors. Such an analysis would require
a much larger study. However, the
data indicate that the majority of these
patients were coming for their annual
check-up and very few had gastro
intestinal symptoms. It is also evident
that as a group they were in the habit
of seeking medical attention on a
regular basis; within the preceding 2
years, 85% had undergone a complete
physician examination, which included
a rectal examination in 59.2%. The
more specific colonic examinations had
been performed much less frequently
within the preceding 2 years (sigmoid
oscopy in 9.8%, colonoscopy in
0.8% and roentgenography after a
barium enema in 10.3%) so that no
large proportion had undergone in
vestigations that would have detected
colonic disease and limited the produc
tivity of Hemoccult® screening.
When a patient has a stool specimen
that is positive for occult blood, we
believe that a minimum follow-up
should consist of roentgenography
after a barium enema and colonoscopic
examination which complement each
other in providing an accurate assess
ment of the condition of the large
bowel at an acceptable cost. The value
of colonoscopic examination is also
demonstrated by the fact that none of
the neoplastic lesions in this study
were detected by conventional roent
genography following a barium enema,
although some might have been de
tected if air contrast had been used.
Furthermore, endoscopic examination
of the bowel with a sigmoidoscope
would have discovered only the one
rectal polyp and possibly the two sig
moid polyps. The four polyps situated
more proximally would not have been
reached. Colonoscopy provides the
added opportunity for immediate defi
nitive management of the majority of
polypoid lesions of the bowel.
Does this type of screening program
identify patients with pathologic con
ditions of the colon? In our opinion,
the answer is yes. All patients investi
gated whose stool contained occult blood
had gastrointestinal disorders, in
volving the colon in most cases. Over
1% of patients had benign colonic
polyps. This is important, as we favour
the theory that the majority of carci
nomas of the colon arise in pre-existing
benign polyps and the existence of such
polyps indicates a tendency for neo
574

plasia in that particular bowel mucosa.10
As substantiated by Gilbertsen,11 sub
sequent carcinoma may be prevented
in some of these patients by removing
polyps with malignant potential. The
detection of benign polyps also alerts
the physician that the patient is in a
high-risk category for colonic cancer.
That no actual carcinoma was dis
covered is not surprising in view of the
number of patients screened. The de
tection rate reported for colonic and
rectal cancers in mass screening of re
cruited patients has been approximately
1 in 450 patients.0,8 We were unable to
test sufficient numbers of patients
during our study to confirm such a
figure, and it is quite possible that the
rate might be even less frequent in
such a completely unselected popula
tion.
The cost of the Hemoccult® test itself
is in our opinion very reasonable. The
total cost of materials used per patient
for the 3 days of testing was 48
cents or 16 cents per slide. Each pa
tient used three slides which, for con
venience, were included on one card
and could be detached easily along the
perforations provided. The developing
solution wias provided with each box
of 100 slides. The developing of the
slide and reading of the result took 30
seconds and we did not add the time
taken by office staff and medical per
sonnel in the cost accounting of this
project.
The major goal of the project, to
determine if such a screening program
could be introduced into a private
practice setting, was achieved. In our
opinion the percentage of patients
entering the study, the 81.5% return
rate of the test slides and the favour
able feedback from patients demon
strates unequivocally that medically
knowledgeable patients from a private
practice today are willing and anxious
to have adjunctive examinations to
evaluate their health more completely.
The study also suggested a format
for introducing the test as a routine
laboratory examination. The protocol
devised is as follows: A patient over
the age of 40 years who presents for
a complete medical examination is
provided with the Hemoccult® test sup
plies and instructions. Negative results
are recorded in the patient’s chart,
while positive results are immediately
passed on to the attending physician
so that a follow-up examination can
be arranged. Those patients not return
ing the slides within 3 weeks are sent
a reminder letter asking them to com
plete the test.
Summary

This small study has provided sup
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plemental information on the merits of
mass screening of patients by Hem
occult® testing of the stool to provide
early detection of colorectal cancers.
We have confirmed that the test does
detect large bowel disease and that it
can be used on a routine basis in
private practice as an adjunct to the
annual medical check-up. Further
studies of large groups of patients are
required to determine if substantial
numbers of colorectal cancers can
be detected and whether patients with
colorectal cancer diagnosed in this
fashion can be shown to have an im
proved survival rate.
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Acute Spinal Cord Injury:
Analysis of Epidemiologic Factors
C harles H. T ator,

The authors studied the epidemiologic
aspects of acute spinal cord injury in
358 patients admitted to the Toronto
General and Sunnybrook hospitals
between 1948 and 1973. The ages of the
patients ranged from 14 to 89 years
(median 32 years) and the maleifemale
ratio was 4.5:1. The most frequent
causes of injury were traffic
accidents (34.4% ), accidents at work
(29.3%), sports-recreational injuries
(15.4%) and falls at home (9.8%).
Several epidemiologic factors were
identified which are important for
developing programs to reduce the
frequency of cord injury. In particular
young persons should be made more
aware of the risks they run as auto
mobile drivers and of the hazards of
diving in shallow water, middle-aged
workers in the construction industry
are at risk of spinal cord injury from
falls and elderly farmers are at risk of
falling from lofts or being crushed
by overturned tractors.

md, ph d, frcs[c ] and

V irginia E. E dmonds,

et les chutes a domicile (9.8%). Plusieurs
facteurs epidemiologiques importants
pour la mise au point de programmes
visant a reduire la frequence des
lesions de la moelle ont ete identifies.
En particulier, les jeunes devraient etre
rendus conscients des risques qu'ils
affrontent en tant que conducteurs
d'automobile, et aux dangers de plonger
en eau peu profonde, les travailleurs
de la construction d'age moyen sont
exposes aux risques de blessures de
la moelle epiniere dues aux chutes et
les fermiers ages risquent de chuter
des greniers ou d'etre ecrases lors du
renversement d’un tracteur.

Major injuries to the spinal cord are
serious for a number of reasons. For
example, in upper cervical cord injuries
especially at an older age, the mortality
from respiratory complications is ex
ceedingly high. Also, the morbidity
of severe injuries to the cord is great
because of the profound effect these
injuries have on most body functions
Les auteurs ont etudie les facteurs
and on the social and psychological
epidemiologiques associes aux
well-being of the patient, his family and
traumatismes de la moelle epiniere chez
society. Indeed, the cost to society of
358 patients hospitalises au Toronto
each new quadriplegic amounts to hun
General Hospital et au Sunnybrook
dreds of thousands of dollars in life
Hospital entre 1948 et 1973. L'age des
long medical costs and lost earnings.
Although much productive research
patients s’etalait entre 14 et 89 ans
(mediane, 32 ans) et la proportion des
during the past 10 years has improved
des hommes par rapport aux femmes
our understanding of the pathophysiol
a ete de 4.5:1. Les causes les plus
ogy of spinal cord injury1 and the
frequentes de ces lesions furent les
management of the acute and rehabil
accidents de la circulation (34.4%), les
itative phases, the mortality and mor
accidents de travail (29.3%), les
bidity rates of spinal cord injury remain
blessures resultant de la pratique des
formidable.
sports ou d'activites recreatives (15.4%)
Prevention of such injury should be
one of the major concerns of the med
ical profession and of society. Study
of the epidemiologic factors should
From the division of neurosurgery and
acute spinal cord injury unit, Sunnybrook provide useful information for pre
Medical Centre, Toronto, Ont.
venting spinal cord injury.
Supported by grants from the Physicians’
Services Incorporated Foundation and
the Ontario Ministry of Health
Presented at conjoint meeting of
Canadian Association of Clinical
Surgeons, eastern division, and Ontario
University Surgeons, Toronto, Ont.
June 3, 1978
Reprint requests to: Dr. C.H. Tator,
Neurosurgical laboratory— r wing,
Sunnybrook Medical Centre,
2075 Bayview Ave., Toronto, Ont.
M4N 3M5

Material and Methods

The records of patients with acute
spinal cord injuries admitted to
the Toronto General and Sunnybrook
hospitals during the 25-year period
from 1948 to 1973 were analysed. For
inclusion in the study a patient must
have been admitted to either hospital
within 30 days of injury, and the pa
tient’s record must have contained com

rn

plete documentation of the cord in
jury, treatment and result. Patients who
had major treatment in other institu
tions before referral or who had spinal
injuries without cord involvement were
excluded. Similarly, those with only
root involvement and those with inju
ries at or below the L2 level were also
excluded. In all, 358 patients were in
cluded in the study. The information
was processed at the University of
Toronto Computer Centre using the
Statistical Package for the Social Sci
ences (SPSS).
Results
Sex and Age

Of the 358 patients, 293 (81.8%)
were male and 65 (18.2%) female,
a ratio of 4.5:1. Females tended to be
older than males at the time of injury,
the median age for females being 37
years compared with 31 years for
males.
The youngest patient in the series
was 14 years of age reflecting the ad
mission policies of the two hospitals in
that younger children are not admitted;
the oldest patient was 89 years of age.
Table I and Fig. 1 show the age distri
bution of patients in decades.
The largest group was that in the
third decade of life, 103 patients
(28.8% of the total), followed in num
ber by the 62 patients (17.3%) in the
second decade and the 58 (16.2%) pa
tients in the fourth decade. Of the
358 patients, 46.1% were 30 years of
age or younger, 62.3% were 40 years
or younger, and 76.3% were 50 or
younger. Only 12.2% of patients were
61 years of age or older. The most
frequent single age was 22, and the
median age was 32 years.
Fig. 1 demonstrates the high fre
quency of spinal cord injuries among
young men, compared with the more
uniform distribution in women.
Location of Accident

Fig. 2 shows the location of the acci
dents in terms of distance from To
ronto. The largest number of injuries
occurred within Metro Toronto which
includes the city and four boroughs.
However, many injuries occurred at a
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considerable distance from the city.
For example, 43 patients sustained a
spinal cord injury at distances ranging
from 250 to 499 miles (400 to 800 km)
from Toronto. The distribution of sites
of accident also reflects the referral
pattern in Ontario, in which the Toron
to hospitals have a catchment area
limited in the east by the areas served
by the Kingston and Ottawa hospitals
and in the west by the areas served by
the Hamilton and London hospitals.
In the north the area served extended
for a considerable distance during most
of the period of this study. Now the
area served is much smaller because of
the establishment of neurosurgical units
in Sudbury and Thunder Bay.
Ninety-nine (27.7%) cord injuries
occurred within 10 miles (16 km) of
the boundary of Metro Toronto includ
ing those in Metro Toronto (Table II).
An additional 10.9% of the total oc
curred from 10 to 24 miles (16 to 39
km) beyond the city boundary and
18.4% occurred at a distance of 25 to
49 miles (40 to 79 km). Thus, 57.0%
occurred within 50 miles (80 km) of
Metro Toronto and almost 75% occur
red within 150 miles (241 km). This in
formation is most important in helping
to plan speedier evacuation of patients
with spinal cord injuries.

Table 1—Age Distribution

Age interval, yr

No. of
patients

Frequency, %

11 - 20
21-30
31-40
41-50
51-60
61-70
71-80
>80

62
103
58
50
41
24
15
5

17.3
28.8
16.2
14.0
11.5
6.7
4.2
1.4

Total

358

100.1

Cumulative
frequency, %
17.3
46.1
62.3
76.3
87.8
94.5
98.7
100.1

Causes of Spinal Cord Injury
We made a detailed analysis of the
causes of the spinal cord injuries in
these patients. Traffic accidents were
the leading cause of spinal cord injury.
They included pedestrian, automobile,
truck, motor cycle and bicycle acci
dents and accounted for 123 (34.4%)
of the injuries. Most were injuries to
the occupants of automobiles. There
were eight motor cyclists and only one
bicyclist with spinal cord injuries.
Accidents at work were the second
most frequent cause of cord injury and
accounted for 105 (29.3%) of the 358
cases; 18 injuries occurred in the log
ging industry, 10 in mining, 24 in con
struction, 15 in farming and 38 in other
fields of work (Table III). Of these 105
patients, 50 were injured in falls and
44 were struck or crushed.
Sports-recreational injuries, the third
most frequent cause, accounted for 55
(15.4%) of the injuries. They occurred
in a variety of sports and recreational
activities (Table IV), of which diving
was the most frequent (69.1%). Of the
38 diving injuries, 3 were sustained
during exhibition or competition while
the remaining 35 were sustained during
recreational activity. The 38 diving in
juries accounted for 10.5% of the 358
spinal cord injuries. Motor sports ex
cluding snowmobiling were responsible
for three injuries and snowmobiling

F IG . 1— N um ber of male and fem ale patients in 10-year age intervals.

F IG . 2— N um ber of patients injured at various distances from Toronto.
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Table II— Location of Accidents
Distance from
Toronto, m
< 1 0 and Toronto
1 0 - 24
2 5 - 49
5 0 - 74
75 -1 4 9
150 - 249
250 - 499
500 - 999
>999
Outside Ontario
Total

No. of
patients

Frequency, %

Cumulative
frequency, %

99
39
66
39
23
37
43
8
1
3

27.7
10.9
18.4
10.9
6.4
10.3
12.0
2.2
0.3
0.8

27.7
38.6
57.0
67.9
74.3
84.6
96.6
98.8
99.1
99.9

358

99.9

resulted in two injuries. The small
number of injuries to the spinal cord
from football was a surprising finding.
The fourth most frequent cause was
a fall at home. Thirty-five (9.8%) sus
tained a spinal cord injury at home,
all due to falls.
Victims of crime accounted for five
spinal cord injuries; two were due to
falls, two to gunshot wounds and one
to a knife wound. Suicide attempts
accounted for five spinal cord injuries,
three due to falls and two to gunshot
wounds.
Discussion

Table I I I —W ork-Related Accidents and T h e ir Occurrence in D ifferent Age Groups
No. of patients injured
Age, yr

Logging

Mining

Construction Farming

Other work

Total no.

Frequency, %

1 1 -2 0
2 1 -3 0
3 1 -4 0
4 1 -5 0
5 1 -6 0
> 60

2
7
4
3
2
0

1
2
6
1
0
0

2
5
6
7
4
0

1
0
1
4
5
4

3
10
9
6
7
3

9
24
26
21
18
7

8.6
22.9
24.8
20.0
17.1
6.7

Total

18

10

24

15

38

105

100.1

17.1

9.5

22.9

14.3

36.2

100.0

Frequency,
%

The marked preponderance of males
over females with spinal cord injury
parallels the experience reported from
other countries.2'6 The very young age
of the majority of the patients has
also been noted by other investi
gators.5'7
Kurtzke2 who has compared the
causes of spinal cord injury in various
countries found that traffic accidents
ranked first in all countries. Falls, both
occupational
and
nonoccupational,
ranked second. Sports accidents gener
ally ranked third, and in all countries
diving injuries were the most common.
Sutton5 reported that 14.0% of all
cord injuries from sports accidents in
Australia were due to diving compared
with our figure of 10.6%.
We analysed in detail the relation
ship between the age of the patient and
the cause of the cord injury. Fig. 3
shows the four most frequent types of
injuries including traffic, work, sportsrecreational and a fall at home which
together accounted for 318 (88.9%)
injuries and relates these to the age of
the patient when the injury occurred.
The majority of traffic and sportsrecreational injuries were in young
adults. Work accidents, which were
most frequent in young and middleaged persons (Fig. 3), were further

T a b le

IV — Sports-R ecreational
Spinal Cord In ju ry

A c tiv ity

o

FIG. 3— Relationship between four main causes of spinal cord injuries and age.
Points represent percentage, in each 5-year age group, of total for each type of injury.
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No. of
patients

Causes of

Frequency,
%

D iving
M otor sport
Football
W ater-skiing
Snowmobiling
Hunting
Snow-skiing
Tobogganing
Soccer
Gymnastics
Horseback riding
W eight-liftin g

38
3
2
2
2
2
1
1
1
1
1
1

69.1
5.5
3.6
3.6
3.6
3.6
1.8
1.8
1.8
1.8
1.8
1.8

Total

55

99.8
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analysed according to exact cause
(Table III). Logging, mining and con
struction accidents occurred mainly
in the 21 to 50-year age groups without
any preponderance of one cause
in any given decade. Farm accidents
showed a definite tendency to occur in
the older age groups. Fig. 3 also shows
the marked increase in the number of
falls at home with increasing age.
In Fig. 4 the percentage of each of
the four main types of accidents occuring at 5-year age intervals is indicated.
For example, in the 11 to 15-year age
group approximately 70% of the ac
cidents were of the sports-recreational
type, approximately 15% were due to
traffic accidents and none were due to
work or falls at home. Of the seven
patients in this age interval, four were
injured while diving, one while playing
another sport, and one in a motor
cycle accident. In the 16 to 20-year
age group there were few work-related
accidents, none at home, but many
automobile and some diving accidents.
Work-related accidents were common
in the 21 to 25-year age group and
made up 20.3% of the injuries in this
group. Traffic accidents constituted
53.6% of the injuries in patients 21 to
25 years old which was the highest
percentage in this category for any age
group. From 26 years of age, the fre
quency of traffic accidents declined
while the number of work accidents
increased considerably. For example,
in the 51 to 55-year age group, traffic
accidents accounted for only 15% of
the injuries, whereas work accidents
accounted for 50%. Accidents at home
were infrequent causes of spinal cord

injury until the age of 50 years, and
from then on the proportion increased
considerably, reaching a peak of 100%
in the patients aged 81 to 85 years.
There were five suicide attempts
which resulted in spinal cord injury,
one in each of the age groups 21 to 25,
51 to 55 and 66 to 70 years and two
in the 56 to 60-year age group.
It has been recommended that all
patients with cord injuries should
reach a centre handling such injuries
within 2 hours of the event.8 Of the
patients in our series 57% were in
jured within 50 miles (80 km) of
Toronto (Table II); these patients
should reach a treatment facility within
the recommended time. Of those in
jured beyond that distance, many
could reach a treatment facility in
Toronto within 2 hours if they were
transported by air ambulance. The
actual interval between injury and ad
mission in these 358 patients will be
the subject of a subsequent report. In
Switzerland, where most patients with
cord injury are transferred by air, the
average delay from injury to arrival in
an appropriate centre has been reduced
from AVi hours to 50 minutes.9 In
Ontario, where the distances involved
are much greater, an additional treat
ment centre will have to be established
in the north as recommended by Botterell and associates.10
Conclusions

This study has identified several
groups of people who are at high risk
of sustaining a spinal cord injury.
Traffic accidents caused almost 35%

of all such injuries and most involved
young men between the ages of 15 and
30 years who were thrown out of
automobiles. Young men must be made
more aware of the great risks to which
they are exposed as drivers. Seat belts
will reduce both the overall incidence
and severity of cord injury by prevent
ing the driver or passengers from being
thrown from the automobile and land
ing on the back, neck or head.
Diving accounted for more than 10%
of all cord injuries, and in this group
were both young males and females.
Greater awareness of the hazards of
shallow-water diving is required, especi
ally in pools, in view of the continued
proliferation of private pools. Methods
of increasing the diver’s awareness of
the great risk should be sought. One
method might be to place large signs
at all swimming pools and public
beaches warning against shallow-water
diving.
Others who should be made aware
of the risk of spinal cord injury include
middle-aged construction workers who
injure their spinal cords by falling into
excavations or from ladders, and
elderly farmers who injure their spinal
cords by falling from high lofts or
being pinned under overturned tractors
on soft ground.
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Metastatic Endometriosis in Abdominal Scars
W.L.M. K in g , m d , fr c s , f r c s [ c ]

incision just over the external inguinal
ring. There were no abnormalities on
examination apart from point tenderness
at the site of the pain. In particular there
was no mass or induration. She was next
seen in December 1977 complaining of a
painful lump at the same site which was
gradually increasing in size. At the time
she did not relate the pain to her men
strual cycle but, in retrospect, recalled
that it was worse at or just before her
period. There was a tender mobile lump
approximately 1 cm in diameter which did
not alter with coughing or straining and
did not trigger a referred pain when pres
sure was applied. The patient had been
using oral contraceptives since the time
she was last seen.
In January 1978 an excisional biopsy
was performed of a mass measuring 1.5
X 1 X 1 cm; on microscopic section the
specimen showed endometriosis involving
subcutaneous tissue and fascia. Since then
the patient has had no local complaints
or symptoms suggestive of pelvic endo
metriosis.

The author presents two examples of
metastatic endometriosis occurring in an
abdominal scar. These case reports
illustrate the two main theories of the
pathogenesis of the condition:
transportation and metaplasia. The
diagnosis is straightforward in the
classic case in which a painful mass
fluctuates with the menstrual cycle,
but a biopsy may be needed to confirm
the diagnosis when the history is
atypical. The treatment of choice, for
those who require treatment, may be
hormonal manipulation, surgery or
irradiation, or a combination of these.
L'auteur decrit deux exemples d'endometriose metastatique apparaissant dans
des cicatrices abdominales. Ces obser
vations illustrent les deux principales
theories de la pathogenese de cette
affection: le transport et la metaplasie.
Dans le cas classique, alors qu'une masse
douloureuse varie avec le cycle
menstruel, le diagnostic est evident,
mais une biopsie peut etre necessaire
pour confirmer le diagnostic quand
I'histoire est atypique. Pour ceux qui
necessitent un traitement, le traitement
de choix peut etre une manipulation
hormonale, la chirurgie ou I'irradiation,
ou une association de celles-ci.

Case 2.—A 17-year-old girl was ad
mitted to hospital in April 1977 with pain
and tenderness in the right lower abdomi
nal quadrant which was diagnosed as
acute appendicitis. At operation the ap
pendix was normal, but the patient had
bled from a right ovarian cyst which was
excised with the normal appendix. The
histologic diagnosis of the ovarian tissue
was “hemorrhagic cystic corpus luteum”.
Again, the early postoperative recovery
was smooth. The girl returned 1 year
later complaining of intermittent swelling
and discomfort of her McBurney incision
during the week preceding her menstrual
period. Her periods had become quite
painful with deep-seated aching discom
fort in both lower quadrants. She was
given cyclic therapy with an estrogenprogesterone combination which satisfac
torily controlled her symptoms. A tissue
diagnosis was not considered necessary in
this case.

Metastatic endometriosis is an unusual
but well-recognized cause of painful
nodules occurring in an abdominal in
cision. Two recent cases in my general
surgical practice have prompted a re
view of this condition.
Case Reports
Case 1.—In September 1976 a 22-yearold married woman, para 0, gravida 0,
was seen with a small but painful right
indirect inguinal hernia which had been
present for about 1 year. She gave no
history of gynecologic problems and
specifically denied having dysmenorrhea
or dyspareunia. She underwent a standard
hernia repair in October 1976. The small
hernial sac was excised and was histo
logically normal. Her early postoperative
recovery was smooth. She returned 3
months later complaining of localized
pain at the lower end of her inguinal

Discussion
Diagnosis
A differential diagnosis of lumps oc
curring in scars would include several
lesions much commoner than endome
triosis. However, in the classic case in
which the degree of discomfort and size
of the mass correlate with the mens
trual cycles, there should be little dif
ficulty in diagnosis. The appropriate
history must, however, be solicited.
In a few cases1 no fluctuation in
symptoms is noted or the mass may not
be painful. In these cases microscopic
examination offers the only means of
obtaining a positive diagnosis.

From the department of surgery,
North York General Hospital,
WiUowdale, Ont.
Reprint requests to: Dr. W.L.M. King,
Ste. 323, North York Medical Arts
Building, 1333 Sheppard Ave. E,
WiUowdale, Ont. M2] I V 1
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Pathogenesis
Several theories purport to explain
how seemingly normal endom etrium
can appear and flourish in extrauterine
sites. These theories fall into two
groups: transportation and metaplasia.
Transportation theories suggest that
endometrial cells migrate, metastasize
or are mechanically transported to sites
as remote as the abdominal wall, um 
bilicus or lower limbs. T he classic
example of a scar endom etriom a which
appears to belong to this group is that
seen following a cesarean section or
abdominal hysterotomy. This may oc
cur in as m any as 5% of patients.2 Our
case 2, in which endometriosis was
probably present at the time of appen
dectomy, might logically be explained
on the basis of m echanical seeding of
the wound with endometrial cells.
Metaplasia theories propose th at m ul
ti potential cells are present in certain
tissues which, under appropriate sti
mulus (perhaps the addition of seeded
endometrial cells) can differentiate to
form endom etrium .3 Such theories
offer a more attractive explanation for
those rare cases in which no direct
transcoelomic, venous or lym phatic
pathway seems to exist between the
normal endometrium and the site of
endometrioma form ation. Such a path
way is difficult to conceive in case I.
Treatment
Three avenues of therapy are open to
those patients requiring treatm ent for
metastatic endometriosis. F o r patients
who tolerate it, horm onal m anipulation
usually in the form of estrogen-proges
terone tablets given in either a cyclic or
continuous course will effect control in
70% to 90% , with the side benefit of
control of the dysm enorrhea caused by
the much-commoner pelvic endom etri
osis. Surgical excision of well-localized
lesions offers the opportunity fo r histo
logic confirm ation and is usually cura
tive. In those for whom surgery is
undesirable, local deep irradiation will
successfully eradicate the aberrant en
dometrium.
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Evaluation de (’utilisation des appareils d’autosuture
en chirurgie digestive
C L. F o r t in ,

m d , fr c s [ c ],

Les auteurs presentent un releve de
345 interventions chirurgicales
pratiquees sur le tube digestif a I’aide
des appareils d’autosuture. La morbidity
par hemorragie, fistules et obstructions
ainsi que les taux de reinterventions
et de mortality sont discutes et
compares avec les taux signales dans
la litterature pour les memes inter
ventions faites selon les techniques
d'anastomoses et de sutures
conventionnelles. Cette etude confirme
la securite de I'emploi de ces appareils
dans une grande variete d’interventions
digestives ou leur usage a permis une
economie de temps operatoire
appreciable.
A review of 345 surgical procedures
performed on the digestive tract with the
use of automatic suturing devices is
presented. The morbidity due to
hemorrhage, fistula formation and
obstruction as well as the reoperation
and mortality rates are discussed and
compared with those reported in the
literature for the same procedures using
standard anastomotic and suturing
techniques. This study confirms the
safety of these stapling instruments in
in a wide variety of gastrointestinal
procedures in which their use resulted
in a considerable saving of operative
time.

A la suite des travaux de Ravitch et
collaborateurs1’* qui rapportaient leur
experience en laboratoire et en chirur
gie humaine, l’usage des appareils d’au
tosuture a pris une expansion conside
rable. De nombreuses publications
depuis ont demontre les avantages de
ces appareils tout en precisant leurs
limites et en decrivant les complica
tions liees a leur emploi.3,4
Nous avons voulu revoir l’utilisation
que nous avons faite des appareils
Service de chirurgie generate,
Hdpital du Saint-Sacrement, Quebec, PQ
*Externe, facutte de medecine,
Universite Laval, Quebec
Les demandes de tires-a-part doivent etre
adressees au Dr Claude L. Fortin,
Service de chirurgie generate,
Hdpital du Saint-Sacrement, 1050, chemin
Ste-Foy, Quebec, PQ G1S 4L8
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d’autosuture en chirurgie digestive dans
le service de chirurgie generate de
l’Hopital de Saint-Sacrement a Quebec,
pour comparer la morbidite et la mor
tality operatoires avec celles des tech
niques de sutures et d’anastomoses
conventionnelles. Notre travail consiste
en une etude retrospective des malades
operes d’avril 1974 a juillet 1977, a
I’aide des appareils GIA*, TA+ no. 55
et TA no. 90 (United States Surgical
Corp., New York, NY).
Patients et Methode

A partir du registre de la salle d’operation et d’une revue des dossiers des
patients, nous avons releve 345 inter
ventions chirurgicales qui ont necessite
783 applications des appareils d’auto
suture chez 292 patients (Tableau I).
Nous avons pratique durant cette
periode, 148 operations gastriques dont
89 gastrectomies de type Billroth II et
4 gastrectomies de type Billroth I faites
entierement avec les appareils TA et
GIA. Treize gastrectomies avec recons
truction gastro-jejunale et 7 gastrecto
mies avec reconstruction gastroduodenale ont ete partiellement effectuees
a l’aide des autosutures, impliquant par
la qu’une ou deux des trois composantes — fermeture du moignon duode
nal, fermeture de la tranche de section
gastrique, anastomose gastro-duodenale
ou gastro-jejunale fut ou furent prati
quees manuellement. De ces 113
gastrectomies, 86 furent effectuees
pour une maladie ulcereuse et 27 pour
une neoplasie maligne de l’estomac. II
y eut, de plus, 20 gastro-jejunostomies
sans resection, 8 fermetures de gastrotomie, 2 pyloroplasties de Finney et
diverses manoeuvres isolees, telles des
fermetures de tranche de section en
cours de demantelement de gastrectomie, des fermetures de moignons duodenaux et des jejuno-jejunostomies en
cours de gastrectomies totales.
Pendant ces 39 mois, nous avons
employe les appareils d’autosuture dans
la chirurgie du petit intestin au cours
de 66 operations. La continuity intestinale a ete retablie par 38 anastomoses
*Gastrointestinal anastomosis.
tTransverse anastomosis.
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termino-terminales fonctionnelles, par
10 entero-enterostomies latero-laterales
et par 5 entero-enterostomies terminolaterales. Six conduits ileaux ont ete
fabriques a l’aide du TA 55 pour la
fermeture de 1’extremite proximale de
l’anse isolee, cinq diverticules de
Meckel ont ete excises apres Implica
tion du TA 55 a sa base et finalement
une enterotomie laterale a ete fermee
ainsi qu’un poche de Hunt-Lawrence
fabriquee par l’application des appa
reils d’autosuture.
Nous avons releve 118 operations
sur le colon faites a l’aide des appa
reils d’autosuture. II y eut 52 hemico
lectomies droites, 40 anastomoses colocoliques et 15 anastomoses colo-rectales. Sept colostomies furent fermees
a l’aide des appareils TA et GIA, soit
ptr l’application laterale d’un TA, soit
au GIA apres resection segmentaire.
Deux anastomoses ileo-rectales apres
colectomie totale, une polypectomie et
une fermeture de colotomie completent
T a b le a u 1— In te rv e n tio n s

T y p e d 'in te rv e n tio n

No
d ’ in te rv e n tio n s

G a s triq u e (n = 148)
G a s tre c to m ie : B illro th 1
B illro th II
G a s tro je ju n o s to m ie
P y lo ro p la s tie (F in n e y )
F e rm e tu re de gastro to m ie
D iv e r s

11
102
20
2
8
5

G re le (n = 66)
R e se ctio n -a n a s to m o s e
C o n d u its ile a u x
M eckel
F e rm e tu re d ’e nte roto m ie
P o ch e d e H u n t-L a w re n c e

53
6
5
1
1

C o liq u e (n = 118)
H e m ico le cto m ie d ro ite
R e se c tio n tra n s v e rs e
R e se c tio n sigm oi'de
R e se c tio n rectosigm oi'de
H e m ico le cto m ie g a u ch e
lle o -re c to s to m ie
F e rm e tu re co lo sto m ie
F e rm e tu re co lo to m ie
P o ly p e cto m ie

52
11
22
15
7
2
7
1
1

D iv e r s (n = 13)
D iv e r t ic u le de Z e n k e r
D iv e r t ic u le e p ip h re n iq u e
C h o le c y s to -je ju n o s to m ie
P a n cre a te cto m ie d ista le

2
1
6
4
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decompensee, et le quatrieme de metastases.
A la suite de la chirurgie de l’intestin
grele, trois patients (4.5%) ont presente
des complications, soit une dehiscence
anastomotique a la suite d’une resection
pour thrombose mesenterique qui dut
d’ailleurs etre reoperee, et deux fistules
anastomotiques chez deux malades
operes pour maladie de Crohn. Elies
se tarirent sous traitement conservateur. II n’y eut aucun deces chez ces
66 patients.
Le releve de la morbidite apres chi
rurgie colique revele un taux de com
plication de 5.9%, soit chez 7 patients
sur un total de 118. En effet six fistules
colo-cutanees furent demontrees cliniquement, soit trois apres hemicolecto
mies droites et trois apres anastomoses
colocoliques gauches ou colo-rectales.
Une patiente a presente une stenose
anastomotique apres colectomie gauche
et elle dut etre reoperee, 3 mois apres
sa resection initiale. Un autre patient
ayant subi une hemicolectomie droite
suivie d’une fistule, a ete reopere a la
suite de complications septiques.
Deux patients sont decedes de metastases hepatiques et un troisieme d’une
insuffisance respiratoire, ce qui constitue une mortalite operatoire dans la
Resulfats (Tableau II)
chirurgie du colon et du rectum de
Nous avons releve 10 complications 2.5%.
Nous n’avons a deplorer ni morbi
de la chirurgie gastrique chez ces 148
patients soit un taux de 6.6%. Des 108 dite ni mortalite chez les 13 patients
fermetures de moignons duodenaux, 4 qui ont subi des diverticulectomies
(3.7%) ont fistulise et un de ces ma- oesophagiennes, des pancreatectomies
lades a du etre reopere. Deux patients distales et des anastomoses cholecystoont presente une fistule gastro-jejunale enteriques.
et un troisieme une hemorragie de la
ligne anastomotique gastro-jejunale neDiscussion
cessitant une intervention. Nous avons
Nous avons, dans notre milieu, utilise
eu trois patients qui ont presente un
syndrome de l’anse efferente, et deux les appareils d’autosuture selon les
donnees techniques decrites par Ra
ont du subir une revision chirurgicale.
Quatre des 148 patients sont decedes vitch et collaborateurs1-3 en respectant
a la suite de la chirurgie gastrique soit les principes fondamentaux generaleune mortalite de 2.7%. Aucun de ces ment acceptes en chirurgie digestive.
deces n’est relie a l’usage des appareils Avec l’experience, nous avons elargi
d’autosuture: le premier malade est les indications de l’emploi de ces appa
decede d’une embolie pulmonaire, le reils que nous utilisons maintenant plus
deuxieme d’un arret cardiaque, le couramment dans les anastomoses
troisieme d’une coagulopathie, le pa gastro-duodenales et les fermetures des
tient etant porteur d’une cirrhose orifices d’insertion de l’appareil GIA.

notre experience de l’usage de ces appareils en chirurgie colique.
Nous avons employe les autosutures
dans la chirurgie de l’oesophage lors
de deux excisions de diverticules de
zenker apres l’application du TA 55 et
lors d’une diverticulectomie epiphrenique, celle-ci combinee a une longue
myotomie oesophagienne.
A six reprises, pour des derivations
bilio-digestives de palliation, une anas
tomose cholecysto-jejunale au GIA fut
pratiquee.
Finalement, le TA 55 fut utilise a
quatre reprises pour fermer la tranche
de section d’une excision pancreatique
distale pratiquee dans l’execution d’une
chirurgie d’exerese large d’une neoplasie d’un organe avoisinant.
Nous avons, dans l’emploi de ces
appareils, suivi les principes techniques
proposes par Ravitch et Steichen1 et
avons retenu comme morbidite imputa
ble a leur usage, les fistules, les stenoses
et les hemorragies aux points d u p l i 
cation des agraffes metalliques. Nous
avons de plus considere comme deces
operatoire toute mort survenant dans
les trente jours suivant l’intervention
chirurgicale.

Tableau II--C om plications

Chirurgie colique
(n = 118), no (e t % )

Complication

Chirurgie gastrique
(n = 148), no (et % )

Chirurgie du grele
(n = 66), no ( et %

Hemorragie
Fistule
Obstruction

1 (0.6)
6 (4.0)
3 (2.0)

0
3 (4.5)
0

0
6 (5.0)
1 (0.8)

Deces

4 (2.7)

0

3 (2.5)

Reintervention

4 (2.7)

1 (1.5)

2 (1.6)

)

L ’utilisation frequente de ces appa
reils nous a permis de constater qu’un
complement d’hemostase est souvent
requis et que le risque hemorragique
nous est apparu directement proportionnel a la hauteur du segment opere.
C’est ainsi que la majorite des lignes
anastomotiques gastro-duodenales ou
gastro-jejunales, tout comme les tran
ches de section gastriques et duodenales, requierent quelques points d’he
mostase. Les anastomoses et les tran
ches de section de l’intestin grele
necessitent moins frequemment une
hemostase supplementaire alors que les
memes manipulations sur le colon et le
rectum ont rarement besoin de com
plement hemostatique.
Dans notre serie, un seul patient
(0.6%) a du subir une reintervention
pour hemorragie survenue au niveau
d’une ligne d’anastomose gastro-jeju
nale et, ceci, au tout debut de notre
experience. Pearce, Jordan et De
Bakey,5 revisant leur chirurgie gastrique
chez 406 patients operes par les tech
niques conventionnelles, rapportent un
taux de 1% d’hemorragie necessitant
une reintervention.
Nous tenons a souligner la securite
avec laquelle les six anastomoses cholecysto-jejunales ont ete faites malgre
la restriction theorique imposee par la
difference d’epaisseur des deux parois
impliquees.
Un certain danger dans l’usage des
appareils d’autosuture lors des anasto
moses colo-rectales basses devrait etre
mentionne: en effet, a ce niveau, toute
erreur technique ou malfonctionnement
de l’appareil GIA, peut se traduire par
un traumatisme irreparable du rectum,
obligeant la transformation de l’intervention en procedure de Hartman ou
en resection abdomino-perineale avec
alors, colostomie permanente pour le
patient. Nous avons eu a regretter un
tel incident. Depuis, cependant, nous
sommes a faire notre propre experience
avec l’appareil EE A* (United States
Surgical Corp.) qui permet une anasto
mose termino-terminale par voie endoluminale. Cette nouvelle approche nous
semble beaucoup plus securitaire sur le
plan technique.
Chez les 292 patients operes, nous
avons eu un taux de mortalite de 2.7%
en chirurgie gastrique, de 0% en chi
rurgie du petit intestin et de 2.5% en
chirurgie du colon et du rectum. Ces
taux de mortalite sont comparables a
ceux releves dans la litterature pour le
meme type d’interventions, utilisant les
techniques d’anastomose convention
nelles.
Ainsi Palumbo et Sharpe6 dans une
etude retrospective de 611 malades
operes pour ulcere duodenal par gas*End-to-end anastomosis.
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trectomie de type Billroth II rapportent
une stenose anastomotique importante
une m ortalite de 2.2% . Lorsqu’une re quelques mois apres resection colique
section gastrique est pratiquee pour une gauche.
neoplasie maligne, la mortalite apres
Enfin, quoiqu’il soit difficile d’anagastrectomie sub-totale se situe entre lyser de fagon objective l’effet de
4% et 8% , dependant du nombre
l’usage des appareils d’autosuture sur
d ’organes excises.7-8 Schrock, Deveney
la duree des interventions chirurgicales,
et D unphy,9 rapportant leur experience
les chirurgiens qui ont participe a cette
globale en chirurgie colique chez 1703
etude ont note une diminution appre
patients, ont signale un taux de m orta ciable de la duree de l’acte operatoire
lite operatoire de 4% .
en comparaison avec la duree d’operaAucun deces n’est survenu a la suite tion similaire employant les methodes
de fistules digestives cliniquement m a d’anastomoses conventionnelles.
nifestoes et bien etablies par les tech
niques usuelles de diagnostic, soit
Conclusion
l’investigation radiologique a l’aide de
Gastrografin®, la fistulographie ou
L ’etude du releve retrospectif de
l’instillation de bleu de methylene.
notre experience de l’utilisation des
Le taux de 3.7% de fistules duode- appareils d’autosuture en chirurgie di
nales apres gastrectomies de type Bill gestive chez pres de 300 malades nous
roth II et gastrectomies totales se permet de conclure que d ’une part, la
compare a ceux de 1% a 6% rap- morbidity de la technique de suture
portes dans la litterature.5'6
mecanique est comparable a celle des
Les 18 anastomoses faites a l’aide methodes conventionnelles et que,
des appareils d’autosuture a la suite de d’autre part, aucune mortalite, chez
resection du colon transverse, du colon nos patients, n’est attribuable a l’usage
gauche ou des deux a la fois n’ont des appareils.
presente aucune fistule alors que les
37 anastomoses pratiquees a la suite de
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Solitary Pulmonary Nodules due to Sarcoidosis
S. N utting , md ,* I. C arr, mb , ch b, ph d, frc path , FRCP[c],f F.M . C ole , mb , b ch , frcp [c]J
and L.L. B lack, md , frcs [c ]*

Two patients, a 67-year-old woman and
a 33-year-old man, had asymptomatic
solitary nodular masses in the lung
detected by roentgenographic
examination. The preoperative investtigations failed to make a firm diagnosis
or to rule out the presence of a
malignant lesion. In both patients the
lesions were resected and found to
contain noncaseating granulomas.
Electron microscopy and immuno
chemical studies for lysozyme supported
the diagnosis of solitary nodular
sarcoidosis. Such roentgenographic
presentations of sarcoid are rare.
L’examen radiologique a permis de
deceler un nodule solitaire asymptomatique chez deux patients, une femme
de 67 ans et un homme de 33 ans.
Les etudes preoperatoires n'ont pas
reussi a etablir un diagnostic ferme ou
a exclure une affection maligne. Chez
les deux patients, les lesions resequees
contenaient des granulomes non
caseeux. La microscopie
electronique et la recherche
immunochimique du lisozyme appuyerent
un diagnostic de sarcoidose nodulaire
solitaire. II est rare de rencontrer une
telle presentation radiographique
d’une sarcoide.

Roentgenographic manifestations of
sarcoidosis are those of either hilar
adenopathy or diffuse pulmonary paren
chymal involvement alone or in com
bination.1 Recently, several less com
mon
roentgenographic
appearances
have also been reported.2-5 This report
notes an even rarer mode of presenta
tion and provides detailed pathologic
and biochemical confirmation of the
diagnosis.

right lung associated with bilateral hilar
lymphadenopathy. These findings were
noted on a chest roentgenogram done dur
ing investigation of bilateral ankle edema.
The patient admitted that she had ex
perienced mild exertional dyspnea for the
previous 3 to 4 months and had occasional
nonproductive cough. She denied having
any other chest symptoms. She had
smoked one package of cigarettes every
3 days for 10 years, but had stopped
1 year earlier.
Physical examination revealed no ab
normalities. Laboratory investigations in
cluding complete blood count, urinalysis
and the measurement of serum electro
lyte, urea, creatinine, protein, calcium
and liver enzyme concentrations were
normal. The electrocardiogram was also
normal. The serum lysozyme value was
13.8 Mg/ml.
The roentgenographic appearance of an
ill-defined mass in the right posterior costophrenic angle with bilateral hilar lym
phadenopathy was clarified by tomo
graphy (Fig. 1).
Pulmonary function studies revealed a
vital capacity of 1.97 1 (79% of normal),
a residual volume of 2.22 1 (134% of
normal), a total lung capacity of 4.19
1 (99% of normal), functional residual
capacity of 2.76 1 (108% of normal),
a 1-second forced expiratory volume of
1.45 1 (72% of normal), maximum midexpiratory flow rate of 1.15 1/s (52% of
normal) and a steady state diffusing ca
pacity of 18.71 ml/min.mm Hg (155% of
normal).
Arterial pH was 7.43, oxygen pressure
82 mm Hg and carbon dioxide pressure
35 mm Hg.
Skin tests were negative for tuber
culosis, histoplasmosis and blastomy
cosis but positive for mumps (induration

8 mm X 8 mm) and Candida (indura
tion 8 mm X 11 mm). Multiple sputum
samples showed no evidence of malignant
cells, and on routine culture of the spu
tum there was no growth of acid fast
organisms or fungi.
Shortly after admission bronchoscopy
and mediastinoscopy were carried out. No
endobronchial lesions were seen and no
malignant cells were found in bronchial
washings and culture from the lower
lobe of the right lung. In the paratracheal
area there were many large rubbery nodes
which contained noncaseating granulomas.
Thoracotomy revealed a 3 x 2 cm intrapulmonary lesion in the periphery of
the lower lobe of the right lung extending
to the diaphragmatic pleura (Fig. 2).
No other lesions were noted in the lung
or on the pleural surfaces, but many of
the hilar and mediastinal lymph nodes
were enlarged. Pathological examination
of the lung lesion removed by wedge re
section revealed extensive noncaseating
granulomas with giant cells. No asteroid
or Schauman bodies were found. No
acid fast bacilli or fungi were seen in
the microscopic sections of the lesion
nor were they detected on culture. The
histologic appearances of the lung lesion
were identical to those of the mediastinal
nodes.
Immunocytochemical testing for lyso
zyme showed a positive reaction in some
mononuclear macrophages and in most
multinucleate giant cells. Staining in the
latter was dense and granular in the centre
of the cells while control specimens
in which normal serum was substituted
for antilysozyme antiserum showed no
staining, thus indicating the specificity of
the reaction (Fig. 3).
Electron
microscopic
examination
showed that the giant cells had a promi
nent secretory apparatus (granular endo
plasmic reticulum etc.) and contained
numerous membrane-bound granules of
varying density. The smaller and more
dense of these were of similar dimen
sions to those demonstrated by light

FIG. 1— Case 1. Lateral tomogram
showing poorly defined lesion in right
posterior costophrenic angle.

FIG. 2— Case 1. Operative view of
solid lesion in periphery of lower lobe
of right lung (arrow).

Case Reports
Case 1.—A 67-year-old white woman
was referred to the University Hospital,
Saskatoon, for investigation of a solitary
nodule located in the lower lobe of the
From the departments of *surgery
and t pathology, University Hospital,
Saskatoon, Sask., and the idepartment
of pathology, McMaster University
Medical Centre, Hamilton, Ont.
Reprint requests to: Dr. L.L. Black,
Department of surgery, University
Hospital, Saskatoon, Sask. S7N 0W8
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microscopy with immunoperoxidase (Fig.
4). These findings are in accord with the
current view that macrophages and sec
retory cells, in this case, produce lyso
zyme.
The patient had a smooth recovery and
reported a marked reduction in exertional
dyspnea at her 4-month follow up. The
hilar adenopathy was still present on roentgenographic examination after 2 years
and the pulmonary function studies had
changed little.
Case 2.—A 33-year-old man was found
to have a solitary peripheral lung mass on
a roentgenogram of the lungs obtained as
part of a routine physical check-up. It
measured 3 cm in diameter and was sit
uated in the upper lobe of the left lung.
He had no symptoms referable to the le
sion. He smoked about 25 cigarettes per
day and had done so for 17 years. He had
a mild cough and occasionally produced
yellow sputum. His medical history in
cluded rheumatic fever at 8 years of age,
scarlet fever at 10 and a right-sided pneu
mothorax at 18, following rib fractures
sustained in a motor vehicle accident. The
family history was noncontributory.
On examination at the McMaster Uni
versity Medical Centre in Hamilton, he
had no cardiac murmurs. There was no
lymphadenopathy and no splenomegaly.
The electrocardiogram appeared normal.
Laboratory investigations included com
plete blood count, urinalysis, measure
ment of serum electrolyte, creatinine,
urea, calcium, protein and liver enzyme
concentrations, all of which were normal.
The serum lysozyme concentration was
not measured. Examination of the sputum
for organisms and malignant cells gave
negative results. Bronchoscopy showed no

endobronchial lesion and bronchial wash
ings did not show tumour cells. The lung
lesion was shown on tomographic exami
nation. On microscopic examination of
the sputum there was no evidence of
fungus or of tuberculosis. Culture of
the sputum gave a negative result. The
complement fixation test for histoplas
mosis also gave a negative result. Pul
monary function tests revealed no abnor
mality. A thoracotomy was performed
and wedge resection of the lesion carried
out. No other abnormalities were noted
at the time of operation. In particular
there was no evidence of mediastinal or
hilar lymphadenopathy. Postoperative re
covery was smooth and follow-up has
so far been satisfactory.
The resected specimen consisted of a
wedge of lung tissue measuring 4 X 3.5
X 2 cm containing a firm, well-circum
scribed oval mass situated just beneath
the pleura and measuring 1.5 cm in
maximum dimension. Microscopically the
mass consisted of multiple noncaseating
granulomas with numerous multinucleated
giant cells. No organisms were detected
on culture or with the use of special
stains. An occasional asteroid body was
seen. A prominent feature was the strik
ing vascular involvement by the granu
lomatous process. Both small arteries
and veins were involved. Immunocy.tochemical and electron microscopic exami
nation showed findings similar to those
seen in case 1.

Discussion
Thoracic sarcoidosis presents radiologically in a variety of ways. Freundlich and associates1 found typical hilar
lymphadenopathy in 58% of patients,
atypical lymphadenopathy in 17% and
none in 25% . Unilateral lymphadeno
pathy was not noted in that series, but
has been reported by Kent.6
Changes in the pulmonary paren
chyma were found in two thirds of the

300 patients in Freundlich’s study and
complications such as bullous and
bronchiectatic cyst formation, fibrotic
contraction and cavitation were recog
nized in 28% .
The presence of multiple pulm onary
nodules in sarcoidosis is being appre
ciated with increased frequency. Turiaf
and associates7 found multiple nodules
in 2% of 135 patients, and Sharma,
Hewlett and Gordonson8 noted mul
tiple nodules in 44 of 150 cases. Previ
ously, it was thought that this presenta
tion was peculiar to the Am erican
Negro, but in a Scandinavian series
reported by Rom er,2 multiple nodules
were found in 1.6% of the patients.
Solitary nodular sarcoidosis with or
w ithout hilar lymphadenopathy has
been reported rarely.9
O ur first patient, a middle-aged
white woman, was presumed to have a
peripheral
bronchogenic
carcinom a
with metastases to the hilar lymph
nodes. The nature of the lesion in the
second patient was not known preoperatively. The presence of granulom as
consistent with sarcoidosis in the m edi
astinal nodes as in case 1 did not
provide a definitive diagnosis since
sarcoid-like reactions have been seen
in nodes draining peripheral broncho
genic carcinomas. Both intrapulm onary
nodules removed at thoracotom y were
found on frozen and paraffin sections
to contain granulomas. The striking
vascular involvement seen in case 2 is
not at all unusual in sarcoid lesions.
Carrington and associates10 reported
that it occurred in 42% of cases of
pulmonary sarcoid lesions. The absence
of demonstrable organisms, the typical
electron microscopic appearance and
the results of lysozyme studies almost
certainly establish the diagnosis of sar
coidosis.
It is now generally believed that
macrophages are secretory cells pro
ducing a wide variety of substances:
hydrolytic enzymes, elastase, collagenase and lysozyme among others.11'12
In human sarcoidosis the granulom a
has been shown immunochemically to
produce lysozyme with resultant eleva
tion of the serum lysozyme concentra
tion.12,14 While it is likely th at the
lysozyme is contained within m em 
brane-bound granules, there has been
no unequivocal demonstration of this.
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Postmastectomy Lymphangiosarcoma:
Experience with Three Patients
and Electron Microscopic Observations in One
H. U nruh ,

The clinical features are presented
of three patients in whom lymphangio
sarcoma developed after radical
mastectomy followed by local irradi
ation. The median time between radical
mastectomy and the diagnosis by biopsy
of lymphangiosarcoma was 9.9 years.
No form of therapy, including high-dose
combination chemotherapy, appeared
able to control the disease. All three
patients died with residual lymphangio
sarcoma and in two it was the direct
cause of death. These results stress
that prevention of postmastectomy
lymphangiosarcoma is vital. This can be
accomplished by avoiding radical
mastectomy followed by local
irradiation.
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Ultrastructural observations in one
case suggest that the tumour has a
primitive vasoformative origin.

On decrit le tableau clinique de trois
patientes chez qui un lymphangiosarcome est apparu apres une mastectomie radicale suivie d'irradiation locale.
La duree mediane ecoulee entre la
mastectomie radicale et le diagnostic
par biopsie du lymphangiosarcome a
ete de 9.9 annees. Aucun traitement,
y compris la polychimiotherapie a forte
dose n’a semble capable de juguler la
maladie. Les trois patientes moururent
avec un lymphangiosarcome residuel
et celui-ci fut la cause immediate du
deces dans deux cas. Ces resultats
soulignent que la prevention du
lymphangiosarcome consecutif a une
mastectomie est vitaie. Ceci peut etre
realise en evitant la mastectomie
radicale suivie d'irradiation locale.
Dans un cas, I'examen des ultra
structures indique que la tumeur
possede une origine qui ressemble a
la formation de vaisseaux primitifs.

Postmastectomy lymphangiosarcoma is
a rare complication of breast carci
noma and its treatment. Fewer than
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200 cases of this disease have been re
ported in the literature.1 Since few
centres admit many patients with this
condition we report our results in three
patients using various therapeutic
modalities including chemotherapy.
These three patients represent the total
experience with this tumour in Mani
toba as ascertained by a search of the
files of the Manitoba Cancer Treat
ment and Research Foundation from
1937 to 1978. The clinical details of
the three cases are summarized in
Table I.
Case Reports
Case 1.—On July 3, 1954, a 43-year-old
woman underwent right radical mastec
tomy followed by irradiation (3506 rads
to the axilla, supraclavicular and para
sternal regions) for an infiltrating duct
carcinoma metastatic to all resected
nodes. In October 1961, follow-up chest
roentgenogram suggested the presence of
a lesion in the right lung field. In April
1962, a purplish lesion appeared on the
lateral aspect of her edematous right arm.
Results of biopsy of this lesion indicated
that the patient had lymphangiosarcoma.
Another chest roentgenogram showed that
the lesion in her right lung had increased
in size. Between Apr. 18, 1962 and May
3, 1962, she received a course of cobalt-
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tremity. On examination her upper limb
was indurated and lymphedematous with
multiple typical angiomatous lesions meas
uring up to 2 cm in diameter. Results of
chest roentgenography, liver scanning and
liver function tests were normal. Biopsy
of one of the arm lesions was inter
preted as lymphangiosarcoma.
Interscapulothoracic amputation was
proposed but the patient declined treat
ment and returned home. On Apr. 9,
1972, she died of uncontrollable local
disease with no evidence of systemic
metastases. Permission for autopsy was
not obtained.

60 irradiation to the right arm (6090 rads
in 30 treatments). The lymphangiosarcoma
regressed completely but the area re
mained indurated.
On Oct. 1, 1962, the patient underwent
an operation for cholelithiasis and bi
opsies were done of the gallbladder
neck and greater omentum. The spec
imens were reported to contain meta
static adenocarcinoma consistent with
breast origin. Histologically, there was no
evidence of lymphangiosarcoma in these
lesions. Over the ensuing months, the
metastatic disease in the abdomen and
chest rapidly progressed, and, on Aug. 8,
1963, lymphangiosarcoma was again
noted in the skin adjacent to the previous
area of irradiation on the arm. These
lesions rapidly increased in number and
size. On Nov. 20, 1963, the patient died
of intestinal obstruction presumably due
to diffuse metastases. Permission for
autopsy was not obtained.

Case 3.—In June 1962, at the age of
48 years, this woman underwent left
radical mastectomy followed by irradia
tion (3692 rads) for an infiltrating duct
carcinoma. The lymph nodes were not in
volved by metastatic tumour. In October
1964, an osteolytic lesion was noted in the
head of the left humerus and was treated
with irradiation (3500 rads). In March
1965, bilateral osteolytic lesions were
noted in the sixth and seventh cervical
vertebrae. Both lesions were outside any
previous portals of irradiation. Bilateral
oophorectomy was done. The lesion in
the left upper humerus persisted and in
July 1966, another course of radiotherapy
was given to this area (2268 rads). In
April 1975, xeromammograms of the
right breast were suggestive of a lesion.
Simple mastectomy was performed for an
infiltrating duct carcinoma dissimilar to
the previous carcinoma. Bone scanning
and roentgenography of the left upper
humerus demonstrated avascular necrosis
presumably due to irradiation.
In June 1977, the patient returned com
plaining of massive swelling of the left
upper extremity. A 5 X 5 x 3-cm necro
tic, fungating mass was noted on the left
anterior axillary fold. Biopsy was per
formed and the specimen reported to con
tain lymphangiosarcoma. There was also
considerable telangiectasis over the entire
left shoulder. On July 12, 1977, at the age
of 63 years, the patient was admitted to
the Health Sciences Centre with a 3-week
history of pain and increasing swelling of

Case 2.—A 61-year-old woman under
went left radical mastectomy on Mar. 8,
1961 followed by irradiation (3380 rads)
for an infiltrating comedocarcinoma with
many nodes containing malignant cells.
Annual follow-up revealed no evidence of
residual disease although there was con
siderable lymphedema of the left upper
extremity. In 1967, she noted a small,
red, painless lesion on the anterior surface
of her left arm. After 3 to 4 months
several similar lesions appeared around
the initial lesion. In April 1968, she un
derwent wide local excision of the lesions
on the anterior aspect of her arm, with
primary closure. Two months later she
returned with several more lesions which
were also locally excised. In March 1969,
she returned with further recurrences
which were excised and repaired with
split-thickness skin grafts. These excisional
biopsies were variously interpreted as
containing Kaposi’s sarcoma, angioendothelioma and lymphangioma.
The patient was transferred to the
Health Sciences Centre, Winnipeg, in July
1971. She had been well until May of that
year when she had noted rapidly progres
sive severe edema of her left upper ex

the left upper extremity. Radiation ther
apy was begun but several life-threaten
ing hemorrhages from the necrotic mass
prompted cauterization of the tumour. To
determine operability, skin biopsies were
done of the telangiectatic areas on the
posterior aspect of the shoulder. The
specimens showed irradiation changes but
no evidence of lymphangiosarcoma. Seven
days after the previous cauterization the
patient had another life-threatening hem
orrhage. On Aug. 3, 1977, she underwent
a left interscapulothoracic amputation
leaving wide margins of normal appear
ing soft tissue. Frozen section at the time
of operation showed no tumour at the
lines of resection. Estrogen receptor
studies of the tumour gave negative re
sults as did the assay for carcinoembryonic antigen. However, 3 weeks later a
recurrence of the lymphangiosarcoma
was clinically apparent on the medial
aspect of the skin flap on the anterior
chest wall. This was excised.
Because of the repeated failure of ex
cisional therapy, chemotherapy was in
stituted. The patient was given vincristine
(20 mg intravenously on day 1), doxoru
bicin (90 mg intravenously on day 1) and
dimethyltriazeno-imidazole
carboxamide
(DTIC) (150 mg intravenously on days 1
and 2). By the time of discharge a small
recurrence was apparent clinically but was
not excised in order that the effect of
chemotherapy could be observed. The
patient was discharged but returned ap
proximately 1 month later with multiple
chest wall recurrences (Fig. 1). She had
had four or five hemorrhages in the
previous month. She had had only one
course of the combination chemotherapy
but since this had not altered the disease,
high-dose methotrexate with folinic acid
rescue was recommended. Treatments
were given weekly and the dosage was
increased over 3 weeks from 100 mg/kg
to 200 mg/kg to 250 mg/kg body weight.
Bleeding was controlled with local
thrombin application and electrocautery.
Despite these high doses of metho-

Table I— Summary of Three Cases Showing Relationship between Radical Mastectomy and
Subsequent Lymphangiosarcoma
B reast tumour
Patient
no.

Age at
diagnosis,
yr

i

43

Radical
mastectomy,
postoperative
irradiation

2

61

3

48

Treatm ent

Lymphangiosarcoma

Disease-free
interval

Interval
Age at
since
diagnosis,
mastectomy
yr

Site

51

7yr
10 mo

Lateral
aspect,
right
arm

No evidence of
Radical
recurrent
mastectomy
disease
postoperative
irradiation

68

7 yr

A nterior
aspect,
le ft arm

Radical
mastectomy,
postoperative
irradiation

63

15 yr

Left an terior
axillary
fold

7 y r 3 mo

2 yr 4 mo
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FIG. 1— Case 3, 1 month after inter
scapulothoracic amputation. Note multiple
recurrences of lymphangiosarcoma on
chest wall.
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trexate, pulmonary metastasis was dis
covered on Nov. 14, 1977. Electron beam
therapy (6000 rads in 21 treatments) was
given to the chest wall to control the
bleeding and this was temporarily success
ful. How'ever, the pulmonary metastasis
continued to increase with further recur
rence of the chest wall disease after
radiation therapy was discontinued. She
died on Feb. 11, 1978 in a rural hospital.
Autopsy was not performed.

FIG. 2— Vascular channel lined by attentuated endothelium (large arrow). In
complete basal lamina surrounds part of
outer plasma membrane (small arrow)
(reduced by 45% from X 5000).

FIG. 3— Small vascular channel (V)
containing erythrocyte (E). Wall o f chan
nel is incomplete and malignant cell (C)
protrudes from wall into lumen. Cell junc
tions (arrow) appear as dark bands be
tween adjacent cytoplasmic processes. Thin
basal lamina is incomplete (reduced by
16% from X5000).
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Pathology
All histologic sections were reviewed
except those from the mastectomy
specimen of the patient in case 2 (re
ported as being “infiltrating comedocarcinoma”). The mastectomy speci
mens from the other two patients each
contained an infiltrating duct carci
noma. The lesion which developed in
the controlateral breast of the patient
in case 3, 13 years after her first mas
tectomy, was a mucin-producing adeno
carcinoma which appeared histologi
cally dissimilar to her first breast car
cinoma. It was considered a second
primary breast cancer.
The lymphangiosarcomas from cases
1 and 2 were located in the dermis and
subcutaneous tissues and had a similar
appearance^ The tumours were com
posed of predominantly small spaces
lined with endothelium, some of which
contained erythrocytes. The nuclei were
enlarged, hyperchromatic and bulged
into the lumen. Mitoses were rare.
The lymphangiosarcoma in case 3
also arose in the dermis and sub
cutaneous tissues but it invaded much
deeper than in the other two patients.
In the left arm, the tumour extended
from an ulced on the skin to the hum
erus, which it invaded in the region of
avascular necrosis. The tumour was
composed of sheets of spindle-shaped
cells with large pleomorphic nuclei and
scanty eosinophilic cytoplasm. Mitoses
were abundant. On sections stained

with hematoxylin and eosin, little ten
dency to form vascular channels could
be discerned although erythrocytes
could be seen between spindle cells. A
reticulin stain was necessary to demon
strate the anastomotic vascular chan
nels.
Material for electron microscopy
was available only in case 3. Vascular
channels with a well-defined lumen,
endothelial lining and a basal lamina
were only occasionally identified (Figs.
2 and 3). Instead, the tumour cells
were separated by abundant extra
cellular space which contained am
orphous material similar to basal lamina
(Fig. 4). Incomplete basement mem
branes surrounded many cells and their
numerous processes. Tight junctions
were observed usually between cyto
plasmic processes; desmosomes were
found, even in the endothelial cells
forming well-defined vascular channels.
Cytoplasmic microfilaments were abun
dant. Smooth and rough endoplasmic
reticulum was present in variable
amounts, mitochondria were round or
ovoid and polyribosomes and glycogen
granules were noted in varying
amounts. The nuclei were bizarre with
irregular outlines and often contained
large nucleoli.
Discussion
Lymphangiosarcoma classically arises
in a chronically lymphedematous limb.
Lymphangiosarcoma arising in conge-

FIG. 4— Tumour cells separated by abundant extracellular space containing
material similar to basal lamina. Occasional cell junctions appear as dark opacities
(arrows) between adjacent cells (reduced by 19% from X7200).
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nitally lymphedematous limbs has been
reported2-4 but in most cases it has
arisen in the upper extremity fol
lowing radical mastectomy with or
without local radiation therapy.1,5 How
ever, the histogenetic origin of this
tumour remains obscure. Stewart and
Treves6 in the original description of
postmastectomy
lymphangiosarcoma
suggested it was derived from lymphatic
endothelial
cells.6 Other
popular
theories have included a dual bloodlymphatic origin7 and retrograde metastases for the antecedent breast carci
noma.8 Silverberg, Kay and Koss9 sug
gested that postmastectomy lymphan
giosarcoma was a “vascular mesen
chymal tumor closely related to Kap
osi’s sarcoma”.9 Harrison and Kahn10
in an ultrastructural study of Kaposi’s
sarcoma found numerous primitive
cells with myogenic features between
the endothelial cell groups and postul
ated that Kaposi’s sarcoma arises from
a primitive multipotential cell. How
ever, we were unable to find a second
cell type as described by Silverberg,
Kay and Koss,9 in their case 2, or cells
with specific myogenic features as de
scribed by Harrison and Kahn10 to
suggest a close histogenetic relationship
to Kaposi’s sarcoma. We suggest that

postmastectomy
lymphangiosarcoma
is a primitive vasoformative tumour,
derived from a mesenchymal pre
cursor, but showing development to
wards endothelial cells.
Lymphangiosarcoma is a rare but
often lethal complication of radical
mastectomy1 and was directly respon
sible for the death of two of our
patients. The third patient died of com
plications of her breast carcinoma but
had evidence of residual lymphangio
sarcoma at the time of her death. The
mean time from radical mastectomy to
biopsy-proven diagnosis of lymphangio
sarcoma was 9.9 years, similar to the
interval of 10.25 years reported by
Woodward, Ivins and Soule.1
There is no established method for
treating postmastectomy lymphangio
sarcoma. Woodward, Ivins and S'oule1
reported that recurrences were treated
by irradiation, further ablative surgery,
chemotherapy or a combination of
these modalities.1 Tragus and Wagner5
reported on the use of single chemo
therapeutic agents and found that only
two out of five patients who received
nitrogen mustard (by regional per
fusion) showed a response.5 A response
was also obtained with regional per
fusion using melphalan and sarcolysine

in two cases. We were unable to find
any reference to combination chemo
therapy for this tumour. In view of the
aggressive nature of this disease and
the disappointing results with single
chemotherapeutic agents, we elected to
try a combination of vincristine, doxo
rubicin and DTIC in case 3. The pa
tient showed no response to one in
tensive course of these three agents.
Therapy was then changed to highdose methotrexate but again the pa
tient failed to respond and metastases
progressed.
The median survival for postmastec
tomy lymphangiosarcoma as reported
by Woodward, Ivins and Soule1 was 19
months. This dismal prognosis has not
been altered much by previously re
ported therapeutic regimens or by highdose combination chemotherapy used
in one of our patients. Prevention of
this disease, therefore, is of vital im
portance. Radical mastectomy com
monly results in chronic lymphedema
of the upper extremity which is proba
bly the most important cause of post
mastectomy lymphangiosarcoma.1 Thus,
avoidance of the traditional radical
mastectomy with or without local irra
diation should prevent this highly ag
gressive complication of breast cancer.

For post-operative pa
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We hope by this report to stimulate
further multidisciplinary therapeutic
trials for the treatment of postmastecomy lymphangiosarcoma for which no
effective therapy is yet available.
We thank Mrs. Yvette Quass and Mrs.
Rina Timberg for technical assistance
and Mrs. Langrell for typing the manu
script.
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Follicular Carcinoma in a Thyroglossal Duct
L.J.

VAN ZU ID EN , BA SC, MD, G.A. MACHIN, BM , PH D, MRC PATH, FRCS[C] AND
W .E . MYDLAND, MD, FRCS[C]

The case of a 24-year-old woman with
follicular carcinoma arising de novo
in a thyroglossal duct is reported. A
review of the literature disclosed seven
case reports of thyroglossal duct
carcinoma with a mixed papillaryfollicular pattern. There are three criteria
for the diagnosis of follicular
carcinoma of a thyroglossal duct:
presence of a thyroglossal duct,
absence of carcinoma within the thyroid
gland and angioinvasion. A plan of
treatment, based on the literature
survey, should include Sistrunk excision
of the tumour if possible, and subtotal
thyroidectomy should be performed
to eliminate the presence of a primary
thyroid carcinoma.
On signale le cas d'une femme de 24 ans
ayant un carcinome folliculaire qui se
developpa de novo dans le canal
thyreo-glossien. Une revue de la litterature a revele sept cas de carcinomes
du canal thyreo-glossien presentant
des caracteristiques papillaires et
folliculaires mixtes. II existe trois
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criteres pour etablir le diagnostic du
carcinome folliculaire d’un canal thyreoglossien: la presence d'un canal
thyreo-glossien, I'absence d’un carci
nome dans la glande thyroide et
I'envahissement des parois des
vaisseaux. Selon cette revue de la
litterature, le traitement comprend
I'excision de Sistrunk de la tumeur,
si possible, et une thyroi'dectomie soustotale devrait etre effectuee afin
d’eliminer la presence d'un carcinome
primaire de la thyroide.

To date, 80 cancers arising in thyro
glossal ducts have been reported, 85%
of which were papillary carcinomas.1
Only one possible case of follicular car
cinoma of a thyroglossal duct has been
reported.2
We describe another case of follicular
carcinoma of the thyroglossal duct and
review the published cases of follicular
and mixed papillary—follicular carci
noma.
Case Report

Three months before admission to hos
pital, a 24-year-old commerce student had
a sore throat. At the time she noticed a
small, slightly tender lump in the middle
of her neck anteriorly. The lump did not
change in size.
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She gave no history of voice change,
dysphagia or difficulty in breathing and
had not had radiation therapy of the neck.
There were no constitutional symptoms of
malaise or weight loss.
On physical examination she appeared
to be a healthy young woman whose pulse
rate was 68 beats/min, blood pressure
100/50 mm Hg and temperature 37°C.
There was a palpable mass, 1 cm in
diameter, just to the right of the midline
between the hyoid bone and the thyroid
cartilage. It was mobile and moved on
swallowing. The thyroid was normal to
palpation. There was no cervical lymphadenopathy.
Laboratory examination revealed nor
mal serum triiodothyronine and thyroxine
values. The SMA 12 biochemical profile
was normal. The chest roentgenogram
was normal and a thyroid scan showed a
normal radionuclide uptake.
A preoperative diagnosis of thyro
glossal duct cyst was made and a
Sistrunk operation was performed. There
were no unusual findings apart from the
thyroglossal duct and a presumed cyst.
Pathological examination of the excised
specimen revealed a 4.5-cm portion of
fibrous tissue at one end of which was a
bone fragment. At the other end there was
a firm brownish nodule (1 cm in diam
eter) which, on microscopic examination,
was found to be an encapsulated nodule
of thyroid tissue. At the periphery of the
nodule, foci of compressed normal thyroid
tissue were present. The greater part of
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Nine days later total left thyroid
lobectomy and right subtotal lobectomy
were performed. There was no evidence
of local spread of the malignant lesion.

the nodule consisted of small follicles of
various sizes, containing colloid and lined
by clear cells showing a moderate degree
of pleomorphism. In the capsule of the
nodule there was neoplastic thyroid
tissue in small veins (Fig. 1). There was
no infiltration of the cancer beyond the
capsule.
The thyroglossal duct showed a
squamous and respiratory epithelial lin
ing. Adjacent to the duct were foci of
normal thyroid tissue and mucous glands
(Fig. 2). A diagnosis of angioinvasive
follicular carcinoma was made. Another
thyroid scan was obtained and found to
be normal.

Pathological examination of the thyro
idectomy specimen revealed a fetal type
of adenoma in the lower portion of the
left lobe. There was no evidence of car
cinoma in multiple sections taken from
all parts of the gland.
Postoperatively, the patient was started
on Synthroid®, 1 mg daily. One month
later she was given 40 mCi of iodine-131
to destroy the remnant of thyroid tissue.
This allowed radioisotope scanning of the

neck to be used for follow-up. She is well
28 months after operation.
Discussion
Embryology
The thyroid gland originates from a
diverticulum of thickened endoderm
on the floor of the pharynx. This
bilobed thickening follows the descent
of the heart, remaining attached to the
buccal cavity by a narrow stalk. This
stalk passes through the second and
third branchial arches which fuse in
the midline to form, in part, the hyoid
bone. This may explain the variable
but very close relationship of a thyro
glossal duct to the hyoid bone.
The stalk, composed of variable
amounts of squamous or respiratory
epithelium and occasional rem nants of
thyroid tissue, is obliterated completely.
Failure of complete obliteration results
in a thyroglossal duct or a thyroglossal
cyst.
Thyroid tissue that appears normal
can be found in up to 45% o f thyoglossal ducts3 (Fig. 2). We disagree with
Judd4 who contends that the stalk or
cyst does not have ectopic, apparently
normal thyroid tissue. A lthough the
thyroid tissue shown in Fig. 2 could
represent a pyramidal lobe, no such
lobe was seen at thyroidectomy.
Review of Literature

FIG. 1—Follicular carcinoma invades capsule of thyroglossal duct. Angioinvasion
is also present (arrows) (hematoxylin and eosin, reduced by 28% from X40 approx.).
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FIG. 2—Thyroglossal duct is dilated by cyst and is lined by squamous epithelium
(large solid arrow). Adjacent is nodule of ectopic thyroid tissue (open arrow), and there
is associated group of ectopic mucus-secreting glands (small arrow) (hematoxylin and
eosin, reduced by 28% from X l6 approx.).
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Eighty cases of carcinom a of a thyro
glossal duct have been reported and
85% of these were papillary in type.
A further 8% had a mixed papil
lary-follicular pattern. W oolner and
colleagues5 in their review of prim 
ary thyroid tum ours included the mixed
papillary-follicular carcinom as with
papillary carcinoma. The remaining
7% include: epidermoid,5 anaplastic,7
squamous cell8 and adenocarcinom a.
Our patient represents the eighth re
ported case of follicular carcinom a and
the only definite case of true follicular
carcinoma of a thyroglossal duct. The
criteria that we used for the diagnosis
were (a) the presence of a thyroglossal
duct, (b) the absence of any carcinoma
within the thyroid gland and (c) most
importantly, angioinvasion, as shown in
Fig. 1.
Table I 2*9-13 summarizes the clinical,
laboratory and pathological findings
of the other seven reported cases. In
the majority of these, the histologic
pattern was that of papillary carcinoma
with only occasional areas of follicular
carcinoma. The case reported by
Weber9 does not qualify for inclusion
in this group, according to our criteria,
because carcinom a (4 mm in diameter)
was found within the thyroid gland at
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T a b le 1

Case
no.

C lin ic a l, L a b o ra to ry and P a th o lo g ic a l F in d in g s in S e v e n R e p o rte d C ases o f M ix e d P a p illa r y -F o llic u la r C a rc in o m a o f a T h y ro g lo s s a l D u c t

A ge,
yr

Sex

i

G h en t and W augh2

41

F

3 mo

H o a rs e n e s s ,
d y s p h a g ia

M id lin e m ass

C h e s t n o rm a l,
le u k o c y te
c o u n t n o rm a l

S is tru n k o p e ra tio n ,
no ly m p h nodes
in v o lv e d

P o s sib le p u re fo l
lic u la r a d e n o 
c a rc in o m a

2

S a h a r ia 10

54

M

3 mo

M ass in n e c k

T e n d e r m ass, 5
X 4 cm , o v e r
th y ro id

N o t a v a ila b le

M o d ifie d ra d ic a l
n e c k d is s e c tio n ,
s tr a p m u s c le s in 
v o lv e d . Ir r a d ia 
tio n

M ix e d p a p illa r y f o llic u la r p a t
te r n w ith lo c a l
s p re a d

3

P ag e and
c o lle a g u e s 11

23

F

2 yr

R ig h t a n d le f t
c e rv ic a l m a s s

M a s s , 3 c m , o v e r T h y ro id scan
h y o id
b o n e,
n o rm a l
b ila te r a l e n la rg e d
ly m p h nodes

M o d ifie d n e c k d is 
s e c tio n , t h y r o i
d e c to m y , 1311

M ix e d p a p illa r y f o llic u la r p a t
te r n w ith lo c a l
s p rea d

4

P age and
c o lle a g u e s 11

24

F

N o t n o te d

M ass in n e c k

P re v io u s th y r o 
g lo s s a l d u c t
c y s t e x c is e d

N o t a v a ila b le

S is tru n k o p e ra tio n
X 2

M ix e d p a p illa r y fo llic u la r p a t
te r n

5

A k b a r i, R ic h te r a n d
P a p a d a k is 12

38

F

5 mo

W e ig h t loss
11.4 k g ,
c h o k in g s e n 
s a tio n

M id lin e m ass

N o t a v a ila b le

S is tru n k o p e ra tio n

M ix e d p a p illa r y fo llic u la r p a t
te r n

6

W e b e r8

23

F

N o t n o te d

M ass in n e c k
d o u b le d in
s iz e in ly r

F ix e d 6 cm m ass
ir r e g u la r in
s h ap e

131l scan n o rm a l

E x c is io n o f
a n d s tr a p
c le s , to ta l
ro id e c to m y
la te r

4 m m , m ixed
p a p illa r y fo llic u la r t u 
m o u r in th y ro id

7

L u i a n d L i t t l e r 13

24

M

2w k

M ass in n e c k

M a s s , 2 X 2 cm ,
a t h y o id bone

C h e s t n o rm a l,
a re a s o f c a lc i
fic a tio n in
neck

S is tru n k o p e ra tio n

D u ra tio n
o f s y m p to m s

the tim e of thyroidectomy. In three of
the seven cases (nos. 2, 3 and 6) the
tum our behaved clinically like a papil
lary carcinom a with local invasion and
spread to the regional lymph nodes.
O f the seven cases of follicular car
cinoma of a thyroglossal duct, the
m ajority (66% ) were treated by a
Sistrunk operation.14 Since primary
carcinom a of thyroglossal duct origin
can only be distinguished with cer
tainty from metastatic carcinoma if
there is no primary thyroid carcinoma,
thyroidectom y is indicated. A modified
radical neck dissection may be necessary
if there is preoperative or intraoper
ative evidence of local spread of the
cancer.
Summary and Conclusions
A case of follicular carcinoma arising
de novo in ectopic thyroid tissue of
a thyroglossal duct has been described.
Review of the literature reveals a total
of six cases of mixed papillary-folli
cular carcinoma, arising in a thyro
glossal duct, and possibly one case of
pure follicular carcinoma.2
The criteria we have used for the
diagnosis of this entity are: (a) demon
stration of carcinoma within a histo
logically proven thyroglossal duct, (b)
absence of carcinoma in a pyramidal
lobe, if present, or within the substance
592

L a b o ra to ry a n d
ro e n tg e n o g ra p h ic
fin d in g s

A u th o r

S ym p tom s

P h y s ic a l
fin d in g s

of the thyroid gland and (c) angioinvasion.
Of those cases described in the liter
ature, three were clinically similar to
papillary carcinoma, with local metastases. Four patients were treated by a
Sistrunk operation while two patients
had a modified radical neck dissection.
Considering the paucity of cases of
carcinoma in a thyroglossal duct, the
validity of various therapeutic modal
ities cannot be assessed. However, we
believe that all thyroglossal ducts
should be excised by a Sistrunk oper
ation. If a malignant tumour is found,
subtotal thyroidectomy should be per
form ed to rule out the possibility of a
primary thyroid carcinoma. The pre
sence of a papillary carcinoma with
obvious local metastases is an indica
tion for bilateral modified neck dis
section.

5.

6.

7.

8.

9.

10.

11.
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Knitted Dacron Ultra-lightweight Grafts —
a Warning
R.B. L y n n , m d , frcs

A 61-year-old man presented with gross
femoral and abdominal pulsation
secondary to severe ectasia of an
ultra-lightweight Dacron graft. All
patients who have received this
particular graft should be followed up
closely and probably the graft should be
replaced if progressive enlargement
occurs.
A la consultation, un homme de 61 ans
a presente une pulsation femorale et
abdominale secondaire a une importante
ectasie d'un greffon de Dacron
ultra-leger. Tous les patients qui ont
repu une telle greffe devraient faire
I'objet d'une surveillance minutieuse et
le greffon devrait probablement etre
remplace si un elargissement progressif
survient.

Over the years great improvements have
been made in the quality of prosthetic
grafts used for reconstructive arterial
surgery. Unfortunately, it may be years
after implantation when it becomes
apparent that, in some patients, the
graft is not accepted. I believe a warning
should be issued to doctors whose pa
tients have received an ultra-lightweight
knitted Dacron graft (621-S; USCI
Division, C.R. Bard Inc., Glen Falls,
NY). In the last 6 months I have seen
three patients in whom the original
graft has become seriously dilated. One
of these cases is reported briefly.

groin masses (Fig. 1) and much more
pronounced abdominal pulsation. Ultra
sonography of the abdominal aorta
showed that the anteroposterior diameter
of the aorta measured 70 mm immediately
below the xiphoid process, 35 mm at the
umbilicus and 35 mm at 5 cm below the
umbilicus. The greatest width of the distal
aorta appeared to be about 50 mm. (It
should be remembered that the last two
measurements are those of the previously
inserted graft.) Computerized tomography
of the abdomen showed that 11 cm below
the xiphoid process just above the iliac
crest the aorta measured 60.3 mm. The
dilatation persisted but was less pro
nounced 13 cm below the iliac crest. The
patient was operated uipon on Oct. 24,
1978. A Dacron velour graft (22 x 11
mm) was inserted inside the previous
graft, reanastomosed to the abdominal
aorta just beyond the renal arteries and
extended into both groins. The previous
graft now measured approximately 60 mm
in diameter in the abdomen (Fig. 2) and
17 mm in diameter in the groins (original
size was 22 x U mm). Cross-sectional
views of the femoral arms of the new and
old grafts are shown in Fig. 3 (new graft
= 78.5 mm2; old graft = 176.5 mm2).

The surgery was uncomplicated but the
patient suffered a massive myocardial in
farction following the operation and died.
Discussion

This case report is presented so that
anyone who has a patient in whom an
ultra-lightweight Dacron graft has been
inserted can be alerted to the develop
ment of this uncommon but not rare
complication. Similar problems with this
graft have previously been reported by
Ottinger and associates.1
Addendum

Since this patient was operated upon
another patient has returned with dilata
tion of an ultra-lightweight Dacron graft.
Over a period of 9 years the 22-mm aortic
tube graft had dilated to more than 50
mm in diameter.
Reference

1. O ttinger LW, D arling RC, W irthlin
LS, et al: Failure of ultralightweight
knitted Dacron grafts in arterial re
construction. Arch Surg 111: 146, 1976

Case R eport

A 61-year-old man with aortoiliac ob
struction had had a 22 x 11-mm aortobifemoral graft (ultra-lightweight knitted
Dacron 621-S) inserted in April 1972.
1—Enlarged groin masses indicat
Apart from brisk bleeding through the ingFIG.
of bilateral femoral artery
substance of the preclotted graft at the (graft)presence
aneurysms.
time of operation there were no untoward
difficulties. The postoperative course was
smooth and the patient was not seen again
until March 1978 when he presented with
pulsatile masses in both groins and with
abdominal pulsation. Aortography con
firmed dilatation and unfolding of the
graft. The patient was followed up closely
until October 1978 when he was read
mitted with substantial enlargement of the
From the division of thoracic and
cardiovascular surgery, Kingston General
Hospital, Queen’s University, Kingston,
Ont.
Reprint requests to: Dr. R. Beverley Lynn,
FIG. 2—Inside view of dilated abdo
Cardiovascular and thoracic surgery,
minal component of bifurcation graft (60
Queen's University, Richardson House,
102 Stuart St., Kingston, Ont. K7L 2V6 mm).

FIG. 3—Cross-sectional views showing
original size of femoral component of
graft (11 mm, at top) and ectatic arm
(17 mm, below).
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an urgent problem
,
postoperative anaerobic
in gynecological
infections

. clindamycin is an important antibiotic in the
therapy of such [gynecological] infections.”
Swenson, R.M., et at. (1974). Obstet. & Gynecol., 44 :699.

in abdominal
infections

This study suggests “ ...clindamycin is an excellent
and relatively safe antibiotic for treatment of
[abdominal] infection caused by anaerobes when
combined with surgery (when indicated) or other
antibiotics active against aerobic gram-negative
bacilli, if present.”
Levison, M.E., et al. (Mar., 1974).
Antimicrob. Agents &Chemother., p.276-280.

an a cce p te d solution
Dalacin C Phosphate S.S.
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Indica tions: Dalacin C Phosphate (clindam ycin phosphate in je c tio n N.F.) Dalacin C P hosphate S terile S o lu tio n is in d ic a te d fo r the tre
m ent of in fe c tio n s where the oral route is not indicated or feasible.
C lindam ycin phosphate is indicated in the treatm ent o f serious in fe c tio n s due to sensitive anaerobic bacteria, s u c h as Bacteroid
species, peptostreptococcus, anaerobic streptococci, C lo s trid iu m species and m icro-aero philic stre p to c o c c i.

infections
in pulmonary
anaerobic infections

C lindam ycin phosphate is also in dicated in serious in fe c tio n s due to sensitive G ram -positive organism s s ta p h y lo c o c c i (in c lu d in g penic
linase-producing staphylococci), strep tococci and p n e um o cocci w hen the patient is in tolerant of, or the o rg a n ism re s is ta n t to, o tf
appropriate antib iotics.
C o ntraindica tions: The use of Dalacin C Phosphate is co n tra in d ic a te d in patie nts previously found to be h y p e rs e n s itiv e to th is com pour
the parent com pound, clindam ycin, or clindam ycin p alm ita te. A lth o u g h c ross-se nsitisatio n w ith L in c o c in (lin c o m y c in ) has not be
dem onstrated, it is recommended that Dalacin C P hosphate not be used in patie nts w ho have dem onstrated lin c o m y c in sensitivity. Ur
further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (infants below 30 days of age), o r in pregnant womi
W arnings: Some cases o f severe and persistent diarrhoea have been reported durin g or a fte r therapy w ith D alacin C Phosphate. Tt
diarrhoea has been occasionally associated with blood and m ucus in the s tools and has at tim es resulted in a c u te c o litis . W hen endosco
has been perform ed, some of these cases have show n pseudom em brane form ation.
If s ig n ific a n t diarrhoea occurs during therapy, this drug shou ld be disco n tin u e d or, if necessary, contin u e d o nly w ith c lo s e observatic
S ig n ific a n t diarrhoea occurring up to several weeks post-therapy s h ou ld be managed as if a n tib iotic-associated .
If c o litis is suspected, endoscopy is recommended. M ild cases sho w in g m inim al m ucosal changes may respond to sim p le drug d
continuance. M oderate to severe cases, including those show ing u lc e ra tio n or pseudom em brane form ation , s h o u ld be m anaged w ith flu
electrolyte, and protein supplem entation as indicated. C o rtic o id re te n tio n enemas and s yste m ic c o rtic o id s may be o f help in persiste
cases. A n tic h o lin e rg ic s and a n tip e ris ta ltic agents may w orsen the c o n d itio n . O ther causes o f c o litis shou ld be co n sidered.
Precautions: Dalacin C Phosphate, like any drug, shou ld be prescribed w ith cautio n in ato p ic individuals.
The use of a n tib io tic s occasionally re s u lts in over-growth o f n o n s u s c e p tib le organism s - p a rtic u la rly yeasts. S h ould s u p e rin fe c tio n s occ
appropriate measures should be taken as dictated by the c lin ic a l s itu a tio n .
Since abnorm alities of liver function te s ts have been noted occ a s io n a lly in anim als and man, perio dic liver fu n c tio n te s ts sh o u ld be p
form ed during prolonged therapy. Blood counts should a lso be m o nitored during extended therapy.
As w ith all a n tib io tic s , perform culture and sensitivity stu d ie s in c o n ju n c tio n w ith drug therapy.
C lindam ycin phosphate may be used in*anuretic p a tie n ts and p a tie n ts w ith im paired liver fu n c tio n . The serum h a lf-life o f clindam y(
phosphate in patie nts w ith m arkedly reduced renal fu n c tio n is greater than that of the ha lf-life o f the c o m poun d in n orm al patie nts. T
dose of clindam ycin phosphate should, therefore, be a pp rop riately decreased. H a em odialysis and p eritone al d ia ly s is are not e ffe c t
means o f removing the com pound from the blood. Periodic serum levels o f c lindam ycin shou ld be determ ined in p a tie n ts w ith severe rei
insufficiency.

Adverse R eactions: Local.
(a) Intram uscular Injectio ns: Of 404 p atie nts treated w ith clin d a m y c in phosphate in tram uscula rly (w ith a s o lu tio n c o n ta in in g 150 m g /n
six (1.5%) dem onstrated local reactions as follows: Two com pla ined o f pain at the in je c tio n site, tw o d e m onstrated in d u ra tio n at th e inj«
tion s ite and tw o developed sterile abscesses.
(b) Intravenous Infusion: Of 192 p atie nts t^ a te d w ith clin d a m y c in phosphate by intravenous in fusion, 14 (7.3% ) d e m o n stra te d loj
.•
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The m ajority o f these cases developed in conjunction w ith the use o f in d w e llin g IV ca th e te rs and it is d iffic u lt to kn o w h o w m uch the dr
contrib u te d to the irritation. Two p atie nts developed lo ca lise d erythem a, sw elling and pain at the s ite of the in fu sio n .
S ystem ic Side E ffects: Twenty-eight patie nts of 596 treated w ith clin d a m y c in phosphate by e ith e r the in tra m u scu la r or in tra ve n o u s rout
developed system ic side e ffe c ts as fo llo w s:
N u m b e r o f Pah
Num ber o f P a tients
H yp ote nsion............................
................................... 7
Rash . . . .
H y p e rte n s io n ..........................
....................................1
Urticaria.
S hortness of B re a th ..............
....................................1
P ru ritis ..
S u p e rin fe c tio n *......................
................................. 1
Fever, Leucocytosis.
Cardiac arre st* ......................
Nausea, w ith or w ith o u t vo m itin g ........................................................ 1
Bad or b itte r ta s te in m outh .
Diarrhoea (See also under “ W arnings” ) .............................................4
‘ S u perinfection is a com plication o f an tib io tic therapy in general and is not necessarily a true sid e effe c t o f c lin d a m y c in pho sphate.

;

* * Due to underlying m yocarditis in th is patient.

C linical and Laboratory Findings: Patients treated durin g c lin ic a l tria ls o f c lindam ycin phosphate were fo llo w e d w ith c lin ic a l laboratt
tests, including com plete haematology, urinalysis and liver and kidney fu n c tio n tests. Some o f these te s ts w ere a bn orm al in itia lly a
returned to normal during therapy w ith clindam ycin phosphate, w h ile others were norm al in itia lly and becam e a bn orm al du rin g thera
Overall evaluation o f clin ic a l laboratory values in these p a tie n ts does not indicate that clin d a m y c in phosphate therapy has a to x ic e ffe ct'
the haem atopoietic, hepatic or renal system s. Transient elevations o f serum transam inases have occurred in som e p a tie n ts , but o th e r li1
function tests (alkaline phosphatase, serum bilirubin) have not show n any tendency to increase and there have been no c lin ic a l sig ns
drug-induced hepatic toxicity.
Sym ptom s and Treatment o f Oversoage: No cases o f overdosage have been reported. No s p e c ific a n tid o te is know n. Doses as high
1200 mg every six hours (4800 m g/day) by infusion fo r five days have been given w ith o u t adverse effect.
DOSAGE AND ADMINISTRATION
Adults
Intram uscular In je c tio n : 600 m g/d ay in tw o equal doses.
M oderately severe in fe c tio n s : 600 to 1200 m g/day in tw o or three equal doses.

'. clindamycin has been reported to be the most Severe in fe c tio n s : 1200 to 2400 m g /d a y in two, three or fo u r equal doses. Intram uscular in je c tio n s of m ore than 600 m g in to a sin g le s
active antimicrobial agent tested in vitro against are not recommended.
Intravenous A d m inistra tion: Dalacin C Phosphate m ust be d ilu te d p rio r to IV a d m in is tra tio n to a d ilu tio n o f 300 m g in 50 m l o f dilui
anaerobic bacteria; [in the pulmonary tract]
(6 m g /m l) or more, and infused in not less than 10 m inutes. A d m in is tra tio n o f m ore than 1200 mg in a sin gle one -ho ur in fu s io n is not recc
concentrations of 3.1 /jg/ml or less inhibited 96% mended. Dalacin C Phosphate should not be in jected in traveno usly u n d ilu te d as a bolus.
M oderately severe in fe ctio n s: 900 to 1800 m g/day by co n tin u o u s drip o r in tw o or three equal doses, each in fu se d over 20 m in u te s or Ion*
of strains tested...”
Severe in fe c tio n s : 1800 to 2700 m g /d a y by continuous d rip or in three or four equal doses, each infused over 20 m in u te s or longer. In I
£ass, R.J., et al. (1973). Annals Intern. Med.,

78:853.

threatening in fectio ns, doses of 2700 to 4800 m g/d ay by c o n tin u o u s drip or in three or fo u r equal doses each in fu s e d over 20 m inutes
longer may be given.
C hildren: (Over one m onth of age)
Intram uscular Injectio n: 10 to 15 m g /k g /d a y in two, three o r four equal doses.
M oderately severe in fe c tio n s : 15 to 20 m g /k g /d a y in three or fo u r equal doses.
S e vere infections: 20 to 30 m g /k g /d a y in three or four equal doses.
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Intravenous A d m inistra tion:
M oderately severe in fe c tio n s : 15 to 25 m g /k g /d a y by c o n tin u o u s drip or in three or fo u r equal doses, each in fu se d over 20 m inutes
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Orthopedic Surgery Today
R.L. C ruess,

md, frcs[c]

Je vous remercie de votre aimable in
troduction. II y a peu d’occasions dans
la vie ou l’on se voit donner la possi
bility de s’adresser a un large groupe
d’amis et de confreres pour leur parler
sur un theme librement choisi. Pour
cette raison, les mots des presidents
sortant se ressemblent peu et refletent
en fait les interets personnels de chacun ainsi que les problemes auxquels a
du faire face la chirurgie orthopedique
durant les 34 annees d’existence de
notre association. II y a cependant un
theme que l’on retrouve dans tous les
discours presidentiels, c’est celui de la
gratitude du president envers les membres de l’association. Si vous, qui etes
ici aujourd’hui, quittez cette salle en
ne retenant qu’une seule note ce que je
vais vous dire, j’espere que ce sera
celle de la reconnaissance que mon
epouse et moi eprouvons pour le grand
honneur que vous nous avez fait en
m’elisant President de l’Association
canadienne d’orthopedie. Recevoir de
maniere aussi tangible l’approbation de
ses confreres est une des experiences
les plus profondement satisfaisantes de
nos vies relativement courtes.
Wilder Penfield, in his autobiog
raphy, correctly pointed out that those
of us in medicine do not travel the
path of our professional lives alone.
We carry with us the traditions of
Western medicine which have evolved
through the years and which are so im
portant in preserving both the proper
purpose and the dignity of our profes
sion. He also stated that we benefit
from the direct influences of the great
teachers and advisors with whom we
have had contact. As a self-perpetuat
ing discipline, it is our obligation to
pass on the body of knowledge that
represents modern medicine to those
who must continue in the future. Pro
fessional associations are also rooted
in the past and carry with them the
influences of former leaders. We, in the
Canadian Orthopaedic Association,
therefore, become the custodians of
our past and it is our responsibility to
conduct our affairs in such a fashion
that those in the future will be as
fortunate as we have been. I would
like this morning briefly to review our
past accomplishments, emphasizing the
legacy that we have inherited from

those who built orthopedics in this
country, many of whom are in this
room today. I would then like to look
ahead because I believe that we must
redirect some of our creative energies
as we are now facing a different set of
problems and therefore of opportunities
compared with those previously en
countered.
Canadian orthopedics and this or
ganization are closely related. In re
trospect, the history of both is admir
able and exciting and has as its stars,
individuals working in hospitals and
medical schools who patiently built the
organizations and structures that
allowed for the growth of the specialty.
If one considers numbers, we began
with 86 members in 1951, the year in
which I graduated from university.
There was steady growth until about
1960, when the rate of expansion
began
to increase and recently it has
L’histoire de la chirurgie orthopedique
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about the importance of research or
education we must remember that
Presidential address to the 35th annual
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Let us next consider how we have
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The history of orthopedic surgery in
Canada is briefly reviewed. It appears
that the problems which were posed
in the 1960s and early 1970s have
diminished in importance. They related
to the shortage of orthopedic manpower
and to the lack of a sound scientific
base within universities. There appears
now to be an adequate number of
orthopedic surgeons to handle the needs
of the population, and Canadian training
programs are providing replacements
at an appropriate rate. Future problems
w ill in all probability relate to the
interrelationship between society and
the medical profession. Academic
freedom and mobility of medical man
power must be preserved at all costs
and the orthopedic profession must
adapt to an ever-changing situation if
future developments are to be as
satisfying as our very exciting past.

edly been assisted by the publication
of a major Canadian textbook of or
thopedic surgery aimed specifically at
the medical student.
At the postgraduate level, residency
training programs have evolved to the
point where they should in many ways
be the envy of the English speaking
world. We have, because of our for
tunate situation, been able to select
aspects of American and British train
ing and adapt them to our own use.
We must share the credit for this ac
complishment with the Royal College
of Physicians and Surgeons of Canada
because it was their policy decision in
shifting responsibility for residency
training from the hospital to the univer
sity which allowed postgraduate train
ing to be designed primarily in response
to educational needs rather than to
hospital service requirements. This
immediately changed the picture of
postgraduate training across Canada.
While we all could suggest further
often dramatic changes or local im
provements in specific programs, truth
fully not many of us would wish to
trade our overall supervisory and or
ganizational structures with any other
country nor would we wish to employ
any other known method of certifica
tion of competence.
Finally, let us consider the status of
orthopedic research in Canada before
attempting to identify and face the
problems of the future. Twenty-five
years ago, orthopedic research was in
its infancy. We were undoubtedly
judged to be intellectually inferior to
many other disciplines within medical
faculties. Without going into the causes
in detail, it must be mentioned that the
service commitment of the early ortho
pedic surgeon was considerable and
that his principal problems related to
the establishment of orthopedics as a
recognized discipline, much less a re
search discipline, and to the lack of
technical tools suited to solving the
problems presented to orthopedic
surgeons. Gradually, individuals trained
in research have been attracted to or
thopedic faculties, facilities have been
developed, funds have been attracted
and the Canadian Orthopaedic Re
search Society has been founded. We
have, I believe, underestimated the
strength and contributions of the or
thopedic research community in Can
ada. The investigations being carried
out vary greatly across the country.
They range from almost pure basic
science through bioengineering, mate
rials testing and implant design, applied
immunology,
ultrastructure,
classic
pathology, experimental surgery de
signed to solve problems in the human,
to some of the finest clinical research
in the world. There are many indivi

fared at the hospital and university
levels and how we are discharging our
academic responsibilities. The same
period of time has seen orthopedic
surgery established within university
and hospital structures as an integral
part of the organization of every major
medical institution in Canada. We
have gone from a situation where indi
viduals were practising in isolation,
often in university centres, usually
under the domination of general sur
geons, to a point where every medical
school now has a division of ortho
pedic surgery. There are no full depart
ments in Canada. As a young acade
mician, I had been led to think that
departmental status was a major pro
fessional objective. I no longer believe
this to be true. It is my firm convic
tion that the unity of surgery is of far
greater importance and that depart
ments of surgery should be run demo
cratically with all surgical disciplines
participating in decision-making. We
must not continue to fight the battles
of the past. Our major arguments are
no longer with general surgery. We are
as powerful as any surgical discipline
in most centres. We must be certain
that surgery, including orthopedics, has
adequate facilities to treat patients re
quiring care, adequate time in the
medical school curriculum and ade
quate resources to train those who
must carry on the practice of ortho
pedic surgery in the years to come. We
have gradually arrived at the point
where I think these objectives are
realized in most universities, and the
next few years should see the com
pletion of the “mop-up” operations in
the remaining problem areas.
Within Canadian universities, ortho
pedic surgeons have risen to positions
of prominence coincident with their
ability to function competitively within
an academic milieu. Orthopedic sur
geons have served and are serving as
chief surgeons in teaching hospitals, the
first orthopedic surgeon is now func
tioning as chairman of a university
department of surgery and there will
be others. Orthopedic surgeons have
directed major university committees
determining medical school policies and
have worked effectively within deans’
offices. While information on under
graduate curricula is notoriously dif
ficult to obtain, during the past 15
years the subject has been taught well
enough so that many medical students
have been attracted into the specialty
of orthopedic surgery from Canadian
medical schools and these students
have often arrived with admirable
academic records. It is unlikely that
they elected to train in orthopedic
surgery merely to find out more about
the subject. This interest has undoubt
VOLUME 22, NO. 6, NOVEMBER 1979
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duals who have proven themselves to
be consistent producers of new and
valuable information. It is not widely
known but of the total funding devoted
to surgical research in Canada in 1976,
orthopedic surgery, according to figures
supplied by the Medical Research
Council, received 48% and general
surgery 43% . We have been fortunate
because our research community con
tinues to have an impact upon the
clinical practice of orthopedic surgery.
The Canadian Orthopaedic Research
Society has as its stated objective, the
mounting of a scientific meeting which
will be understandable to the practising
orthopedic surgeon, and, indeed, a
greater percentage of practising ortho
pedic surgeons who attend the annual
meeting of the Canadian Orthopaedic
Association also attend our research
society meeting than do orthopedic
surgeons in any other country of the
world.
We do have important problems
which are related to the geographical
disparity of our research output. This
has implications not so much on the
research community as upon the educa
tional potential of some institutions.
Research is well established in about
one third of Canadian medical schools.
Another one third has research taking
place on a limited scale and the re
maining one third has essentially no
active laboratory research. The causes
of this situation are complex and relate
to the failure of orthopedic divisional
chairmen as well as chairmen of sur
gical departments and deans to obtain
adequate salary support and space for
orthopedic research when budgetary
expansion was taking place. The
financial situation makes expansion at
present unlikely. It is not proper to
blame orthopedic surgery on a national
level for this deficiency and it is diffi
cult to envisage any correction other
than at the level of local initiative. If
salary support, space and sufficient
status for the researcher are adequate
on a local level, individuals will go into
research and will attract their own
research money from granting agencies.
The spotty geographical distribution
of qualified investigators has educa
tional implications which appear to be
important. Each medical school at pre
sent trains residents. I do not believe
that there would be any argument in
1978 with the statement that surgery
must be taught on a sound scientific
basis if it is to be taught well. Who is
to teach the science of orthopedics if
no active investigation is taking place
in a medical school? It takes an extra
ordinarily talented and well-motivated
practising orthopedic urgeon to keep
abreast of research developments in
sufficient detail to pass this knowledge
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on to residents. My personal opinion is
that this remains the major deficiency
of some Canadian training programs.
I hope that this association will sponsor
a basic science sound-slide program
aimed specifically at partially correct
ing this lack and assisting those schools
in need. By sharing our skills we can
improve the entire fabric of our
specialty.
Un examen critique de l’Association
canadienne d’orthopedie montre que la
structure de ses comites a evolue en
reponse aux problemes qui se sont
poses dans le passe. Le comite executif
est largement representatif du groupe
puisqu’il est compose de personnes
provenant aussi bien de la communaute
que des milieux universitaires et qu’il
y existe une representation geographique reelle. Le comite sur la formation
et la qualification des jeunes orthopedistes a produit un rapport qui nous a
permis de nous exprimer avec autorite
au niveau national et egalement travailler etroitement avec le comite du
College royal pour ameliorer la forma
tion post-graduee et l’obtention du
certificat de competence. II a egale
ment servi d’information pour l’etablissement des donnees du programme
sous-gradue. La Societe de recherche
en orthopedic a prouve qu’elle pouvait
etre un stimulant pour l’investigation
au Canada et un forum oil les infor
mations obtenues pouvait etre presen
tees a la communaute orthopedique.
Nous pouvons egalement etre fiers des
contributions faites par nos representants au College royal et ceci inclut
son premier president qui fut un orthopediste. Ils ont litteralement revolutionne les mecanismes d’examens au
Canada et ont ete en premiere ligne
pour faire comprendre au College qu’il
devait repondre plus adequatement au
besoin changeant des differentes disci
plines. Les problemes du passe ont ete
identifies et des solutions, parfois brillantes, parfois seulement acceptables,
ont ete developpees. Shakespeare tells
us that “what is past is also prologue”.
Let us attempt to look to our present
problems in the hope that we can
ensure that the past is a prologue to an
equally successful future.
According to my admittedly opti
mistic view, we appear to be in the
fortunate position of having achieved
many of our past objectives. Indeed, if
15 years ago I had been told that I
would be standing on this platform I
would have been sceptical. But if in
addition I had been informed that I
would be able to relate such a record
of achievement for the specialty, I
would have been frankly incredulous.
Why, then, the cause for alarm? The
major reason, as you all know, relates
to the position of the medical profes
598

sion in society and to the close atten
tion to the cost of the health care
system being paid by government. Our
problems are not unique in the West.
Both Great Britain and the United
States are facing a true crisis in health
care but, because each country employs
a different organization, each has
different problems and must evolve
different solutions. We, in Canada,
have an essentially decentralized sys
tem partly financed under a federal
umbrella law. We must cope in the
near future with a new and fluid situa
tion in which the partnership between
the federal and provincial governments
has been modified and provincial
governments alone are the full financers
of health care following the transfer of
a fixed percentage of the income tax
irrespective of the cost of services.
This is already leading to difficulties
relating to the allocation of funds for
medical facilities, to the remuneration
of the medical profession and to deter
mining manpower needs. Mark Twain
believed that “he who swings the cat
by the tail learns things which can only
be learned by swinging a cat by the
tail”. Government in Canada has a
firm hold of the health care cat and is
looking for ways to shift its grip, pre
sumably to the throat of the animal.
Today we are attempting to discuss the
matter from the point of view of the
cat, and that is not a very enviable
position.
Society must decide what percentage
of its resources will be devoted to
health. When looked at carefully, the
recent increases in health care costs in
all Western countries including our own
have been staggering if one considers
merely the annual rate of growth. How
ever, the true measure of a country’s
resources appears better presented by
studying its gross national product
(Table I). Our record using this meas
urement does not appear as critical. In
1965, before the institution of medi
care but well after universal hospitali
zation had been established, Canada
was devoting 6.0% of its gross natio
nal product to health care. We were,
in fact, devoting a higher percentage

T a b le 1— P e rc e n ta g e o f th e G ross N a tio n a l
P ro d u c t (G N P ) D e v o te d to H e a lth C a re in
V a rio u s W e s te rn C o u n trie s
C o u n try

1965

1975

C anada
U n ite d S tates
S w ed en
N e th e rla n d s
F ra n c e
W e s t G e rm a n y
G re a t B rita in
S w itz e rla n d

6.0
5.9
5.5
5.4
4 .9
4.4
4.1
3.8

6.9
8.5
8.4
9.5
5.9
7.8
5.7
6.7

VOLUME 22, NO. 6, NOVEMBER 1979

of our GNP to health care services
than any other country in the West.
By 1975, after medicare had been in
force for 5 years, our portion of the
GNP devoted to health care had risen
to 6.9% and was exceeded by four
other Western countries, namely, the
United States, Sweden, West Germany
and the Netherlands. All other coun
tries had experienced a higher per
centage increase in health care costs
than had Canada. These appear, to me,
to be important figures.
Furthermore, if one analyses the
cost of total health care as a per
centage of the GNP it is found that
after an initial increase there was a
drop from the peak that was reached
in 1971 (Table II). It should be men
tioned that the Hall commission in re
commending the establishment of the
organization now operating in Canada
estimated that we should by 1980 be
devoting 8.0% of our GNP to health
care, and we will not be doing so—in
fact, we will not even be approaching
that figure. It is also, of course, of
great interest to us as physicians to
note that the percentage of the GNP
devoted to physician remuneration has
been falling steadily since 1970 and
will have dropped below 1% for 1977.
II est evident qu’une certaine stabi
lity des depenses de sante est necessaire
pour la sante economique generate
d’un pays et, en fait, le probleme
economique est la racine de nos diffi
culty. Une economic canadienne
stagnante, une inflation persistante et
1’augmentation du cout de tous les
avantages sociaux ont tres severement
limite la possibility des gouvernements
federal et provinciaux de promouvoir
de nouveaux programmes susceptibles
d’etre a la fois benefiques pour la po
pulation et payant sur le plan politique.
II apparait certain que la plupart des
niveaux de gouvernement ont une tres
petite marge de manoeuvre etant donne
que leurs depenses fixes, incluant les
soins de sante, sont devenus si grandes.
We, in the medical profession, are
consequently being asked to produce
fewer doctors from our medical schools
and training programs and to accept
T a b le

1^ P e r c e n t a g e of G N P
H e a lth in C a n ad a

Y ear

T o ta l h e a lth
c a re

1971
1972
1973
1974
1975
1976
1977

7.2
7.0
6.7
6.7
6.9
6.9
7 .0 - 7 .1 *

D e v o te d to

P h y s ic ia n
re m u n e ra tio n
1.33
1.3
1.2
1.1
1.1
1 .0 *
< 1 .0 *

* ln e x a c t fig u r e .
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without the federal financial umbrella,
individual provinces will attempt to
reinstitute some form of deterrent fee
to limit access to the system. This will
lead to a return to a double standard
of care which I personally abhor. The
other equally disturbing alternative is
that a single standard of care will be
preserved but at a level which is not
consistent with standards of excellence
known previously. Mediocrity rather
than excellence will be expected in
return for uniformity. There are exam
ples of both sorts of compromise read
ily available to us. As members of the
Canadian medical community, we must
do our utmost to avoid either alter
native. Our responsibility is for the
orthopedic portion of medical care. If
we do not make our opinions known,
we will be responsible for the conse
quences within our own field of
interest.
A major corollary of the budgetary
situation relates to manpower. The
federal government has data, which
are probably sound, indicating that the
Canadian educational system is capable
of producing sufficient physicians and
surgeons to meet the needs of the
country in the foreseeable future as
suming that we do not lose excessive
numbers of practising doctors. Whether
one agrees or disagrees with immigra
tion restrictions is less important than
analysing the harm that can be done
to our profession by a severely restric
tive policy and devising sound means
of coping with the problem.
We have functioned thus far in an
essentially open-ended system. The
need for orthopedic surgeons was ob
vious and any university centre that
could demonstrate adequate training
facilities could expand its capacity if it
wished to do so. Part of the excitement
of the past 15 years has resulted from
the possibility of expansion and in the
development of new programs. We
have attracted into the specialty many
individuals who derived pleasure from
participating in this expansion. It will
certainly require a different perspective
to find gratification from reversing the
process. It is obvious that we must look
carefully at postgraduate education
across the country. It is probable that
not all university centres should main
tain orthopedic training programs.
We must make decisions which
are based on educational considera
tions rather than local pride, the ser
vice requirements of hospitals, or past
history. Perhaps the energies of some
institutions should be redirected so that
they may better train family physicians
in the diagnosis and management of
common musculoskeletal disease. There
is a real chance that we can further
improve the quality of postgraduate

fewer from the outside world through
immigration. There is even a suspicion
that many provinces are not reluctant
to see an increased loss through emi
gration. We are also being asked to
utilize fewer services including labora
tory tests and beds, and the remunera
tion of the medical profession has not
increased with the cost of either medical
practice or of living. Finally, we are
being burdened with a largely un
earned collective feeling of guilt with
government attempting to shift respon
sibility for the economic problems of
the health care system to the medical
profession which has, in general, done
its best to adapt to an essentially
socialized structure. Once the not very
startling and not entirely accurate dis
covery had been made that doctors
generate health care costs, government
began to seek means of limiting the
number of individuals capable of lead
ing to these costs and of limiting the
facilities available to physicians and
surgeons already in practice. I need not
go into detail about the restriction of
funds of medical schools and hospitals
across the country. Both manpower
needs and budgets are causing our
present problems and all evidence in
dicates that they will increase and not
decrease.
We should not forget that we have
arrived at our present most fortunate
situation because most decisions lead
ing to the establishment of our health
care system utilized excellence as the
standard. While solutions varied some
what across the country, making the
best medical care available to all Can
adians was the objective of most
physicians and administrators. Perhaps
the most disturbing aspect of our
present situation appears to me to lie
in the relegation of excellence to second
place with economy being substituted
as the primary objective. There clearly
are some medical programs which no
society can afford, but recent decisions
appear to be aimed at limiting health
care to an unacceptable level. We
have a health care system which is
well planned and imaginative. It aims
at a single standard of care while
making all reasonable services avail
able to every Canadian. It received and
still receives a large measure of support
from the Canadian medical community.
Of even greater significance, all polls
have indicated that the Canadian
public is very satisfied with the present
arrangement. Our political confreres
appear to have forgotten this point.
Excessive budgetary trimming can
have only two consequences and may
well have both. It will either limit the
amount of health care available to Can
adians or it will lower the quality of
that care. My own fear is that
VOLUME 22, NO. 6, NOVEMBER 1979
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education available to Canadians if we
can do these two things wisely.
One thing that we must preserve at
all cost is the mobility of the ortho
pedic trainee. Professor Inglis of Sas
katoon has warned of the dangers of
excessive balkanization of residency
training in Canada. If each province
determines its own manpower needs,
establishes its own training programs
and trains people from its own medical
schools, we shall be forced into a
narrow provincialism which will give
joy to very few. The mobility of people
and of ideas are closely linked and we
in Canadian orthopedics have derived
tremendous benefit from the infusion
of individuals from outside Canada
and from the placing of trainees in
centres remote from their homes or
future places of practice.
There are disturbing rumours eman
ating from both provincial and federal
backrooms which would indicate a
desire to foster this regional approach.
If we once more refer to the pursuit
of excellence as a major objective, we
must maintain centres of excellence
which are available to individuals
throughout our country. An expansion
of existing fellowship programs such
as those offered by the McLaughlin
Foundation and the Medical Research
Council of Canada will help to achieve
this. I also believe that on a local level
we must make every effort to redirect
some of the funds which will result
from the reduction of residency pro
grams so that they may be utilized to
finance years of specialty training in
orthopedics in centres of excellence.
Hpw we are to cope with these
problems which are indeed already
with us poses, I believe, the challenge
of the future. Canadian orthopedics
will have to devise new structures in
response to these new problems. We
are a national body speaking for
orthopedic surgery at a national level.
The decisions that will most affect us
will be made at two levels into which
we now have minimal input. Clearly
the economic decisions of the future
will be made at a provincial level and
the Canadian Orthopaedic Association
is not now and will not in the future
be a party to the discussions leading
up to these decisions. I believe very
strongly that for this reason we must
set up the equivalent of a regional
council and that it must include not
individuals selected by us but those
who are chosen either by their local
association or their provincial govern
ment to serve as orthopedic representa
tives in various provinces. I think it is
important that they meet at least once
a year to exchange information, to
support each other and to make cer
tain that serious unrecognized regional
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CONTRAINDICATIONS: Carbenicillin
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DOS AG E :R e la tiv e ly h ig h d o s e s o f
carbenicillin are required in the treat
ment of severe Pseudomonas infec
tions. ADULTS—Severe and overwhelm
ing infections (septicemia, extensive
burns and wounds, pneumonia, men
ingitis, peritonitis): 12 to 30 g daily in
travenously or by infusion with or
without 1 g of probenecid orally 3 times
daily. In moderately severe infections:
ig every 4 hours for 5 to 10 days.
CHILDREN—Dosage, according to
w e igh t, age and severity of infec
tio n , may vary fro m 100-300 m g/
kg /b o d y weight.AVAILABILITY: Vials
containing: 1 g or 5 g carbenicillin.
Complete prescribing information and
references available on request.

disparities do not develop. I am pleased
to report to you that your executive
has established such a council. We
hope that we can in this way make
certain that the interests of national
orthopedics can be expressed easily at
a regional level.
We must recognize that our influence
on federal decision-making is very
slight when we speak as orthopedic
surgeons. The Canadian Medical Asso
ciation, the Royal College of Physicians
and Surgeons of Canada and the Asso
ciation of Canadian Medical Colleges
are the bodies consulted by the federal
government when it wishes to solicit
the opinion of organized medicine. It
would, therefore, appear to be imper
ative that after 15 years of growth
somewhat apart from the medical pro
fession, we establish new and perhaps
formal relationships with these three
organizations based upon the willing
ness of our members to participate
actively in the work of institutions only
marginally related to orthopedic sur
gery. I hope that some members of
this association would be willing to
commit a significant portion of their
creative energy to insuring our input
into national decision-making. It will
not be as rewarding as work directly
related to orthopedic surgery, but if
we can make our opinions heard we
will indeed owe a debt of gratitude to
the involved members.
We cannot and must not become a
political body or even directly enter
the political arena, but our major
problems now lie within that sphere.
We must, therefore, continue to do
what we have been doing so well in
recent years, while at the same time
ensuring that we are well represented
in areas where we interact with poli
tical or quasipolitical bodies.
We have recognized since the time of
Darwin that the world of nature of
which we form a part is in constant
evolution. We often forget that this
process is still going on. We also some
times fail to recognize that institutions
and organizations must also evolve in
order that their strongest and most

useful characteristics may be preserved
and strengthened and that character
istics which are no longer appropriate
may be discarded. It is fortunate that
we can to some degree control the
evolution of our own institutions by
conscious decisions. What I have at
tempted to outline to you this morning
is the direction in which I believe the
Canadian Orthopaedic Association
should evolve in the next few years.
There is one further matter that
cannot be ignored by anyone holding
an executive position in a Canadian
organization. I refer, of course, to the
problems facing our country. I have
been proud to be a Canadian ortho
pedic surgeon during my entire profes
sional career. Along with many of
you. I have remained so by conscious
choice. J’ai ete aussi fier d’etre un
orthopediste au Quebec. Without con
juring up divisive political matters, it
must be stated that no matter what
happens to this country in the future,
there will be patients requiring ortho
pedic care and there will be orthopedic
surgeons dispensing this care. No
matter where we live in Canada, we
will face similar clinical situations. We
must retain our ability to communicate
in the future as we have in the past.
It is how we make certain that progress
reaches each Canadian patient. Let us,
therefore, remember that countries and
associations are directly affected by the
individual actions of their citizens or
members. We can by our individual
acts do either immense harm or great
good to both our country and to the
Canadian Orthopaedic Association.
Let each of us attempt to conduct our
selves so that our contribution is a
positive one. If we do so, there will
always be hope.
Before closing, I would like to ex
press my gratitude to my wife who has
found the time to create her own very
successful professional career while at
the same time giving me support in
mine.
I thank you all for the immense
honour which you have bestowed upon
me and for your attention this morning.

NOTICES
continued from page 553

Course for General Surgeons

Ayerst

Quality has
no substitute

AYERST LABORATORIES
Division of Ayerst, McKenna & Harrison Limited
Montreal, Canada
Made in Canada by arrangement with
BEECHAM, INC.
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The University of Toronto will present
the 20th annual refresher course for
general surgeons, which will be held
from Feb. 4 to 6, 1980 at the Toronto
Western Hospital. For information
please contact the Office of Continuing
Medical Education, Faculty of Medi
cine, Rm. 245, Fitzgerald Building,
University of Toronto, Toronto, Ont.
M5S 1A8 (telephone: 416-978-2718 or
2719).
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Symposium on Hand Surgery
The American Association for Hand
Surgery will present the 2nd annual
Stowe hand symposium entitled “Hand
Surgery—a Search for the Common
Truth”. It will be held at the Toll
House Inn, Mountain Rd., Stowe,
Vermont, from Ian. 27 to 30, 1980.
Additional details may be obtained
from Dr. Peter Linton, Cochairman,
1 South Prospect St., Burlington, VT,
USA 05401.
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Primary Malignant Tumours Associated
with Renal Cell Carcinoma
M artin G. M cL oughlin, md, frcs[c], L orne D. Sullivan , md ,
D avid D. Westmore, mb , bs , frcs, frcs ( edin )

Of 360 patients with primary renal cell
carcinoma seen at the Vancouver
General Hospital between 1957 and 1976,
33 had associated primary malignant
lesions. A review of the 166 patients
who had ablative surgery revealed that
they were four times more likely to
have a synchronous primary malignant
tumour than the other patients. The
incidence of asynchronous primary
malignant tumours was not increased.
This may be related to the fact that the
patients' full life charts were not
available. In 18 patients dying of other
causes in whom an incidental renal cell
carcinoma was found, 5 (28% ) died of
other malignant tumours. In a compar
able age group from the general
population, 19% are at risk of death from
malignant disease. The frequency of
synchronous contralateral renal cell
carcinoma in our series was 50 times
greater than the frequency of primary
renal cell carcinoma in a corresponding
sector of the general population.

serie de patients la frequence des
cancers contralateraux synchrones des
cellules renales a ete 50 fois plus grande
que la frequence des cancers
primaires des cellules renales au sein
d'un segment correspondant de la
population.

The fact that other primary malignant
lesions can toccur in association with
renal cell carcinoma prompted us to
review our experience with renal cell
carcinoma at the Vancouver General
Hospital.
Patients and Methods

Between January 1957 and December
1976, 360 patients with renal cell car
cinoma were treated at the Vancouver
General Hospital. Thirty-three patients
(9%) had associated primary malignant
tumours. The tumours were found
either synchronously or asynchronous
ly (an interval of more than 1 year
separates the two diagnoses). Renal

Parmi 360 patients ayant un cancer
primaire des cellules renales, vus au
Vancouver General Hospital entre
1957 et 1976, 33 avaient des lesions
malignes primaires associees. Une etude
de 166 patients qui subirent une
ablation chirurgicale a revele que
ceux-ci etaient quatre fois plus
susceptibles d'avoir une tumeur maligne
primaire synchrone que les autres
patients. La frequence des tumeurs
malignes asynchrones n'etait pas
augmentee. Ceci peut etre du au fait
que le dossier complet des patients
n'etait pas disponible. Parmi 18 patients
qui decederent d'autres causes et
chez qui un cancer intercurrent des
cellules renales fut decouvert, 5 (28%)
moururent d'autres tumeurs malignes.
Dans un groupe de personnes d'age
comparable prises dans la population
en general, 19% sont exposes a mourir
d’une maladie maligne. Dans notre

cell carcinomas found at autopsy
in patients who died of other malignant,
conditions were also included. Bilateral
primary carcinomas were included if
there was a primary tumour in the
second kidney without evidence of
metastatic disease.
Eighteen of the 33 patients were
found to have renal cell carcinoma at
autopsy. These patients had not had
ablative surgery for this tumour and
therefore could be said to have clini
cally silent renal cell carcinomas. Of
these 18 patients, 5 died of malignant
disease other than the renal cell car
cinoma and 13 died of nonmalignant
disease.
In the remaining 15 patients an as
sociated carcinoma was diagnosed.
Five patients (3%) had synchronous
primary malignant tumours (Table I).
The mean age of these patients was
58 years. The frequency of synchron
ous primary malignant lesions at the
age of 58 years in British Columbia is
0.75%, indicating a fourfold increase

Table I—Synchronous Primary Malignant Tumours
Patient no. Age,yr
1
2

61
55

3

54

4
5

Other tumour

Treatment

57

Breast
Rectum (squamous cell
carcinoma)
Bladder (transitional cell
carcinoma), myeloma
Stomach

Radical mastectomy
Radical abdominoperineal
resection
Cystodiathermy, simple
excision
Radical gastrectomy

62

Rectum

Radical colectomy

Follow-up
Alive at4yr
Alive at3yr
Dead at 2 yr of renal
cell carcinoma
Dead at 2 yr of renal
cell carcinoma
Dead at 2 yr of colonic
cancer

Table II—Asynchronous Primary Malignant Tumours
Patient no. Age, yr

From the department of surgery, division
of urology, University of British Columbia
and Vancouver General Hospital,
Vancouver, BC
Reprint requests to: Dr. M.G.
McLoughlin, Department of surgery,
division of urology, 1-855 West 10th Ave.,
Vancouver, BC V5Z 1L5
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Other tumour

Interval, yr

Treatment

Follow-up

1956 excision of
renal cell carcinoma
1954 renal cell carci
noma, Inoperable
1959 adrenalectomy,
excision of renal cell
carcinoma
1964 excision of renal
cell carcinoma

Died of pneumonia
after 4 mo
Died of renal cell
carcinoma
Died of breast
cancer after 6
mo
Died of colonic
cancer after 2
yr
Died of metastases
from renal cell
carcinoma

6

72

Bladder, 1953

3

7

66

Colon, 1953

1.5

8

59

Breast, 1954

5

9

62

10

79

Jejunum X 1
Colon X 4
1943-1964
Colon, 1965

21
3

1968 renal cell
carcinoma.
No treatment
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in the frequency of other primary
m alignant tumours in patients who had
excision of a renal cell carcinoma. The
distribution of the associated tumours
was general (Table I).
Five of the 15 patients had asyn
chronous primary malignant tumours
in association with renal cell carcinoma
(Table II). The mean age at the time
of diagnosis was 69 years. One patient
had five different primary tumours,
one of the jejunum and four of the
colon, and finally died of metastatic
colonic carcinoma 23 years after his
first colonic tumour had been diag
nosed and 2 years after he had under
gone nephrectomy for renal cell car
cinoma.
There were five patients with bi
lateral prim ary renal cell carcinoma of
the kidney (a primary tum our in the
contralateral kidney without evidence
of metastatic disease). The frequency
of bilateral renal cell carcinoma in the
patients who had ablative surgery was
3% , a 50-fold increase over the fre
quency of renal cell carcinoma in the
general population.

Discussion
The occurrence of multiple primary
m alignant lesions was originally re
ported by Billroth in 1889.1 In 1932,
W arren and Gates1 reported on 1259
cases of documented multiple tumours
reported in the literature and defined
the criteria needed for this diagnosis.
The two criteria most emphasized in
their paper were that each tumour
must represent a definite picture of
m alignant disease and that each tumour
must be distinct so that the possibility
that one tumour was metastatic from
the other is ruled out.
The number of other malignant
lesions in patients with renal cell car
cinoma suggests that the occurrence of

multiple primary tumours is more fre
quent than in the general population.2
Our finding of a fourfold increase
of synchronous primary malignant
tumours in patients who underwent
nephrectomy for renal cell carcinoma
suggests that these patients have an
increased susceptibility to carcinoma;
therefore patients with renal cell carci
noma should be carefully evaluated for
other primary tumours. In a recent
autopsy study reported by Hajdu, Berg
and Foote,3 tumours of the lung, breast
and colon were found most frequently
as associated primary malignant tu
mours in patients with silent carcinoma
of the kidney.They did not show any
statistical evidence that the frequency
of these tumours in patients with silent
renal cell carcinoma was different
from that in the general population. The
age of patients with asymptomatic
renal cell carcinoma was greater than
that of the patients with symptomatic
renal cell carcinoma although the over
all frequency was not different. In our
series, there was a 28% frequency (5
of 18) of patients with silent renal cell
carcinomas presenting with second
prim ary neoplasms compared with
42% in the series reported by Hajdu,
Berge and Foote.3 The higher incidence
in their series may reflect the prim
ary interest in cancer at their insti
tution.
Bilateral parietal renal cell carci
noma occurring in a patient without
metastases may represent bilateral syn
chronous renal cell carcinoma or a
metastasis from one kidney to the
other. Various forms of therapy have
combined radical nephrectomy with
partial nephrectomy and bilateral
nephrectomy with in-vivo surgery.4"6
The frequency of bilateral renal cell
carcinoma in our series was 3% com
pared with 3.8% in the literature.
Survival of these patients is shorter

than for unilateral renal cell carcinoma.
This suggests that many of the tumours
in the second kidney are really meta
static and that the outcome of the dis
ease depends on the aggressiveness of
the primary tumour.
In conclusion, we found a fourfold
increase in the frequency of syn
chronous primary malignant tumours
in a series of 166 patients who under
went operation for primary renal cell
carcinoma. This suggests that patients
with renal cell carcinoma are more
susceptible to other tumours and there
is need to distinguish multiple primary
malignant tumours from metastatic dis
ease in these patients. The finding of a
primary malignant neoplasm in associ
ation with a renal cell carcinoma is
im portant in that the treatment of the
renal cell carcinoma may have to be
altered depending on the type and
stage of the associated tumour.
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BOOK REVIEWS
ANATOMY. Regional and Applied. 6th
ed. R.J. Last. 598 pp. Illust. Churchill
Livingstone, Edinburgh; Longman Can
ada Limited, Don Mills, Ont., 1978.
$35, paperbound. ISN 0-443-01317-9.

More than 25 years ago I was retaught
anatomy by Last at the Royal College of
Surgeons in London. The first edition of
his book was not published until 1954;
had it been available earlier it would
surely have increased the pass rate of the
primary fellowship examination from the
miserable 18% that then obtained.
602

In the preface to his first edition Last
emphasized that his book was intended to
be read with appropriate bones and prosected parts or museum specimens avail
able for constant reference, and that the
material covered was that which should
occupy a place in the knowledge and un
derstanding of the student or general
practitioner; details having neither prac
tical application nor value in illustrating
general principles were excluded. This is
still true in the present edition, which has
larger pages and two columns of type.
As a result there are approximately 300
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fewer pages than in the previous edition,
although over 50 new figures are in
cluded. Another change is that the ex
cellent colour drawings have all been
grouped together at the beginning of the
book.
The first section, some 50 pages long,
deals in the basics of tissues and struc
tures encountered during studies of gross
anatomy and the general arrangement of
the nervous system (including the auto
nomic system), together with a useful
description of the arrangement of the
spinal centres for joint movements in
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limbs. The section continues with a
description of early embryology and ends
with details of some special features of
the newborn as opposed to the adult.
Five separate sections, the real meat of
the book, are devoted to the regional
anatomy of the upper limb, lower limb,
thorax, abdomen and pelvis, and head
and neck. Also included is an 80-page
section on the central nervous system,
cranial nerves and osteology of the skull.
This book is not really written for
students commencing the study of an
atomy, althoughj it should be of great
value to them as their studies progress,
rather it is one of the best books on
general anatomy for surgical residents
who, often quite rightly, feel that their
knowledge of anatomy is lacking.
The writing style makes the text easy
to read, generating and sustaining in
terest. One of the most fascinating fea
tures is the frequency with which more or
less well-known human anatomical facts
are lifted to an entirely new plane of
interest by an explanation or discussion,
or both, of their importance, derived from
the author’s wide experience of functional
anatomy.
The section on the central nervous sys
tem is perhaps of less value, containing
numerous errors, but overall the book is
an excellent one which both undergradu
ate and postgraduate students cannot fail
to read without enhancing their appre
ciation and understanding of anatomy.

correctly only with a thorough knowledge
of basic anatomy, the ultrastructure of
capillary endothelium and the physiology
and pharmacology of blood tissue bar
riers, all of which are contained in this
book. These descriptions are accompanied
by electromicroscopy studies and his
tology, which serve as an introduction to
chapters dealing with the fundamentals of
interpretation of the normal and abnormal
angiogram. The authors acknowledge the
difficulty in distinguishing and separating
some of the abnormal findings from
normal variations, which is a problem
that may eventually be resolved when
more evidence from different sources and
larger series becomes available. Every
effort is made to train the reader to
become a more critical observer and to
develop finesse in interpretation. The
conjunctiva, sclera and cornea are re
viewed, but as these structures are readily
accessible to direct observation, fluor
escein photography has provided little new
information. The remaining half of the
book describes abnormalities of the iris.
Congenital, dystrophic and degenerative
lesions are considered with introductory
comments on the embryology of the iris.
A chapter on intraocular inflammation
also describes the mechanisms of inflam
mation. Fluorescein photography can
help differentiate a large iris granuloma
from a cystic lesion and from a melanoma.
Rubeosis iridis and diabetic microangio
pathy are considered separately accom
panied by comments on the pathogen
esis. Rubeosis iridis is a serious complica
tion of numerous diseases and can be
detected by iris angiography before ab
normal vessels are visible by biomicro
scopy. Even in darkly pigmented eyes,
the technique will detect early rubeosis
because a vascular growth is superficial
to the iris stroma. Serial photography can
be used to follow the response of iris neo
vascularization to treatment of the retina
by panretinal photocoagulation and it has
been shown that the apparent involution
of rubeosis is no more than a reduction
in the size of neovascular channels. In
diabetes, fluorescein photography is of
little help in' distinguishing conjunctival
signs from normal variations in the vas
culature. One chapter describes the mani
festations of occlusive disease of vessels
that do not directly supply the anterior
segment and another covers anterior seg
ment necrosis. In the differential diag
nosis of space-occupying lesions of the
iris, fluorescein angiography plays an im
portant but still controversial role in the
evaluation of type, size and extension.
The technique offers some guidelines to
assist in the evaluation and therapeutic
approach to iris tumours, but, as in other
tests, there are borderline cases, and
frankly misleading interpretations can
occur. Soon after the introduction of iris
angiography, the technique was applied to
investigate glaucoma. The chapter on
this subject provides a thorough and ob
jective reappraisal which is required to
clear up misconceptions. To date, no re
liable conclusions can be drawn from ob
servations confined to the anterior ciliary
and perilimbal vascular systems. Interest

J.D.W. T omlinson , ma , m b , b chir (camb)
Professor of anatomy,
Memorial University of Newfoundland,
St. John’s, Nfld.
ANTERIOR SEGMENT FLUORESCEIN
ANGIOGRAPHY. Michael H. Kottow.
270 pp. IUust. The Williams & Wilkins
Company, Baltimore; Burns & MacEachern Limited, Don Mills, Ont.,
1978. $46. ISBN 0-683-04757-4.

Since the initial description of anterior
segment fluorescein photography: in 1968,
the technique has slowly become estab
lished as a diagnostic and research aid.
Many readers will be familiar with the
fundus camera and the technique of in
vestigating retinal disease by fluorescein
angiography. While it is possible to use
the fundus camera to investigate the an
terior segment, the optical system is not
ideal as it was designed for the concavity
of the retinal plane rather than the iris,
which is a planoconvex structure. Less
sophisticated imaging systems provide
better results and allow a choice of equip
ment, much of which can be assembled
or adapted from parts already present in
a photographic department. The photo
graphic technique and equipment are well
reviewed in this book and the successful
methods are illustrated by numerous
photographs taken by the author and
others. Unfortunately the author does not
describe the equipment he currently uses.
Fluorescein angiography provides informa
tion on the anatomic integrity and physio
logic behaviour of normal and diseased
small vessels which can ba interpreted
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ingly, there is a surprisingly high fre
quency of neovascularization in pseudo
exfoliation with or without glaucoma
which is undetected by biomicroscopy.
Miotics cause hyperemia of the anterior
segment and increased permeability, which
is important when interpreting underlying
disease in a patient who is receiving
miotic therapy for glaucoma. Anterior
segment involvement is found in some
chorioretinal diseases. In retinal pigment
dystrophy, an increased permeability of
retinal capillaries has sometimes been
shown by fluorescein angiography, and it
has recently been discovered that many of
these patients also show peripupillary
leakage.
On the whole, anterior segment fluor
escein photography has provided a rather
limited amount of reliable diagnostic in
formation, but there are many findings
that have contributed to our understand
ing of disease principally located in other
parts of the eye. The technique is not
quantitative, and as a pharmacologic
marker, will probably be superseded by
fluorophotometry.
I enjoyed reading this book which will
of course be most valuable to physicians
who interpret fluorescein angiograms. It
is sufficiently well written to be enjoyed
by all ophthalmologists.
I an S. B egg , m b , ch b , frcs (ed in )
FRCS[C]

Department of ophthalmology,
University of British Columbia,
Vancouver, BC
BONE TUMORS. General Aspects and
Data on 6,221 Cases. 3rd ed. David C.
Dahlin. 445 pp. Illust. Charles C
Thomas, Publisher, Springfield, IL,
1978. $32.75. ISBN 0-398-03692-6.

The third edition of Dahlin’s book on
bone tumours is of the same high quality
as previous editions. It pretends neither
to be an exhaustive treatise on the sub
ject nor to compile all data available in
the literature. It is a useful and practical
book for the general pathologist and the
orthopedic surgeon, as well as for their
resident physicians, because it represents
a complete although brief, and thus prac
tical, reference of all the common
tumours of bone and their important re
lated conditions, based on a study of
6221 cases at the Mayo Clinic. It also con
tains both pertinent classic and recent
references. Dahlin has kept his traditional
format which is didactic, easy to read and
follows a logical sequence, adhering to
the classification based on that proposed
by Lichtenstein in 1951. He has also
added several chapters to describe condi
tions that within the past 10 years have
been accepted as specific entities or have
been reclassified. Among these are benign
and malignant fibrous histiocytoma, de
differentiated and clear cell chondro
sarcoma, low-grade intramedullary osteo
sarcoma, hemangiosarcoma and heman
giopericytoma. Dahlin has expanded the
discussions on cysts of bone and on
odontogenic and related tumours. At the
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end of the book he considers those con
ditions that simulate neoplasms or whose
pathogenesis is not yet clear.
There is no description of synoviomas,
the chapter on vascular tumours is rather
brief and incomplete as are the descrip
tions of synovial chondromatosis and
small extraosseous cartilagenous tumours
of the hand and foot. Clinical descriptions
are kept to a minimum, with good reason,
and the emphasis throughout the book is
laid on the radiologic (gross) and micro
scopic descriptions, which are supported
by an excellent series of photographs illus
trating the characteristic radiologic ap
pearances and the microscopic criteria
used for diagnosis. The latter are based on
the study of satisfactory specimens, often
reassessed retrospectively. This correlation
of radiologic appearance and microscopic
criteria emphasizes the indispensable con
certed effort needed between radiologist,
pathologist and surgeon to diagnose and
treat neoplasms of bone adequately. Little
detail is given in discussions of the
similarities and differential diagnosis
among the various neoplasms.
The introduction contains useful tables
depicting the skeletal distribution of
various tumours, where one can see, at a
glance, the comparative incidence of a
specific neoplasm in various bones, and
emphasizing the relative immunity of
some bones to certain tumours or the
predilection of the latter for some bones.
A similar table indicates the preference
of tumours for certain bones at a given
age.
After discussing the diagnostic intrica
cies of the neoplasms the author includes
in every chapter a brief but up-to-date
comment on the methods of treatment ac
cepted at the Mayo Clinic with reference
to long-term follow-up in many of the
cases, an advantage encountered in a
largo referral centre in spite of the intro
duction of “a possible selection factor of
questionable significance” as he puts it.
The author’s emphasis is on routine
histologic methods of diagnosis available
in any general hospital. Cumbersome tech
niques and special stains are not con
sidered useful in most cases and electronmicroscopic descriptions are not included.
In summary, this is a very useful, brief
and well-illustrated reference book that
belongs on the bookshelf of any physician
faced with the problems of diagnosing
and treating bone tumours.
M. O rizaga,

md , f r c p [c ]

Pathologist,
Ottawa Civic Hospital,
Ottawa, Ont.

COLOR ATLAS OF GYNECOLOGICAL
SURGERY. Volume 2: Abdominal
Operations for Benign Conditions.
Davis H. Lees and Albert Singer. 288
pp. Illust. Year Book Medical Pub
lishers, Inc., Chicago, 1978. Price not
stated. ISBN 0-8151-5352-X.

This book is the second in the series of
atlases which, the authors state, are to
604

provide detailed instruction in the tech
niques of standard gynecologic operations.
They also state in the introduction that
there is probably no substitute for the
type of personal tuition provided by a
teacher and pupil working together in the
operating room as surgeon and assistant
with knowledge and experience being
passed on directly.
How true this statement is. Although
this volume sets out to take the reader
through 11 gynecologic operations in great
detail, I do not think that it can sub
stitute for first-hand experience gained in
the operating room. The first chapter on
surgical anatomy and instruments deals
with the exposure of the ureter, the blood
supply and venous drainage of the pelvis
and some of the more common instru
ments used in gynecologic surgery. Taken
for granted is the reader’s knowledge of
the rest of the pelvic anatomy. The
second chapter deals with opening and
closing of the abdomen and quite rightly
points out the objections to the standard
vertical low abdominal incision. The
main advantages of the low transverse
(Pfannenstiel) incision, which is becoming
widely used, are also detailed. More than
half the book focuses on abdominal hys
terectomy, with modifications of the basic
hysterectomy technique in cases involving
a broad ligament fibroid, cervical fibroid,
pelvic endometriosis, chronic pelvic in
flammatory disease and accompanying
vaginal vault prolapse. Also included is a
description of subtotal hysterectomy and
removal of a cervical stump; many of the
colour photographs in this chapter are
repeated because the basic technique for
hysterectomy is the same. The chapter
does, however, point out a fundamental
surgical principle that when chronic
pelvic inflammatory disease or severe
endometriosis is present, the ureters must
be delineated.
The remaining chapters outline the
steps taken in myomectomy, ovarian cys
tectomy with reconstruction of the ovary,
salpingoophorectomy and tubal ligation.
There is an excellent chapter on con
servative pelvic surgery for the treatment
of endometriosis, which includes the tech
nique of ventrosuspension of the uterus.
There is also a chapter on laparotomy for
acute pelvic inflammatory disease. One
wonders why the pelvic abscess was not
drained vaginally in this case. The closing
chapters of the book deal with appendec
tomy, laparoscopic tubal ligation, cystourethropexy, drainage of wound hema
tomas and abdominal closure of pelvic
fistulas.
Presumably this publication is intended
as a teaching aid to the novice gyne
cologic surgeon. If so, I am not sure
that it fulfils this role. Although the illus
trations are in vivid colour, many of them
are very close-up making identification of
adjacent structures difficult. The text is
clear and informative and correctly in
forms the reader that there are different
techniques for performing the same
procedure. I believe that this set of
atlases might be a useful addition to a
library of standard gynecologic texts, but
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they are not a substitute for the teaching
of gynecologic surgery, which belongs in
the operating room.
J osef Z. Scott , m b , ch b , frcs [c]

Department of obstetrics and gynecology,
University of Alberta,
Edmonton, Alta.

COMPREHENSIVE
ARTHROSCOPIC
EXAMINATION OF THE KNEE.
Lanny L. Johnson. 156 pp. Illust. The
C.V. Mosby Company, Saint Louis,
1977. $51.25. ISBN 0-8016-2534-3.

There is little doubt that arthroscopic
examination has added much to our
knowledge of the disease processes that
afflict joints. Much has been written
over the past decade describing in detail
not only the practical considerations of
arthroscopy and its instrumentation, but
also pathologic entities and their vari
ations from the “intra-articular” point of
view. With this publication, the author
joins the ranks of those who have added
to the general knowledge of this subject
by sharing with us their personal experi
ences.
This book is one man’s experience with
one type of arthroscope and a rigid
arthroscopic technique. The arthroscope
used is the Needlescope and the procedure
is performed under local anesthesia with
the use of a tourniquet. This is done,
according to the author, in order to
eliminate the larger bore scopes which
require single stitch closure, elaborate
irrigation systems and the use of general
anesthesia. Although his particular tech
nique has merit in that posteromedial and
posterolateral views can be directly ob
tained, the author, in his introductory
chapters, unjustly criticizes the wellestablished techniques. Those readers who
have effectively used the Watanabe, Wolfe
or Storz arthroscopes with irrigation
techniques will realize that, in practice,
statements such as “ . . . the knee, includ
ing its anterior chambers, could be better
visualized by arthrotomy in less time and
with a less elaborate set-up than with a
large diameter endoscope . . .” have no
merit.
Apart from chapters dealing with the
author’s technique of arthroscopy, the re
mainder of the text is generally sound but
offers no new material. The author has,
however, because of his preoccupation
with the “no general anesthetic” ap
proach, omitted a very important part of
the overall clinical examination of the
knee — the examination of ligamentus lax
ity which only a general anesthetic can
afford. Further, his views of the ill effects
of subtotal meniscectomies versus the lack
of degenerative changes in a 10-year
follow-up of complete meniscectomies
are questionable.
R.B. D zioba ,

md

Division of orthopedics,
Toronto Western Hospital,
Toronto, Ont.
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for all those who perform hip surgery.
The presentations are divided into three
sections, which deal with femoral neck
fractures, deep wound infections follow
ing total hip arthroplasty and areas of
special interest.
Fractures of the femoral neck continue
to be designated by some as the “un
solved fractures”. Although much has
been done in the past to change this label
to “solvable fractures”, the authors’ re
views clearly demonstrate that even with
an improved armamentarium, the inci
dence of poor results following treatment
of these fractures has remained at 20%.
Failure of initial reduction, poor choice
of internal fixation and late segmental
collapse all play a role in the prognosis.
Perhaps the solution lies in a better un
derstanding of the pathologic features and
in the realization that femoral neck frac
ture differ from one another just as the
patients who present with this problem
differ. Far too often, the fractured hip is
treated in the emergency department by
house staff with varied abilities and skills
and its pathologic features are never
clearly delineated.
A new approach to the unsolved frac
ture is that of Meyers who describes the
treatment of displaced femoral neck frac
tures with internal fixation and muscle
pedicle grafting. In his series of 116 frac
tured hips, he was able to increase the
rate of union from 85% to 93% and to
reduce the frequency of late segmental
collapse from 25% to 8.5% with this
method of treatment. I would agree with
Ferguson that this success should be
ascribed to bony buttressing of the
posterior femoral neck defect rather than
to an improved blood supply as a result
of muscle transplantation. Perhaps in
future Hip Society meetings, a paper will
be presented comparing the use of the
posterior muscle pedicle grafting with
simple bone grafting to the comminuted
posterior wall of the femoral neck so
often found in displaced fractures.
Sepsis, early or late, has always been of
great concern to those involved in total
hip replacement and in this area Nelson’s
contribution is substantial. In his paper
on operating room environment and deep
wound infection, he compares the fre
quency of sepsis under five different
categories. His results are well presented
and cannot be disregarded. The infection
rates cited in his paper are as follows:
1. No clean air — no antibiotics, 5.8%.
2. No clean air — antibiotics preoperatively, 1.3%.
3. Clean air — no antibiotics, 0.7%.
4. Clean air — antibiotics preoperatively, 0.6%.
5. Ultraviolet light in operating room
— antibiotics, 1.0%.
These results speak for themselves and
are of value to the orthopedic surgeon.
Among the excellent papers included in
this book is one by Hunter and Dandy
on the diagnosis and natural history of the
infected total hip. This work should be
read and re-read by all since it collates
experience collected from across Canada.
The conclusions reached are indeed

CURRENT TECHNIQUES IN OPER
ATIVE NEUROSURGERY. Edited by
Henry H. Schmidek and William H.
Sweet. 517 pp. Illust. Grune & Stratton
Inc., New York; Longman Canada
Limited, Don Mills, Ont., 1977. $81.25.
ISBN 0-8089-1026-4.

The contents of this book represent the
papers delivered to a neurosurgical post
graduate course in Philadelphia in late
1976. It is questionable whether the
market place can absorb the increasing
number of publications of proceedings of
diverse postgraduate specialty courses.
While some refresher programs are
theme-oriented many, especially those
productions of larger neurosurgical units,
are not. Furthermore, if the actual lecture
had some cohesion, it is not always main
tained in the published proceedings. Such
seems to be the case in this text.
The 33 chapters cover such diverse
topics as peripheral nerve surgery, elec
trothermocoagulation of spinal nerve
trunks, stereotactic biopsy of deep intra
cranial tumours and thrombosis of carotid
cavernous fistulas. To be fair, the spine
and its contents are apparently the major
topic under discussion, for over one
third of the papers are on various aspects
of exposure of the bony spinal column,
entry, fusion and spinal cord surgery for
dysraphic states and neurophysiologic
ablation.
Closer examination of individual chap
ters reveals that over 40% of the papers
can be found in almost identical form in
other journals or texts published in the
few years before the release of this book.
Admittedly the emphasis may have
changed in the current presentation to
meet the “see and do” theme implied in
the book’s title, but the reader is left
with the feeling that he has read it all
before.
Notwithstanding the excellence of the
art work generally and a few original and
polished papers (for example the Cana
dian contributions), I shall save the
rather substantial purchase price to main
tain my subscriptions to journals in which
surgical technique and results first
appear.
R.P. H um phreys ,

md , frcs [c]

Division of neurosurgery,
The Hospital for Sick Children,
Toronto, Ont.
THE HIP. Proceedings of the Fifth Open
Scientific Meeting of The Hip Society,
1977. 291 pp. Illust. The C.V. Mosby
Company, Saint Louis, 1977. $39.25.
ISBN 0-8016-0038-3.

Perhaps the commonest surgical proce
dures performed by orthopedic surgeons
in North America are those that deal with
trauma or diseases affecting the hip joint.
To this end, The Hip Society, founded in
1968, continues to publish the proceed
ings of its scientific meeting in book
form for the benefit of the orthopedic
community. This, their latest offering,
can be recommended as excellent reading
VOLUME 22, NO. 6, NOVEMBER 1979
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sobering. The authors, for example, can
not support the idea “that a second total
hip prosthesis should be inserted follow
ing deep infection of the first implant”
no matter how long the sepsis free period
is.
Included in the section for special
interest articles is a paper dealing with
the modern concept of surface replace
ment arthroplasty for the arthritic hip.
The THARIES (Total Hip Articular Re
placement by Internally Eccentric Shells)
arthroplasty warrants close attention and
further study. However, one major
criticism of the whole concept is that
pertaining to the surgical procedure itself.
The authors describe in detail the surgical
exposure which, of necessity, must prod
uce an avascular femoral head. The cap
sule is circumferentially released after
osteotomy of the greater trochanter and
the ligamentum teres is sectioned to per
mit dislocation of the hip. Following
special reaming, the femoral head is
covered or capped with a cemented metal
femoral cup. The longest follow-up in this
study is 16 months, well within the time
period when avascular necrosis and sub
sequent late segmental collapse may be
expected. In this situation avascular
necrosis is difficult to diagnose because
the femoral head is now well hidden
under the metal cap and cannot be
evaluated radiologically. A longer follow
up period is therefore mandatory before
this new approach can be included in the
armentarium of hip surgeons.
Finally, it should be re-emphasized
that this publication is of excellent calibre
and is recommended for practising ortho
pedic surgeons, whether or not they are
stimulated by new and exciting research.
R.B. D zioba ,

md

Division of orthopedics,
Toronto Western Hospital,
Toronto, Ont.
HLA AND DISEASE. Edited by Jean
Dausset and Arne Svejgaard. 316 pp.
Illust. Munksgaard International Pub
lishers Ltd., Copenhagen, 1977. Price
not stated. ISBN 87-16-02287-4.

It is virtually impossible to pick up a
medical journal these days without find
ing therein a report of an association be
tween some disease entity and specific
HLA tissue antigens. This multiauthored
book is a timely text dealing with a
complex and increasingly important area.
It was written following the first inter
national symposium on HLA and disease
held in Paris in June 1976. It does not
constitute the conference proceedings but
was stimulated by it as a state-of-the-art
summary.
The material is well organized, factual
and eminently readable. The contributors
are authorities in their field and the ma
terial is reasonably up-to-date, many of
the references being as current as 1976.
At the beginning of the text, two chap
ters are devoted to the basic immunology
of the HLA complex and the major histo
compatibility complex. Although these
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chapters provide information important to
the interpretation of the remainder of the
book, a great deal of information is
presented in abbreviated form, making
the chapters difficult to follow for those
without a knowledge of immunology and
genetics. On the other hand, presentation
of more basic and detailed information
would be inappropriate for a text of this
scope and readers are provided with re
ferences to more basic material.
In general, two approaches are em
ployed by investigators studying the rela
tionship of HLA antigens to a specific
disease entity. In population studies, the
frequency of specific HLA characters in
a group of unrelated patients with the
disease is compared with the correspond
ing frequency in a group of healthy sub
jects. In family studies, investigation is
undertaken to determine if affected re
latives share HLA haplotypes more often
than expected on the basis of general
genetic rules. Although these two types of
study would seem to be easy to perform,
many factors (race, environmental factors,
complex genetic transmission, numbers of
patients and controls studied, assessment
of negative versus positive genetic asso
ciations, effects due to combinations of
antigens, etc.) must be taken into con
sideration in attempting to establish a
relationship between HLA tissue antigens
and a specific disease entity. In several
valuable chapters, the methodology, statis
tical methods and pitfalls of such studies
are described and appropriate examples
are given.
In the main body of the text, disease
entities are discussed by organ system,
and information for HLA-disease asso
ciation is detailed. Within these chapters,
disease entities are defined, selected in
formation regarding pathogenesis is sum
marized and detailed analysis of currently
published studies is provided. Where ap
propriate, the authors comment upon the
methodologic problem encountered in
studying a particular disease.
The book ends with what are, in my
view, the most interesting chapters, name
ly, those dealing with theoretical con
siderations in the association between
HLA and disease. Possible mechanisms
are reviewed. A clinical “identikit” of a
typical HLA associated disease is de
scribed and discussed (unknown physiopathogenicity, no known agent, very often
hereditary but weak penetrance, not simple
Mendelian segregation, many immuno
logic abnormalities, subacute or chronic
course, weak or no effect on reproduc
tion). Finally, future directions in this
exciting area of research are addressed.
This review is timely, well organized,
factual and readable. It is of limited
value to the average clinician but is
essential to the investigator in this area
of study. I would recommend this text
as a reference volume in hospital libraries.

SURGERY OF THE ESOPHAGUS. R.W.
Postlethwait and Will C. Sealy. 616 pp.
Illust. Appleton-Century-Crofts, New
York, 1979. Price not stated. ISBN
0-8385-8714-3.

This book is a completely revised version
of a similarly titled text published more
than 15 years ago. As the title suggests it
is a surgical treatise on congenital and
acquired diseases of the esophagus.
The text is well written and reflects
the authors’ extensive experience with
esophageal surgery. Each chapter begins
with a complete historical background
and covers the diagnosis and therapy of
the particular condition. The roentgeno
grams used in the text and their repro
duction are particularly good. The black
and white line drawings and illustrations
of various surgical procedures are ex
cellent. The bibliography at the end of
each chapter reflects the tremendous in
crease in the literature on surgical dis
eases of the esophagus.
The chapter on squamous cell carcinoma
of the esophagus is comprehensive and is
further evidence of the wide clinical ex
perience with this disease at Duke Uni
versity. Epidemiologic features are dealt
with in great detail and are followed by
the various therapeutic options for treat
ing carcinoma of the esophagus today.
The authors recommend a highly selective
surgical approach as providing the only
possibility of cure. They support this con
cept with carefully analysed life-table
survival curves. Useful methods of palli
ation are also presented.
There is excellent coverage of chemical
burns of the esophagus with a complete
update on etiology and pathogenesis. This
leads naturally into the intelligent inves
tigation and therapy of this difficult
problem. Controversial methods of man
agement are well presented and the
authors’ personal practices are stressed.
The organization of the text is some
what unusual in that short chapters on
anatomy and physiology are placed at the
end of the book. The major advances in
esophageal diseases in the past 15 years
have been related to the tremendous
progress in manometric and motility
studies of esophageal disorders and the
advent of fiberoptic esophagoscopy. There
have also been many new developments
in the area of noninvasive assessment of
gastroesophageal reflux which are only
briefly mentioned. The careful documen
tation of physiologic disorders of the
esophagus could have received more em
phasis. There is little discussion of recent
advances in hyperalimentation for the
metabolic and immunologic defects of
prolonged starvation seen so commonly in
patients with obstructive lesions of the
esophagus.
This textbook will be of greatest value
to surgeons and surgical residents who
are called upon to treat diseases of the
esophagus.
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